Name	Gene(s)	Protein change	Condition(s)	Clinical significance (Last reviewed)	Review status	Accession	GRCh37Chromosome	GRCh37Location	GRCh38Chromosome	GRCh38Location	VariationID	AlleleID(s)	dbSNP ID	Canonical SPDI	
NM_000518.5(HBB):c.*132+221G>A	LOC107133510|LOC110006319|HBB		not specified	Benign	criteria provided, single submitter	VCV000256343	11	5246475	11	5225245	256343	254200	rs112988270	NC_000011.10:5225244:C:T
NM_000518.5(HBB):c.*132+184A>C	HBB|LOC107133510|LOC110006319		not specified	Benign	criteria provided, single submitter	VCV000256342	11	5246512	11	5225282	256342	254201	rs7110263	NC_000011.10:5225281:T:G
NC_000011.10:g.5225302A>G	HBB|LOC107133510|LOC110006319		not provided	Benign(Last reviewed: Dec 31, 2019)	criteria provided, single submitter	VCV000703525	11	5246532	11	5225302	703525	695521	rs570662275	NC_000011.10:5225301:A:G
NC_000011.10:g.5225352T>C	HBB|LOC107133510|LOC110006319		not provided	Likely benign(Last reviewed: Dec 31, 2019)	criteria provided, single submitter	VCV000704388	11	5246582	11	5225352	704388	695522	rs111465890	NC_000011.10:5225351:T:C
NM_000518.5(HBB):c.*132+101G>C	HBB|LOC107133510|LOC110006319		beta Thalassemia|not specified|not provided	Benign(Last reviewed: Dec 31, 2019)	criteria provided, multiple submitters, no conflicts	VCV000256341	11	5246595	11	5225365	256341	254202	rs12788013	NC_000011.10:5225364:C:G
NM_000518.5(HBB):c.*132+99T>C	HBB|LOC107133510|LOC110006319		not specified	Likely benign	criteria provided, single submitter	VCV000256340	11	5246597	11	5225367	256340	254203	rs567259408	NC_000011.10:5225366:A:G
NC_000011.10:g.5225416C>T	HBB|LOC107133510|LOC110006319		not provided|not specified|beta Thalassemia	Benign(Last reviewed: Dec 31, 2019)	criteria provided, multiple submitters, no conflicts	VCV000702013	11	5246646	11	5225416	702013	690005	rs113969885	NC_000011.10:5225415:C:T
NM_000518.5(HBB):c.*132+34C>A	HBB|LOC107133510|LOC110006319		beta Thalassemia	Likely benign(Last reviewed: Nov 21, 2017)	criteria provided, single submitter	VCV000549922	11	5246662	11	5225432	549922	546317	rs1277208445	NC_000011.10:5225431:G:T
NC_000011.10:g.5225438T>C	HBB|LOC107133510|LOC110006319		not provided	Uncertain significance(Last reviewed: Aug 16, 2019)	criteria provided, single submitter	VCV000801182	11	5246668	11	5225438	801182	789679	rs1589891018	NC_000011.10:5225437:T:C
NC_000011.10:g.5225460A>C	HBB|LOC107133510|LOC110006319		not provided|not specified	Conflicting interpretations of pathogenicity(Last reviewed: Dec 31, 2019)	criteria provided, conflicting interpretations	VCV000705908	11	5246690	11	5225460	705908	695523	rs560643693	NC_000011.10:5225459:A:C
NM_000518.5(HBB):c.*132C>T	HBB|LOC107133510|LOC110006319		not specified	Uncertain significance(Last reviewed: Nov 4, 2016)	criteria provided, single submitter	VCV000439130	11	5246696	11	5225466	439130	432668	rs1420779550	NC_000011.10:5225465:G:A
NM_000518.5(HBB):c.*129T>A	HBB|LOC107133510|LOC110006319		not provided	Uncertain significance(Last reviewed: Jan 8, 2019)	criteria provided, single submitter	VCV000801181	11	5246699	11	5225469	801181	789494	rs528009939	NC_000011.10:5225468:A:T
NM_000518.5(HBB):c.*115A>C	HBB|LOC107133510|LOC110006319		not provided	Uncertain significance(Last reviewed: Apr 8, 2016)	criteria provided, single submitter	VCV000495967	11	5246713	11	5225483	495967	487418	rs1554917417	NC_000011.10:5225482:T:G
NM_000518.5(HBB):c.*113A>G	HBB|LOC107133510|LOC110006319		beta Thalassemia|Beta-plus-thalassemia|Hemoglobinopathy	Pathogenic/Likely pathogenic(Last reviewed: Dec 18, 2017)	criteria provided, multiple submitters, no conflicts	VCV000015473	11	5246715	11	5225485	15473	30512	rs33985472	NC_000011.10:5225484:T:C
NM_000518.5(HBB):c.*112A>G	HBB|LOC107133510|LOC110006319		Beta-plus-thalassemia	Pathogenic(Last reviewed: Jul 20, 2016)	no assertion criteria provided	VCV000015476	11	5246716	11	5225486	15476	30515	rs63750954	NC_000011.10:5225485:T:C
NM_000518.5(HBB):c.*111A>G	HBB|LOC107133510|LOC110006319		beta Thalassemia|Beta-plus-thalassemia|Hemoglobinopathy|not provided	Pathogenic(Last reviewed: Aug 22, 2019)	criteria provided, multiple submitters, no conflicts	VCV000015488	11	5246717	11	5225487	15488	30527	rs63751128	NC_000011.10:5225486:T:C
NM_000518.5(HBB):c.*110T>C	HBB|LOC107133510|LOC110006319		not provided|Hb SS disease|beta Thalassemia|Beta-plus-thalassemia|not specified	Pathogenic(Last reviewed: Mar 5, 2020)	criteria provided, multiple submitters, no conflicts	VCV000036332	11	5246718	11	5225488	36332	44996	rs33978907	NC_000011.10:5225487:A:G
NM_000518.5(HBB):c.*110T>A	HBB|LOC107133510|LOC110006319		Beta-plus-thalassemia	Pathogenic(Last reviewed: Aug 1, 2004)	no assertion criteria provided	VCV000015616	11	5246718	11	5225488	15616	30655	rs33978907	NC_000011.10:5225487:A:T
NM_000518.5(HBB):c.*108A>G	HBB|LOC107133510|LOC110006319		beta Thalassemia	Pathogenic(Last reviewed: Nov 25, 2019)	no assertion criteria provided	VCV000869258	11	5246720	11	5225490	869258	857429		NC_000011.10:5225489:T:C
NM_000518.5(HBB):c.*104G>A	HBB|LOC107133510|LOC110006319		not provided|not specified	Uncertain significance(Last reviewed: Jan 2, 2019)	criteria provided, multiple submitters, no conflicts	VCV000618161	11	5246724	11	5225494	618161	609789	rs1564873881	NC_000011.10:5225493:C:T
NM_000518.5(HBB):c.*102C>T	HBB|LOC107133510|LOC110006319		not specified	Uncertain significance(Last reviewed: Apr 12, 2019)	criteria provided, single submitter	VCV000495966	11	5246726	11	5225496	495966	487419	rs1554917429	NC_000011.10:5225495:G:A
NM_000518.5(HBB):c.*97G>C	HBB|LOC107133510|LOC110006319		not specified	Uncertain significance(Last reviewed: Mar 26, 2019)	criteria provided, single submitter	VCV000811372	11	5246731	11	5225501	811372	799647	rs770911771	NC_000011.10:5225500:C:G
NM_000518.5(HBB):c.*96T>C	HBB|LOC107133510|LOC110006319		not provided|beta Thalassemia|not specified	Conflicting interpretations of pathogenicity(Last reviewed: Dec 31, 2019)	criteria provided, conflicting interpretations	VCV000036331	11	5246732	11	5225502	36331	44995	rs34029390	NC_000011.10:5225501:A:G
NM_000518.5(HBB):c.*93A>T	HBB|LOC107133510|LOC110006319		not specified|not provided	Uncertain significance(Last reviewed: Jun 25, 2019)	criteria provided, multiple submitters, no conflicts	VCV000619851	11	5246735	11	5225505	619851	611093	rs901033731	NC_000011.10:5225504:T:A
NM_000518.5(HBB):c.*91G>A	HBB|LOC107133510|LOC110006319		not specified	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000036330	11	5246737	11	5225507	36330	44994	rs193922549	NC_000011.10:5225506:C:T
NM_000518.5(HBB):c.*78T>C	HBB|LOC107133510|LOC110006319		not specified	Uncertain significance(Last reviewed: Dec 30, 2016)	criteria provided, single submitter	VCV000439780	11	5246750	11	5225520	439780	433080	rs1554917435	NC_000011.10:5225519:A:G
NM_000518.5(HBB):c.*73T>C	HBB|LOC107133510|LOC110006319		not specified	Uncertain significance(Last reviewed: Oct 30, 2017)	criteria provided, single submitter	VCV000632855	11	5246755	11	5225525	632855	621354	rs1265505530	NC_000011.10:5225524:A:G
NM_000518.5(HBB):c.*67G>T	HBB|LOC107133510|LOC110006319		not provided	Uncertain significance(Last reviewed: Jul 28, 2016)	criteria provided, single submitter	VCV000495970	11	5246761	11	5225531	495970	487305	rs1554917441	NC_000011.10:5225530:C:A
NM_000518.5(HBB):c.*65C>G	HBB|LOC107133510|LOC110006319		not specified	Uncertain significance(Last reviewed: Nov 30, 2018)	criteria provided, single submitter	VCV000632853	11	5246763	11	5225533	632853	621355	rs1490059160	NC_000011.10:5225532:G:C
NM_000518.5(HBB):c.*62A>G	HBB|LOC107133510|LOC110006319		not specified	Uncertain significance(Last reviewed: Jul 27, 2020)	criteria provided, single submitter	VCV000495969	11	5246766	11	5225536	495969	487510	rs1046868746	NC_000011.10:5225535:T:C
NM_000518.5(HBB):c.*59A>G	HBB|LOC107133510|LOC110006319		Hb SS disease|beta Thalassemia|Fetal hemoglobin quantitative trait locus 1|Hemoglobin E	Uncertain significance(Last reviewed: Apr 27, 2017)	criteria provided, single submitter	VCV000878836	11	5246769	11	5225539	878836	868119		NC_000011.10:5225538:T:C
NM_000518.5(HBB):c.*56A>G	HBB|LOC107133510|LOC110006319		not specified|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Dec 31, 2019)	criteria provided, conflicting interpretations	VCV000495968	11	5246772	11	5225542	495968	487309	rs537944366	NC_000011.10:5225541:T:C
NM_000518.5(HBB):c.*56A>T	HBB|LOC107133510|LOC110006319		beta Thalassemia|Hemoglobin E|Hb SS disease|Fetal hemoglobin quantitative trait locus 1	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000305000	11	5246772	11	5225542	305000	320911	rs537944366	NC_000011.10:5225541:T:A
NM_000518.5(HBB):c.*53C>A	HBB|LOC107133510|LOC110006319		Hemoglobin E|Hb SS disease|Fetal hemoglobin quantitative trait locus 1|beta Thalassemia	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000305001	11	5246775	11	5225545	305001	328030	rs886048393	NC_000011.10:5225544:G:T
NM_000518.5(HBB):c.*48T>C	HBB|LOC107133510|LOC110006319		not specified	Uncertain significance(Last reviewed: Oct 4, 2018)	criteria provided, single submitter	VCV000633254	11	5246780	11	5225550	633254	621356	rs759337708	NC_000011.10:5225549:A:G
NM_000518.5(HBB):c.*47C>T	HBB|LOC107133510|LOC110006319		not specified	Uncertain significance(Last reviewed: Oct 20, 2020)	criteria provided, single submitter	VCV000984451	11	5246781	11	5225551	984451	972582		NC_000011.10:5225550:G:A
NM_000518.5(HBB):c.*33G>T	HBB|LOC107133510|LOC110006319		not specified	Uncertain significance(Last reviewed: Feb 20, 2018)	criteria provided, single submitter	VCV000633252	11	5246795	11	5225565	633252	621357	rs1364427740	NC_000011.10:5225564:C:A
NM_000518.5(HBB):c.*32A>C	HBB|LOC107133510|LOC110006319		beta Thalassemia	Pathogenic(Last reviewed: Nov 25, 2019)	no assertion criteria provided	VCV000869260	11	5246796	11	5225566	869260	857431		NC_000011.10:5225565:T:G
NM_000518.5(HBB):c.*25C>G	LOC107133510|LOC110006319|HBB		not provided	Uncertain significance(Last reviewed: Oct 26, 2017)	criteria provided, single submitter	VCV000619684	11	5246803	11	5225573	619684	611094	rs755997419	NC_000011.10:5225572:G:C
NM_000518.5(HBB):c.*18C>A	HBB|LOC107133510|LOC110006319		Hb SS disease|beta Thalassemia|Fetal hemoglobin quantitative trait locus 1|Hemoglobin E	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000879417	11	5246810	11	5225580	879417	868120		NC_000011.10:5225579:G:T
NM_000518.5(HBB):c.*6C>G	HBB|LOC107133510|LOC110006319		beta Thalassemia|Hemoglobinopathy	Pathogenic(Last reviewed: Jun 6, 2018)	criteria provided, single submitter	VCV000393707	11	5246822	11	5225592	393707	380592	rs34809925	NC_000011.10:5225591:G:C
NM_000518.5(HBB):c.441C>G (p.His147Gln)	HBB|LOC107133510|LOC110006319	H146Q, H147Q	HEMOGLOBIN KODAIRA II	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015601	11	5246831	11	5225601	15601	30640	rs33985739	NC_000011.10:5225600:G:C
NM_000518.5(HBB):c.441C>A (p.His147Gln)	HBB|LOC107133510|LOC110006319	H146Q, H147Q	HEMOGLOBIN KODAIRA	other(Last reviewed: Jul 20, 2016)	no assertion criteria provided	VCV000015498	11	5246831	11	5225601	15498	30537	rs33985739	NC_000011.10:5225600:G:T
NM_000518.4(HBB):c.440A>C (p.His147Pro)	HBB|LOC107133510|LOC110006319	H146P, H147P	HEMOGLOBIN YORK|Erythrocytosis 6, familial	Pathogenic, other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015395	11	5246832	11	5225602	15395	30434	rs33954264	NC_000011.10:5225601:T:G
NM_000518.4(HBB):c.440A>T (p.His147Leu)	HBB|LOC107133510|LOC110006319	H146L, H147L	HEMOGLOBIN COWTOWN|Erythrocytosis 6, familial	Pathogenic, other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015144	11	5246832	11	5225602	15144	30183	rs33954264	NC_000011.10:5225601:T:A
NM_000518.4(HBB):c.440A>G (p.His147Arg)	HBB|LOC107133510|LOC110006319	H146R, H147R	HEMOGLOBIN COCHIN-PORT ROYAL	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015139	11	5246832	11	5225602	15139	30178	rs33954264	NC_000011.10:5225601:T:C
NM_000518.4(HBB):c.439C>T (p.His147Tyr)	HBB|LOC107133510|LOC110006319	H146Y, H147Y	HEMOGLOBIN BOLOGNA-ST. ORSOLA	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015577	11	5246833	11	5225603	15577	30616	rs33961444	NC_000011.10:5225602:G:A
NM_000518.4(HBB):c.439C>G (p.His147Asp)	HBB|LOC107133510|LOC110006319	H146D, H147D	HEMOGLOBIN HIROSHIMA|Erythrocytosis 6, familial	Pathogenic, other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015200	11	5246833	11	5225603	15200	30239	rs33961444	NC_000011.10:5225602:G:C
NM_000518.5(HBB):c.438T>A (p.Tyr146Ter)	HBB|LOC107133510|LOC110006319	Y145*, Y146*	HEMOGLOBIN MCKEES ROCKS|Erythrocytosis 6, familial	Pathogenic, other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015265	11	5246834	11	5225604	15265	30304	rs35291591	NC_000011.10:5225603:A:T
NM_000518.5(HBB):c.437A>G (p.Tyr146Cys)	HBB|LOC107133510|LOC110006319	Y145C, Y146C	HEMOGLOBIN RAINIER|Erythrocytosis 6, familial	Pathogenic, other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015322	11	5246835	11	5225605	15322	30361	rs35117167	NC_000011.10:5225604:T:C
NM_000518.5(HBB):c.436T>A (p.Tyr146Asn)	HBB|LOC107133510|LOC110006319	Y146N	Hemoglobinopathy	Pathogenic(Last reviewed: May 30, 2018)	criteria provided, single submitter	VCV000633256	11	5246836	11	5225606	633256	621358	rs33949869	NC_000011.10:5225605:A:T
NM_000518.5(HBB):c.436T>C (p.Tyr146His)	HBB|LOC107133510|LOC110006319	Y145H, Y146H	HEMOGLOBIN BETHESDA|Erythrocytosis 6, familial	Pathogenic, other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015112	11	5246836	11	5225606	15112	30151	rs33949869	NC_000011.10:5225605:A:G
NM_000518.5(HBB):c.435G>T (p.Lys145Asn)	HBB|LOC107133510|LOC110006319	K145N	not provided	not provided	no assertion provided	VCV000156328	11	5246837	11	5225607	156328	166108	rs35020585	NC_000011.10:5225606:C:A
NM_000518.5(HBB):c.435G>C (p.Lys145Asn)	HBB|LOC107133510|LOC110006319	K145N	Erythrocytosis 6, familial|HEMOGLOBIN ANDREW-MINNEAPOLIS|not specified	Pathogenic(Last reviewed: Jan 27, 2019)	criteria provided, single submitter	VCV000015096	11	5246837	11	5225607	15096	30135	rs35020585	NC_000011.10:5225606:C:G
NM_000518.5(HBB):c.434A>T (p.Lys145Met)	HBB|LOC107133510|LOC110006319	K144M, K145M	HEMOGLOBIN BARBIZON	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015576	11	5246838	11	5225608	15576	30615	rs33996892	NC_000011.10:5225607:T:A
NM_000518.5(HBB):c.433A>T (p.Lys145Ter)	LOC110006319|HBB|LOC107133510	K145*		no interpretation for the single variant	no interpretation for the single variant	VCV000478887	11	5246839	11	5225609	478887	38409	rs33964352	NC_000011.10:5225608:T:A
NM_000518.4(HBB):c.[424C>G;433A>T]	HBB|LOC107133510|LOC110006319	K145*, L142V	HEMOGLOBIN KOCHI	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000446749	11|11	5246839	11|11	5225609	446749	38409|30656	rs33964352|rs33970699	NC_000011.10:5225608:T:A|NC_000011.10:5225617:G:C
NM_000518.4(HBB):c.433A>G (p.Lys145Glu)	HBB|LOC107133510|LOC110006319	K145E	HEMOGLOBIN MITO	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015268	11	5246839	11	5225609	15268	30307	rs33964352	NC_000011.10:5225608:T:C
NM_000518.5(HBB):c.432C>T (p.His144=)	LOC107133510|LOC110006319|HBB		not specified|not provided	Benign/Likely benign(Last reviewed: Sep 17, 2020)	criteria provided, multiple submitters, no conflicts	VCV000036329	11	5246840	11	5225610	36329	44993	rs36020563	NC_000011.10:5225609:G:A
Hb Little Rock	HBB|LOC107133510|LOC110006319	H143Q, H144Q	Erythrocytosis 6, familial	Pathogenic(Last reviewed: Jan 1, 1987)	no assertion criteria provided	VCV000015250	11	5246840	11	5225610	15250	30289		NC_000011.10:5225609:G:Y
NM_000518.5(HBB):c.431A>C (p.His144Pro)	HBB|LOC107133510|LOC110006319	H144P	Erythrocytosis 6, familial|not specified|HEMOGLOBIN SYRACUSE	Pathogenic(Last reviewed: Jun 20, 2019)	criteria provided, single submitter	VCV000015365	11	5246841	11	5225611	15365	30404	rs33918338	NC_000011.10:5225610:T:G
NM_000518.5(HBB):c.431A>G (p.His144Arg)	HBB|LOC107133510|LOC110006319	H144R	not specified|HEMOGLOBIN ABRUZZO	Pathogenic(Last reviewed: Jun 7, 2019)	criteria provided, single submitter	VCV000015090	11	5246841	11	5225611	15090	30129	rs33918338	NC_000011.10:5225610:T:C
NM_000518.4(HBB):c.430C>T (p.His144Tyr)	HBB|LOC107133510|LOC110006319	H143Y, H144Y	not specified	Benign(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015565	11	5246842	11	5225612	15565	30604	rs33929415	NC_000011.10:5225611:G:A
NM_000518.4(HBB):c.430C>G (p.His144Asp)	HBB|LOC107133510|LOC110006319	H143D, H144D	HEMOGLOBIN RANCHO MIRAGE	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015503	11	5246842	11	5225612	15503	30542	rs33929415	NC_000011.10:5225611:G:C
NM_000518.5(HBB):c.428C>T (p.Ala143Val)	HBB|LOC107133510|LOC110006319	A143V		no interpretation for the single variant	no interpretation for the single variant	VCV000478854	11	5246844	11	5225614	478854	38472	rs33921821	NC_000011.10:5225613:G:A
NM_000518.4(HBB):c.428C>A (p.Ala143Asp)	HBB|LOC107133510|LOC110006319	A143D	Erythrocytosis 6, familial|HEMOGLOBIN OHIO	Pathogenic, other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015294	11	5246844	11	5225614	15294	30333	rs33921821	NC_000011.10:5225613:G:T
NM_000518.5(HBB):c.427G>A (p.Ala143Thr)	HBB|LOC107133510|LOC110006319	A143T	not provided	Uncertain significance(Last reviewed: Nov 18, 2018)	criteria provided, single submitter	VCV000801193	11	5246845	11	5225615	801193	789495	rs33931806	NC_000011.10:5225614:C:T
NM_000518.5(HBB):c.427G>C (p.Ala143Pro)	HBB|LOC107133510|LOC110006319	A142P, A143P	HEMOGLOBIN TOYOAKE	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015376	11	5246845	11	5225615	15376	30415	rs33931806	NC_000011.10:5225614:C:G
NM_000518.5(HBB):c.425T>G (p.Leu142Arg)	HBB|LOC107133510|LOC110006319	L141R, L142R	HEMOGLOBIN OLMSTED	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015298	11	5246847	11	5225617	15298	30337	rs35854892	NC_000011.10:5225616:A:C
NM_000518.5(HBB):c.424C>G (p.Leu142Val)	HBB|LOC107133510|LOC110006319	L142V		no interpretation for the single variant	no interpretation for the single variant	VCV000478888	11	5246848	11	5225618	478888	30656	rs33970699	NC_000011.10:5225617:G:C
NM_000518.4(HBB):c.422C>T (p.Ala141Val)	HBB|LOC107133510|LOC110006319	A140V, A141V	HEMOGLOBIN PUTTELANGE	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015545	11	5246850	11	5225620	15545	30584	rs33927093	NC_000011.10:5225619:G:A
NM_000518.4(HBB):c.422C>A (p.Ala141Asp)	HBB|LOC107133510|LOC110006319	A141D	not specified|HEMOGLOBIN HIMEJI	Uncertain significance(Last reviewed: Nov 9, 2018)	criteria provided, single submitter	VCV000015197	11	5246850	11	5225620	15197	30236	rs33927093	NC_000011.10:5225619:G:T
NM_000518.5(HBB):c.421G>A (p.Ala141Thr)	HBB|LOC107133510|LOC110006319	A140T, A141T	HEMOGLOBIN SAINT JACQUES|Erythrocytosis 6, familial	Pathogenic, other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015339	11	5246851	11	5225621	15339	30378	rs34980264	NC_000011.10:5225620:C:T
NM_000518.5(HBB):c.420T>A (p.Asn140Lys)	HBB|LOC107133510|LOC110006319	N139K, N140K	HEMOGLOBIN HINSDALE	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015198	11	5246852	11	5225622	15198	30237	rs34240441	NC_000011.10:5225621:A:T
NM_000518.5(HBB):c.419A>C (p.Asn140Thr)	HBB|LOC107133510|LOC110006319	N139T, N140T	HEMOGLOBIN SAGAMI	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015573	11	5246853	11	5225623	15573	30612	rs34407387	NC_000011.10:5225622:T:G
NM_000518.4(HBB):c.418A>T (p.Asn140Tyr)	HBB|LOC107133510|LOC110006319	N139Y, N140Y	HEMOGLOBIN AURORA	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015547	11	5246854	11	5225624	15547	30586	rs33910475	NC_000011.10:5225623:T:A
NM_000518.4(HBB):c.418A>G (p.Asn140Asp)	HBB|LOC107133510|LOC110006319	N139D, N140D	HEMOGLOBIN GEELONG|HEMOGLOBIN JINAN	other(Last reviewed: Jul 20, 2016)	no assertion criteria provided	VCV000015182	11	5246854	11	5225624	15182	30221	rs33910475	NC_000011.10:5225623:T:C
NM_000518.4(HBB):c.415G>A (p.Ala139Thr)	HBB|LOC107133510|LOC110006319	A138T, A139T	HEMOGLOBIN BUZEN	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015606	11	5246857	11	5225627	15606	30645	rs33919821	NC_000011.10:5225626:C:T
NM_000518.4(HBB):c.415G>C (p.Ala139Pro)	HBB|LOC107133510|LOC110006319	A138P, A139P	HEMOGLOBIN BROCKTON	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015119	11	5246857	11	5225627	15119	30158	rs33919821	NC_000011.10:5225626:C:G
NM_000518.4(HBB):c.410G>A (p.Gly137Asp)	HBB|LOC107133510|LOC110006319	G137D	not specified|Hb SS disease|beta Thalassemia	Conflicting interpretations of pathogenicity(Last reviewed: Aug 2, 2019)	criteria provided, conflicting interpretations	VCV000015202	11	5246862	11	5225632	15202	30241	rs33949486	NC_000011.10:5225631:C:T
NM_000518.5(HBB):c.409G>C (p.Gly137Arg)	HBB|LOC107133510|LOC110006319	G136R, G137R	HEMOGLOBIN 'T LANGE LAND	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015590	11	5246863	11	5225633	15590	30629	rs33984863	NC_000011.10:5225632:C:G
NM_000518.5(HBB):c.407C>A (p.Ala136Asp)	HBB|LOC107133510|LOC110006319	A135E, A136D	HEMOGLOBIN BECKMAN	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015531	11	5246865	11	5225635	15531	30570	rs35669628	NC_000011.10:5225634:G:T
NM_000518.5(HBB):c.406G>C (p.Ala136Pro)	HBB|LOC107133510|LOC110006319	A135P, A136P	HEMOGLOBIN ALTDORF	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015095	11	5246866	11	5225636	15095	30134	rs35492035	NC_000011.10:5225635:C:G
NM_000518.4(HBB):c.404T>C (p.Val135Ala)	HBB|LOC107133510|LOC110006319	V134A, V135A	HEMOGLOBIN YAOUNDE|not specified|not provided	Uncertain significance(Last reviewed: Feb 25, 2019)	criteria provided, multiple submitters, no conflicts	VCV000015588	11	5246868	11	5225638	15588	30627	rs33966761	NC_000011.10:5225637:A:G
NM_000518.5(HBB):c.404T>A (p.Val135Glu)	HBB|LOC107133510|LOC110006319	V134E, V135E	Hemoglobinopathy	Pathogenic(Last reviewed: Jan 1, 1987)	no assertion criteria provided	VCV000015290	11	5246868	11	5225638	15290	30329	rs33966761	NC_000011.10:5225637:A:T
NM_000518.5(HBB):c.402G>A (p.Val134=)	HBB|LOC107133510|LOC110006319		not provided	Likely benign(Last reviewed: Jul 24, 2018)	criteria provided, single submitter	VCV000762836	11	5246870	11	5225640	762836	768484	rs113082294	NC_000011.10:5225639:C:T
NM_000518.5(HBB):c.402G>C (p.Val134=)	HBB|LOC107133510|LOC110006319		Fetal hemoglobin quantitative trait locus 1|beta Thalassemia|Hb SS disease|Hemoglobin E|not specified|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Dec 31, 2019)	criteria provided, conflicting interpretations	VCV000036327	11	5246870	11	5225640	36327	44991	rs113082294	NC_000011.10:5225639:C:G
NM_000518.5(HBB):c.401T>C (p.Val134Ala)	HBB|LOC107133510|LOC110006319	V133A, V134A	HEMOGLOBIN RENERT	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015585	11	5246871	11	5225641	15585	30624	rs35825479	NC_000011.10:5225640:A:G
NM_000518.5(HBB):c.400G>C (p.Val134Leu)	HBB|LOC107133510|LOC110006319	V133L, V134L	HEMOGLOBIN EXTREMADURA	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015164	11	5246872	11	5225642	15164	30203	rs34095019	NC_000011.10:5225641:C:G
NM_000518.5(HBB):c.399A>Y (p.Lys133Asn)	HBB|LOC107133510|LOC110006319	K133N	HEMOGLOBIN YAMAGATA	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015392	11	5246873	11	5225643	15392	30431	rs33946775	NC_000011.10:5225642:T:R
NM_000518.5(HBB):c.397A>T (p.Lys133Ter)	HBB|LOC107133510|LOC110006319	K133*	beta Thalassemia	Pathogenic(Last reviewed: Nov 25, 2019)	no assertion criteria provided	VCV000869314	11	5246875	11	5225645	869314	857435		NC_000011.10:5225644:T:A
NM_000518.5(HBB):c.397A>C (p.Lys133Gln)	HBB|LOC107133510|LOC110006319	K133Q	HEMOGLOBIN K (WOOLWICH)|not specified	Likely benign(Last reviewed: Mar 1, 2019)	criteria provided, multiple submitters, no conflicts	VCV000015233	11	5246875	11	5225645	15233	30272	rs33953406	NC_000011.10:5225644:T:G
NM_000518.5(HBB):c.396G>C (p.Gln132His)	HBB|LOC107133510|LOC110006319	Q131H, Q132H	HEMOGLOBIN SILVER SPRINGS	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015564	11	5246876	11	5225646	15564	30603	rs34188626	NC_000011.10:5225645:C:G
NM_000518.4(HBB):c.395A>G (p.Gln132Arg)	HBB|LOC107133510|LOC110006319	Q131R, Q132R	HEMOGLOBIN SARREBOURG	other(Last reviewed: Jul 20, 2016)	no assertion criteria provided	VCV000015523	11	5246877	11	5225647	15523	30562	rs33950778	NC_000011.10:5225646:T:C
NM_000518.4(HBB):c.395A>C (p.Gln132Pro)	HBB|LOC107133510|LOC110006319	Q131P, Q132P	HEMOGLOBIN SHANGHAI	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015348	11	5246877	11	5225647	15348	30387	rs33950778	NC_000011.10:5225646:T:G
NM_000518.5(HBB):c.394C>T (p.Gln132Ter)	HBB|LOC107133510|LOC110006319	Q132*	beta Thalassemia	Pathogenic(Last reviewed: Nov 25, 2019)	no assertion criteria provided	VCV000869311	11	5246878	11	5225648	869311	857437		NC_000011.10:5225647:G:A
NM_000518.5(HBB):c.394C>G (p.Gln132Glu)	LOC110006319|HBB|LOC107133510	Q132E	not specified	Conflicting interpretations of pathogenicity(Last reviewed: Oct 10, 2018)	criteria provided, conflicting interpretations	VCV000439160	11	5246878	11	5225648	439160	432671	rs33910209	NC_000011.10:5225647:G:C
NM_000518.5(HBB):c.394C>A (p.Gln132Lys)	HBB|LOC107133510|LOC110006319	Q132K	not provided|not specified|HEMOGLOBIN LESLIE|HEMOGLOBIN DEACONESS|HEMOGLOBIN SHELBY	Conflicting interpretations of pathogenicity(Last reviewed: Sep 23, 2018)	criteria provided, conflicting interpretations	VCV000015349	11	5246878	11	5225648	15349	30388	rs33910209	NC_000011.10:5225647:G:T
NM_000518.5(HBB):c.393T>A (p.Tyr131Ter)	HBB|LOC107133510|LOC110006319	Y131*	not provided	Pathogenic(Last reviewed: Sep 18, 2018)	criteria provided, single submitter	VCV000801192	11	5246879	11	5225649	801192	789496	rs281864530	NC_000011.10:5225648:A:T
NM_000518.5(HBB):c.392A>C (p.Tyr131Ser)	HBB|LOC107133510|LOC110006319	Y130S, Y131S	HEMOGLOBIN NEVERS	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015284	11	5246880	11	5225650	15284	30323	rs33937535	NC_000011.10:5225649:T:G
NM_000518.5(HBB):c.391T>G (p.Tyr131Asp)	HBB|LOC107133510|LOC110006319	Y130D, Y131D	HEMOGLOBIN WIEN	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015388	11	5246881	11	5225651	15388	30427	rs35834416	NC_000011.10:5225650:A:C
NM_000518.5(HBB):c.389C>T (p.Ala130Val)	HBB|LOC107133510|LOC110006319	A130V	HEMOGLOBIN LA DESIRADE|Hb SS disease|not specified|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Sep 16, 2020)	criteria provided, conflicting interpretations	VCV000015245	11	5246883	11	5225653	15245	30284	rs111645889	NC_000011.10:5225652:G:A
NM_000518.5(HBB):c.389C>A (p.Ala130Asp)	HBB|LOC107133510|LOC110006319	A129D, A130D	HEMOGLOBIN K (CAMEROON)|HEMOGLOBIN J (TAICHUNG)	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015228	11	5246883	11	5225653	15228	30267	rs111645889	NC_000011.10:5225652:G:T
NM_000518.4(HBB):c.388G>C (p.Ala130Pro)	HBB|LOC107133510|LOC110006319	A130P	HEMOGLOBIN CRETE	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015146	11	5246884	11	5225654	15146	30185	rs35939430	NC_000011.10:5225653:C:G
NM_000518.4(HBB):c.386C>T (p.Ala129Val)	HBB|LOC107133510|LOC110006319	A128V, A129V	HEMOGLOBIN SITIA	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015583	11	5246886	11	5225656	15583	30622	rs33957286	NC_000011.10:5225655:G:A
NM_000518.4(HBB):c.386C>A (p.Ala129Asp)	HBB|LOC107133510|LOC110006319	A128D, A129D	HEMOGLOBIN J (GUANTANAMO)	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015220	11	5246886	11	5225656	15220	30259	rs33957286	NC_000011.10:5225655:G:T
NM_000518.4(HBB):c.385G>C (p.Ala129Pro)	HBB|LOC107133510|LOC110006319	A129P	HEMOGLOBIN MONT SAINT-AIGNAN	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015589	11	5246887	11	5225657	15589	30628	rs34139813	NC_000011.10:5225656:C:G
NM_000518.4(HBB):c.383A>G (p.Gln128Arg)	HBB|LOC107133510|LOC110006319	Q128R	beta Thalassemia|HEMOGLOBIN DIEPPE	Pathogenic, other(Last reviewed: Nov 25, 2019)	no assertion criteria provided	VCV000015537	11	5246889	11	5225659	15537	30576	rs33910569	NC_000011.10:5225658:T:C
NM_000518.5(HBB):c.383A>C (p.Gln128Pro)	HBB|LOC107133510|LOC110006319	Q128P	Beta-Houston-thalassemia|Beta-plus-thalassemia, dominant|not specified	Pathogenic(Last reviewed: Jun 7, 2019)	criteria provided, single submitter	VCV000015409	11	5246889	11	5225659	15409	30448	rs33910569	NC_000011.10:5225658:T:G
NM_000518.4(HBB):c.382C>G (p.Gln128Glu)	HBB|LOC107133510|LOC110006319	Q127E, Q128E	HEMOGLOBIN HACETTEPE|HEMOGLOBIN COMPLUTENSE	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015186	11	5246890	11	5225660	15186	30225	rs33971634	NC_000011.10:5225659:G:C
NM_000518.4(HBB):c.382C>A (p.Gln128Lys)	HBB|LOC107133510|LOC110006319	Q127K, Q128K	HEMOGLOBIN BREST	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015115	11	5246890	11	5225660	15115	30154	rs33971634	NC_000011.10:5225659:G:T
NM_000518.5(HBB):c.380T>G (p.Val127Gly)	HBB|LOC107133510|LOC110006319	V127G	Beta thalassemia intermedia|not provided|beta Thalassemia|Hemoglobinopathy	Pathogenic/Likely pathogenic(Last reviewed: Sep 11, 2020)	criteria provided, multiple submitters, no conflicts	VCV000015483	11	5246892	11	5225662	15483	30522	rs33925391	NC_000011.10:5225661:A:C
NM_000518.5(HBB):c.380T>A (p.Val127Glu)	HBB|LOC107133510|LOC110006319	V127E	not provided|not specified|HEMOGLOBIN HOFU	Conflicting interpretations of pathogenicity(Last reviewed: Mar 14, 2019)	criteria provided, conflicting interpretations	VCV000015201	11	5246892	11	5225662	15201	30240	rs33925391	NC_000011.10:5225661:A:T
NM_000518.5(HBB):c.380T>C (p.Val127Ala)	HBB|LOC107133510|LOC110006319	V127A	not specified|HEMOGLOBIN BEIRUT	Likely benign(Last reviewed: Mar 28, 2019)	criteria provided, single submitter	VCV000015106	11	5246892	11	5225662	15106	30145	rs33925391	NC_000011.10:5225661:A:G
NM_000518.5(HBB):c.379G>C (p.Val127Leu)	HBB|LOC107133510|LOC110006319	V126L, V127L	HEMOGLOBIN MOLFETTA	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015597	11	5246893	11	5225663	15597	30636	rs35658323	NC_000011.10:5225662:C:G
NM_000518.5(HBB):c.378A>T (p.Pro126=)	HBB|LOC107133510|LOC110006319		not specified	Likely benign(Last reviewed: Feb 21, 2017)	criteria provided, single submitter	VCV000439158	11	5246894	11	5225664	439158	432673	rs1554917555	NC_000011.10:5225663:T:A
NM_000518.4(HBB):c.374C>T (p.Pro125Leu)	HBB|LOC107133510|LOC110006319	P125L	not provided|HEMOGLOBIN TENDE|not specified	Uncertain significance(Last reviewed: May 6, 2020)	criteria provided, multiple submitters, no conflicts	VCV000015569	11	5246898	11	5225668	15569	30608	rs33983276	NC_000011.10:5225667:G:A
NM_000518.4(HBB):c.374C>A (p.Pro125Gln)	HBB|LOC107133510|LOC110006319	P124Q, P125Q	HEMOGLOBIN TY GARD|Erythrocytosis 6, familial|not provided	Uncertain significance(Last reviewed: Feb 21, 2019)	criteria provided, single submitter	VCV000015380	11	5246898	11	5225668	15380	30419	rs33983276	NC_000011.10:5225667:G:T
NM_000518.4(HBB):c.374C>G (p.Pro125Arg)	HBB|LOC107133510|LOC110006319	P124R, P125R	Hemoglobinopathy|HEMOGLOBIN KHARTOUM	Likely pathogenic(Last reviewed: Dec 20, 2018)	criteria provided, single submitter	VCV000015238	11	5246898	11	5225668	15238	30277	rs33983276	NC_000011.10:5225667:G:C
NM_000518.5(HBB):c.373C>T (p.Pro125Ser)	HBB|LOC107133510|LOC110006319	P124S, P125S	HEMOGLOBIN TUNIS	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015379	11	5246899	11	5225669	15379	30418	rs35461710	NC_000011.10:5225668:G:A
NM_000518.4(HBB):c.371C>A (p.Thr124Asn)	HBB|LOC107133510|LOC110006319	T123N, T124N	HEMOGLOBIN ERNZ	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015584	11	5246901	11	5225671	15584	30623	rs33935383	NC_000011.10:5225670:G:T
NM_000518.4(HBB):c.371C>T (p.Thr124Ile)	HBB|LOC107133510|LOC110006319	T124I	HEMOGLOBIN VILLEJUIF|not specified	Uncertain significance(Last reviewed: Dec 19, 2016)	criteria provided, single submitter	VCV000015385	11	5246901	11	5225671	15385	30424	rs33935383	NC_000011.10:5225670:G:A
NM_000518.5(HBB):c.367T>C (p.Phe123Leu)	HBB|LOC107133510|LOC110006319	F123L	HEMOGLOBIN BUSHEY	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015580	11	5246905	11	5225675	15580	30619	rs33971848	NC_000011.10:5225674:A:G
NM_000518.4(HBB):c.365A>C (p.Glu122Ala)	HBB|LOC107133510|LOC110006319	E121A, E122A	HEMOGLOBIN D (NEATH)	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015534	11	5246907	11	5225677	15534	30573	rs33987957	NC_000011.10:5225676:T:G
NM_000518.4(HBB):c.365A>G (p.Glu122Gly)	HBB|LOC107133510|LOC110006319	E121G, E122G	HEMOGLOBIN ST. FRANCIS	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015501	11	5246907	11	5225677	15501	30540	rs33987957	NC_000011.10:5225676:T:C
NM_000518.4(HBB):c.365A>T (p.Glu122Val)	HBB|LOC107133510|LOC110006319	E121V, E122V	HEMOGLOBIN D (CAMPERDOWN)|HEMOGLOBIN BEOGRAD	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015110	11	5246907	11	5225677	15110	30149	rs33987957	NC_000011.10:5225676:T:A
NM_000518.4(HBB):c.[29C>A;364G>C]	LOC110006319|HBB|LOC106099062|LOC107133510	E122Q, S10Y	HEMOGLOBIN D (AGRI)	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000446745	11|11	5246908	11|11	5225678	446745	30191|30658	rs33946267|rs33918131	NC_000011.10:5225677:C:G|NC_000011.10:5226992:G:T
NM_000518.4(HBB):c.[280T>C;364G>C]	LOC110006319|HBB|LOC106099062|LOC107133510	E122Q, C94R	HEMOGLOBIN CLEVELAND	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000446740	11|11	5246908	11|11	5225678	446740	30191|30336	rs33946267|rs33972927	NC_000011.10:5225677:C:G|NC_000011.10:5226611:A:G
NM_000518.4(HBB):c.[364G>C;79G>A]	LOC110006319|HBB|LOC106099062|LOC107133510	E122Q, E27K	HEMOGLOBIN T (CAMBODIA)	other(Last reviewed: Jul 20, 2016)	no assertion criteria provided	VCV000446739	11|11	5246908	11|11	5225678	446739	30191|30200	rs33946267|rs33950507	NC_000011.10:5225677:C:G|NC_000011.10:5226942:C:T
NM_000518.4(HBB):c.[20A>T;364G>A]	LOC110006319|HBB|LOC106099062|LOC107133510	E122K, E7V	Sickle cell-Hemoglobin O Arab disease	Pathogenic(Last reviewed: Apr 1, 1999)	no assertion criteria provided	VCV000446736	11|11	5246908	11|11	5225678	446736	30331|30372	rs33946267|rs334	NC_000011.10:5225677:C:T|NC_000011.10:5227001:T:A
NM_000518.5(HBB):c.364G>T (p.Glu122Ter)	HBB|LOC107133510|LOC110006319	E122*	beta Thalassemia|Hb SS disease|Beta-thalassemia, dominant inclusion body type|not provided	Pathogenic(Last reviewed: Feb 21, 2017)	criteria provided, multiple submitters, no conflicts	VCV000015404	11	5246908	11	5225678	15404	30443	rs33946267	NC_000011.10:5225677:C:A
NM_000518.4(HBB):c.364G>A (p.Glu122Lys)	HBB|LOC107133510|LOC110006319	E122K	Sickle cell-Hemoglobin O Arab disease|not specified|not provided|HEMOGLOBIN EGYPT|HEMOGLOBIN O (ARAB)|Hb SS disease|beta Thalassemia	Pathogenic/Likely pathogenic(Last reviewed: Dec 17, 2019)	criteria provided, multiple submitters, no conflicts	VCV000015292	11	5246908	11	5225678	15292	30331	rs33946267	NC_000011.10:5225677:C:T
NM_000518.4(HBB):c.364G>C (p.Glu122Gln)	HBB|LOC107133510|LOC110006319	E122Q	Hemoglobin D disease|not specified|not provided|Hb SS disease|HBB-Related Disorders|Hemoglobin E|Hb D-Los Angeles|Fetal hemoglobin quantitative trait locus 1|beta Thalassemia	Conflicting interpretations of pathogenicity(Last reviewed: Dec 23, 2019)	criteria provided, conflicting interpretations	VCV000015152	11	5246908	11	5225678	15152	30191	rs33946267	NC_000011.10:5225677:C:G
NM_000518.5(HBB):c.363A>C (p.Lys121Asn)	HBB|LOC107133510|LOC110006319	K121N	not specified|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Jan 3, 2019)	criteria provided, conflicting interpretations	VCV000015329	11	5246909	11	5225679	15329	30368	rs34726542	NC_000011.10:5225678:T:G
NM_000518.5(HBB):c.362A>T (p.Lys121Ile)	HBB|LOC107133510|LOC110006319	K120I, K121I	HEMOGLOBIN JIANGHUA	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015229	11	5246910	11	5225680	15229	30268	rs34303736	NC_000011.10:5225679:T:A
NM_000518.4(HBB):c.361A>C (p.Lys121Gln)	HBB|LOC107133510|LOC110006319	K120Q, K121Q	HEMOGLOBIN TAKAMATSU	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015370	11	5246911	11	5225681	15370	30409	rs33924134	NC_000011.10:5225680:T:G
NM_000518.4(HBB):c.361A>G (p.Lys121Glu)	HBB|LOC107133510|LOC110006319	K120E, K121E	HEMOGLOBIN HIJIYAMA	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015195	11	5246911	11	5225681	15195	30234	rs33924134	NC_000011.10:5225680:T:C
NM_000518.4(HBB):c.[334G>C;359G>A]	HBB|LOC107133510|LOC110006319	G120D, V112L	HEMOGLOBIN FANNIN-LUBBOCK	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000446732	11|11	5246913	11|11	5225683	446732	38469|30204	rs33947020|rs33957964	NC_000011.10:5225682:C:T|NC_000011.10:5225707:C:G
NM_000518.5(HBB):c.359G>A (p.Gly120Asp)	HBB|LOC107133510|LOC110006319	G120D	not provided	Conflicting interpretations of pathogenicity(Last reviewed: Jun 20, 2019)	criteria provided, conflicting interpretations	VCV000242712	11	5246913	11	5225683	242712	38469	rs33947020	NC_000011.10:5225682:C:T
NM_000518.4(HBB):c.359G>C (p.Gly120Ala)	HBB|LOC107133510|LOC110006319	G119A, G120A	HEMOGLOBIN IOWA	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015484	11	5246913	11	5225683	15484	30523	rs33947020	NC_000011.10:5225682:C:G
NM_000518.4(HBB):c.359G>T (p.Gly120Val)	HBB|LOC107133510|LOC110006319	G119V, G120V	HEMOGLOBIN BOUGARDIREY-MALI	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015109	11	5246913	11	5225683	15109	30148	rs33947020	NC_000011.10:5225682:C:A
NM_000518.4(HBB):c.356T>G (p.Phe119Cys)	HBB|LOC107133510|LOC110006319	F118C, F119C	HEMOGLOBIN HARROW	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015574	11	5246916	11	5225686	15574	30613	rs33928092	NC_000011.10:5225685:A:C
NM_000518.4(HBB):c.356T>A (p.Phe119Tyr)	HBB|LOC107133510|LOC110006319	F118Y, F119Y	HEMOGLOBIN MINNEAPOLIS-LAOS	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015266	11	5246916	11	5225686	15266	30305	rs33928092	NC_000011.10:5225685:A:T
NM_000518.5(HBB):c.353A>G (p.His118Arg)	HBB|LOC107133510|LOC110006319	H118R	not provided	Conflicting interpretations of pathogenicity(Last reviewed: Aug 14, 2017)	criteria provided, conflicting interpretations	VCV000036324	11	5246919	11	5225689	36324	44988	rs33935673	NC_000011.10:5225688:T:C
NM_000518.5(HBB):c.351T>C (p.His117=)	HBB|LOC107133510|LOC110006319		not specified	Likely benign(Last reviewed: Jan 7, 2020)	criteria provided, single submitter	VCV000917608	11	5246921	11	5225691	917608	905926		NC_000011.10:5225690:A:G
NM_000518.5(HBB):c.351T>A (p.His117Gln)	LOC110006319|HBB|LOC107133510	H117Q	not specified	Uncertain significance(Last reviewed: Jun 20, 2017)	criteria provided, single submitter	VCV000439157	11	5246921	11	5225691	439157	432674	rs35209776	NC_000011.10:5225690:A:T
NM_000518.5(HBB):c.351T>R (p.His117Gln)	HBB|LOC107133510|LOC110006319	H117Q	HEMOGLOBIN HAFNIA	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015187	11	5246921	11	5225691	15187	30226	rs35209776	NC_000011.10:5225690:A:Y
NM_000518.5(HBB):c.350A>C (p.His117Pro)	HBB|LOC107133510|LOC110006319	H117P	HEMOGLOBIN SAITAMA	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015340	11	5246922	11	5225692	15340	30379	rs33978082	NC_000011.10:5225691:T:G
NM_000518.5(HBB):c.350A>G (p.His117Arg)	HBB|LOC107133510|LOC110006319	H117R	HEMOGLOBIN P|HEMOGLOBIN P (GALVESTON)	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015303	11	5246922	11	5225692	15303	30342	rs33978082	NC_000011.10:5225691:T:C
NM_000518.5(HBB):c.349C>T (p.His117Tyr)	HBB|LOC107133510|LOC110006319	H117Y	HEMOGLOBIN TSUKUMI	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015582	11	5246923	11	5225693	15582	30621	rs34049764	NC_000011.10:5225692:G:A
NM_000518.5(HBB):c.347C>A (p.Ala116Asp)	HBB|LOC107133510|LOC110006319	A115D, A116D	Hemoglobinopathy	Pathogenic(Last reviewed: Aug 1, 1993)	no assertion criteria provided	VCV000015526	11	5246925	11	5225695	15526	30565	rs35485099	NC_000011.10:5225694:G:T
NM_000518.5(HBB):c.346G>C (p.Ala116Pro)	HBB|LOC107133510|LOC110006319	A115P, A116P	HEMOGLOBIN MADRID	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015257	11	5246926	11	5225696	15257	30296	rs34945623	NC_000011.10:5225695:C:G
NM_000518.5(HBB):c.344T>C (p.Leu115Pro)	HBB|LOC107133510|LOC110006319	L115P	Beta-thalassemia dominant|Beta thalassemia intermedia|HEMOGLOBIN BRESCIA|HEMOGLOBIN DURHAM-N.C.|not provided	Pathogenic(Last reviewed: Feb 21, 2020)	criteria provided, multiple submitters, no conflicts	VCV000015513	11	5246928	11	5225698	15513	30552	rs36015961	NC_000011.10:5225697:A:G
NM_000518.4(HBB):c.[343C>A;359G>A]	HBB|LOC107133510|LOC110006319	L115M, G120D	HEMOGLOBIN MASUDA	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000446733	11|11	5246929	11|11	5225699	446733	30525|38469	rs33917394|rs33947020	NC_000011.10:5225698:G:T|NC_000011.10:5225682:C:T
NM_000518.5(HBB):c.343C>A (p.Leu115Met)	HBB|LOC107133510|LOC110006319	L115M	HEMOGLOBIN ZENGCHENG	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015486	11	5246929	11	5225699	15486	30525	rs33917394	NC_000011.10:5225698:G:T
NM_000518.5(HBB):c.341T>A (p.Val114Glu)	HBB|LOC107133510|LOC110006319	V113E, V114E	Hemoglobinopathy|not specified	Pathogenic(Last reviewed: Oct 14, 2019)	criteria provided, single submitter	VCV000015286	11	5246931	11	5225701	15286	30325	rs34484056	NC_000011.10:5225700:A:T
NM_000518.5(HBB):c.339T>A (p.Cys113Ter)	HBB|LOC107133510|LOC110006319	C113*	beta Thalassemia	Pathogenic(Last reviewed: Nov 25, 2019)	no assertion criteria provided	VCV000869280	11	5246933	11	5225703	869280	857443		NC_000011.10:5225702:A:T
NM_000518.4(HBB):c.338G>T (p.Cys113Phe)	HBB|LOC107133510|LOC110006319	C112F, C113F	HEMOGLOBIN CANTERBURY	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015595	11	5246934	11	5225704	15595	30634	rs33932908	NC_000011.10:5225703:C:A
NM_000518.4(HBB):c.338G>A (p.Cys113Tyr)	HBB|LOC107133510|LOC110006319	C112Y, C113Y	HEMOGLOBIN YAHATA	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015502	11	5246934	11	5225704	15502	30541	rs33932908	NC_000011.10:5225703:C:T
NM_000518.5(HBB):c.337T>C (p.Cys113Arg)	HBB|LOC107133510|LOC110006319	C112R, C113R	Heinz body anemia|HEMOGLOBIN INDIANAPOLIS	Pathogenic, other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015207	11	5246935	11	5225705	15207	30246	rs35849199	NC_000011.10:5225704:A:G
NM_000518.5(HBB):c.335T>C (p.Val112Ala)	HBB|LOC107133510|LOC110006319	V111A, V112A	HEMOGLOBIN STANMORE	other(Last reviewed: Jul 20, 2016)	no assertion criteria provided	VCV000015357	11	5246937	11	5225707	15357	30396	rs35871407	NC_000011.10:5225706:A:G
NM_000518.5(HBB):c.334G>C (p.Val112Leu)	HBB|LOC107133510|LOC110006319	V112L		no interpretation for the single variant	no interpretation for the single variant	VCV000478878	11	5246938	11	5225708	478878	30204	rs33957964	NC_000011.10:5225707:C:G
NM_000518.4(HBB):c.334G>T (p.Val112Phe)	HBB|LOC107133510|LOC110006319	V112F	HEMOGLOBIN PETERBOROUGH	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015309	11	5246938	11	5225708	15309	30348	rs33957964	NC_000011.10:5225707:C:A
NM_000518.5(HBB):c.333G>A (p.Leu111=)	HBB|LOC107133510|LOC110006319		not provided	Uncertain significance(Last reviewed: Mar 12, 2019)	criteria provided, single submitter	VCV000801191	11	5246939	11	5225709	801191	789497	rs1215164743	NC_000011.10:5225708:C:T
NM_000518.4(HBB):c.332T>C (p.Leu111Pro)	HBB|LOC107133510|LOC110006319	L111P	beta Thalassemia|Hb SS disease|not specified|HEMOGLOBIN SHOWA-YAKUSHIJI|Beta-showa-yakushiji thalassemia|Beta-plus-thalassemia	Pathogenic(Last reviewed: Apr 7, 2019)	criteria provided, multiple submitters, no conflicts	VCV000015352	11	5246940	11	5225710	15352	30391	rs35256489	NC_000011.10:5225709:A:G
NM_000518.5(HBB):c.328G>A (p.Val110Met)	HBB|LOC107133510|LOC110006319	V110M	Erythrocytosis 6, familial|not specified|beta Thalassemia|HEMOGLOBIN SAN DIEGO	Pathogenic/Likely pathogenic(Last reviewed: Mar 19, 2019)	criteria provided, multiple submitters, no conflicts	VCV000015342	11	5246944	11	5225714	15342	30381	rs33969677	NC_000011.10:5225713:C:T
NM_000518.5(HBB):c.328G>C (p.Val110Leu)	HBB|LOC107133510|LOC110006319	V109L, V110L	HEMOGLOBIN JOHNSTOWN	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015230	11	5246944	11	5225714	15230	30269	rs33969677	NC_000011.10:5225713:C:G
NM_000518.5(HBB):c.327C>T (p.Asn109=)	HBB|LOC107133510|LOC110006319		not provided	Conflicting interpretations of pathogenicity(Last reviewed: Dec 31, 2019)	criteria provided, conflicting interpretations	VCV000495997	11	5246945	11	5225715	495997	487519	rs34933751	NC_000011.10:5225714:G:A
NM_000518.5(HBB):c.327C>R (p.Asn109Lys)	HBB|LOC107133510|LOC110006319	N109K	HEMOGLOBIN PRESBYTERIAN	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015318	11	5246945	11	5225715	15318	30357	rs34933751	NC_000011.10:5225714:G:Y
NM_000518.5(HBB):c.325A>G (p.Asn109Asp)	HBB|LOC107133510|LOC110006319	N108D, N109D	HEMOGLOBIN YOSHIZUKA	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015396	11	5246947	11	5225717	15396	30435	rs33958637	NC_000011.10:5225716:T:C
NM_000518.5(HBB):c.324C>T (p.Gly108=)	HBB|LOC107133510|LOC110006319		Fetal hemoglobin quantitative trait locus 1|not provided|beta Thalassemia|Hb SS disease|Hemoglobin E|not specified	Conflicting interpretations of pathogenicity(Last reviewed: Oct 28, 2020)	criteria provided, conflicting interpretations	VCV000036322	11	5246948	11	5225718	36322	44986	rs193922562	NC_000011.10:5225717:G:A
NM_000518.5(HBB):c.323G>T (p.Gly108Val)	HBB|LOC107133510|LOC110006319	G108V	not specified	Uncertain significance(Last reviewed: Nov 5, 2018)	criteria provided, single submitter	VCV000633260	11	5246949	11	5225719	633260	621359	rs35519485	NC_000011.10:5225718:C:A
NM_000518.5(HBB):c.322G>C (p.Gly108Arg)	HBB|LOC107133510|LOC110006319	G107R, G108R	HEMOGLOBIN BURKE	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015124	11	5246950	11	5225720	15124	30163	rs35017910	NC_000011.10:5225719:C:G
NM_000518.4(HBB):c.320T>G (p.Leu107Arg)	HBB|LOC107133510|LOC110006319	L106R, L107R	HEMOGLOBIN TERRE HAUTE|Beta-plus-thalassemia	Pathogenic, other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015487	11	5246952	11	5225722	15487	30526	rs33941844	NC_000011.10:5225721:A:C
NM_000518.4(HBB):c.320T>A (p.Leu107Gln)	HBB|LOC107133510|LOC110006319	L106Q, L107Q	Methemoglobinemia, beta-globin type	Pathogenic(Last reviewed: Aug 1, 1993)	no assertion criteria provided	VCV000015378	11	5246952	11	5225722	15378	30417	rs33941844	NC_000011.10:5225721:A:T
NM_000518.4(HBB):c.320T>C (p.Leu107Pro)	HBB|LOC107133510|LOC110006319	L106P, L107P	HEMOGLOBIN SOUTHAMPTON|HEMOGLOBIN CASPER	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015356	11	5246952	11	5225722	15356	30395	rs33941844	NC_000011.10:5225721:A:G
NM_000518.5(HBB):c.319C>G (p.Leu107Val)	HBB|LOC107133510|LOC110006319	L107V	beta Thalassemia	Pathogenic(Last reviewed: Nov 25, 2019)	no assertion criteria provided	VCV000869278	11	5246953	11	5225723	869278	857444		NC_000011.10:5225722:G:C
NM_000518.5(HBB):c.316C>T (p.Leu106Phe)	HBB|LOC107133510|LOC110006319	L105F, L106F	HEMOGLOBIN SOUTH MILWAUKEE|not specified	Uncertain significance(Last reviewed: Feb 15, 2017)	criteria provided, single submitter	VCV000015480	11	5246956	11	5225726	15480	30519	rs34022507	NC_000011.10:5225725:G:A
NM_000518.5(HBB):c.316-1G>A	HBB|LOC107133510|LOC110006319		Hemoglobinopathy|beta Thalassemia|beta^0^ Thalassemia	Pathogenic/Likely pathogenic(Last reviewed: May 14, 2020)	criteria provided, multiple submitters, no conflicts	VCV000552712	11	5246957	11	5225727	552712	546034	rs33952266	NC_000011.10:5225726:C:T
NM_000518.5(HBB):c.316-1G>T	HBB|LOC107133510|LOC110006319		beta Thalassemia|not provided	Pathogenic/Likely pathogenic(Last reviewed: Aug 7, 2019)	criteria provided, multiple submitters, no conflicts	VCV000038671	11	5246957	11	5225727	38671	47276	rs33952266	NC_000011.10:5225726:C:A
NM_000518.5(HBB):c.316-1G>C	HBB|LOC107133510|LOC110006319		beta^0^ Thalassemia|beta Thalassemia	Pathogenic(Last reviewed: Nov 25, 2019)	no assertion criteria provided	VCV000015512	11	5246957	11	5225727	15512	30551	rs33952266	NC_000011.10:5225726:C:G
NM_000518.5(HBB):c.316-2A>G	HBB|LOC107133510|LOC110006319		not provided|not specified|beta Thalassemia|beta^0^ Thalassemia|Hb SS disease	Pathogenic(Last reviewed: Dec 9, 2019)	criteria provided, multiple submitters, no conflicts	VCV000021191	11	5246958	11	5225728	21191	34043	rs33914668	NC_000011.10:5225727:T:C
NM_000518.5(HBB):c.316-2A>C	HBB|LOC107133510|LOC110006319		not provided|beta^0^ Thalassemia|beta Thalassemia	Pathogenic(Last reviewed: Jun 30, 2017)	criteria provided, single submitter	VCV000021190	11	5246958	11	5225728	21190	34042	rs33914668	NC_000011.10:5225727:T:G
NM_000518.5(HBB):c.316-3C>G	HBB|LOC107133510|LOC110006319		not provided|beta^0^ Thalassemia|beta Thalassemia	Likely pathogenic(Last reviewed: Apr 27, 2018)	criteria provided, single submitter	VCV000619687	11	5246959	11	5225729	619687	611303	rs33913413	NC_000011.10:5225728:G:C
NM_000518.5(HBB):c.316-3C>A	HBB|LOC107133510|LOC110006319		not specified|not provided|Beta thalassemia intermedia|beta Thalassemia|Beta-plus-thalassemia	Pathogenic(Last reviewed: May 30, 2019)	criteria provided, multiple submitters, no conflicts	VCV000015451	11	5246959	11	5225729	15451	30490	rs33913413	NC_000011.10:5225728:G:T
NM_000518.4(HBB):c.[316-12T>C;316-7C>A]	LOC110006319|HBB|LOC107133510		beta Thalassemia	Pathogenic(Last reviewed: Mar 5, 2020)	criteria provided, single submitter	VCV000869111	11|11	5246963	11|11	5225733	869111	546448|799648	rs34483965|rs781604042	NC_000011.10:5225732:G:T|NC_000011.10:5225737:A:G
NM_000518.5(HBB):c.316-7C>A	HBB|LOC107133510|LOC110006319		beta Thalassemia|not specified|Hb SS disease	Pathogenic/Likely pathogenic(Last reviewed: Sep 27, 2018)	criteria provided, multiple submitters, no conflicts	VCV000551906	11	5246963	11	5225733	551906	546448	rs34483965	NC_000011.10:5225732:G:T
NM_000518.5(HBB):c.316-7C>G	LOC110006319|HBB|LOC107133510		not specified|beta Thalassemia	Conflicting interpretations of pathogenicity(Last reviewed: May 30, 2018)	criteria provided, conflicting interpretations	VCV000393706	11	5246963	11	5225733	393706	380593	rs34483965	NC_000011.10:5225732:G:C
NM_000518.5(HBB):c.316-8T>G	HBB|LOC107133510|LOC110006319		beta Thalassemia|Beta-plus-thalassemia	Pathogenic(Last reviewed: Nov 25, 2019)	no assertion criteria provided	VCV000015453	11	5246964	11	5225734	15453	30492	rs34793594	NC_000011.10:5225733:A:C
NM_000518.5(HBB):c.316-12T>C	LOC110006319|HBB|LOC107133510		not specified	Likely pathogenic(Last reviewed: Sep 27, 2018)	criteria provided, single submitter	VCV000810861	11	5246968	11	5225738	810861	799648	rs781604042	NC_000011.10:5225737:A:G
NM_000518.5(HBB):c.316-14T>G	HBB|LOC107133510|LOC110006319		beta Thalassemia|not provided	Pathogenic(Last reviewed: Dec 7, 2017)	criteria provided, multiple submitters, no conflicts	VCV000036313	11	5246970	11	5225740	36313	44977	rs35703285	NC_000011.10:5225739:A:C
NM_000518.5(HBB):c.316-19T>A	HBB|LOC107133510|LOC110006319		not provided	Conflicting interpretations of pathogenicity(Last reviewed: Dec 31, 2019)	criteria provided, conflicting interpretations	VCV000495993	11	5246975	11	5225745	495993	487524	rs191535077	NC_000011.10:5225744:A:T
NM_000518.5(HBB):c.316-26T>G	HBB|LOC107133510|LOC110006319		not provided	Likely benign(Last reviewed: Dec 31, 2019)	criteria provided, single submitter	VCV000754508	11	5246982	11	5225752	754508	775832	rs1589891645	NC_000011.10:5225751:A:C
NM_000518.5(HBB):c.316-27T>G	HBB|LOC107133510|LOC110006319		not specified	Uncertain significance(Last reviewed: Mar 16, 2018)	criteria provided, single submitter	VCV000633253	11	5246983	11	5225753	633253	621808	rs1280140490	NC_000011.10:5225752:A:C
NM_000518.5(HBB):c.316-28G>A	LOC110006319|LOC107133510|HBB		not specified	Likely benign(Last reviewed: Sep 25, 2018)	criteria provided, single submitter	VCV000811029	11	5246984	11	5225754	811029	799649	rs771736852	NC_000011.10:5225753:C:T
NM_000518.5(HBB):c.316-28G>C	HBB|LOC107133510|LOC110006319		not specified	Uncertain significance(Last reviewed: Sep 6, 2017)	criteria provided, single submitter	VCV000632850	11	5246984	11	5225754	632850	621809	rs771736852	NC_000011.10:5225753:C:G
NM_000518.5(HBB):c.316-30A>C	HBB|LOC107133510|LOC110006319		not specified|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Dec 31, 2019)	criteria provided, conflicting interpretations	VCV000036317	11	5246986	11	5225756	36317	44981	rs193922558	NC_000011.10:5225755:T:G
NM_000518.5(HBB):c.316-36C>T	HBB|LOC107133510|LOC110006319		not provided	Likely benign(Last reviewed: Dec 31, 2019)	criteria provided, single submitter	VCV000799593	11	5246992	11	5225762	799593	787940	rs908362696	NC_000011.10:5225761:G:A
NM_000518.5(HBB):c.316-37G>T	HBB|LOC107133510|LOC110006319		not provided|not specified	Benign/Likely benign(Last reviewed: Dec 31, 2019)	criteria provided, multiple submitters, no conflicts	VCV000036318	11	5246993	11	5225763	36318	44982	rs193922559	NC_000011.10:5225762:C:A
NM_000518.5(HBB):c.316-42C>T	HBB|LOC107133510|LOC110006319		not provided	Likely benign(Last reviewed: Dec 31, 2019)	criteria provided, single submitter	VCV000766099	11	5246998	11	5225768	766099	775693	rs761649200	NC_000011.10:5225767:G:A
NM_000518.5(HBB):c.316-45G>C	HBB|LOC107133510|LOC110006319		not specified|not provided	Benign/Likely benign(Last reviewed: Jul 2, 2020)	criteria provided, multiple submitters, no conflicts	VCV000495995	11	5247001	11	5225771	495995	487436	rs140033163	NC_000011.10:5225770:C:G
NM_000518.5(HBB):c.316-46G>A	HBB|LOC107133510|LOC110006319		not specified	Uncertain significance(Last reviewed: Aug 28, 2020)	criteria provided, single submitter	VCV000495996	11	5247002	11	5225772	495996	487526	rs1554917642	NC_000011.10:5225771:C:T
NM_000518.5(HBB):c.316-60C>T	HBB|LOC107133510|LOC110006319		not specified	Uncertain significance(Last reviewed: Jun 9, 2020)	criteria provided, single submitter	VCV000933153	11	5247016	11	5225786	933153	921506		NC_000011.10:5225785:G:A
NM_000518.5(HBB):c.316-70C>G	HBB|LOC107133510|LOC110006319		not provided|beta Thalassemia|not specified	Benign/Likely benign(Last reviewed: May 1, 2020)	criteria provided, multiple submitters, no conflicts	VCV000036320	11	5247026	11	5225796	36320	44984	rs193922560	NC_000011.10:5225795:G:C
NM_000518.5(HBB):c.316-71G>T	HBB|LOC107133510|LOC110006319		not provided	Likely benign(Last reviewed: Oct 17, 2018)	criteria provided, single submitter	VCV000793174	11	5247027	11	5225797	793174	787763	rs1589891689	NC_000011.10:5225796:C:A
NM_000518.5(HBB):c.316-81T>A	HBB|LOC107133510|LOC110006319		not specified	Uncertain significance(Last reviewed: May 10, 2019)	criteria provided, single submitter	VCV000929231	11	5247037	11	5225807	929231	917485		NC_000011.10:5225806:A:T
NM_000518.5(HBB):c.316-82G>A	HBB|LOC107133510|LOC110006319		not specified	Benign(Last reviewed: Oct 4, 2016)	criteria provided, single submitter	VCV000439777	11	5247038	11	5225808	439777	433081	rs944935116	NC_000011.10:5225807:C:T
NM_000518.5(HBB):c.316-85A>G	HBB|LOC107133510|LOC110006319		not specified	Uncertain significance(Last reviewed: Oct 15, 2020)	criteria provided, single submitter	VCV000984465	11	5247041	11	5225811	984465	972583		NC_000011.10:5225810:T:C
NM_000518.5(HBB):c.316-95C>T	HBB|LOC107133510|LOC110006319		not provided	Likely benign(Last reviewed: Dec 26, 2018)	criteria provided, single submitter	VCV000797051	11	5247051	11	5225821	797051	787750	rs1589891699	NC_000011.10:5225820:G:A
NM_000518.5(HBB):c.316-96G>A	HBB|LOC107133510|LOC110006319		not specified	Uncertain significance(Last reviewed: Mar 27, 2018)	criteria provided, single submitter	VCV000633255	11	5247052	11	5225822	633255	621810	rs193922561	NC_000011.10:5225821:C:T
NM_000518.5(HBB):c.316-96G>C	HBB|LOC107133510|LOC110006319		not specified|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Dec 31, 2019)	criteria provided, conflicting interpretations	VCV000036321	11	5247052	11	5225822	36321	44985	rs193922561	NC_000011.10:5225821:C:G
NM_000518.5(HBB):c.316-102C>A	HBB|LOC107133510|LOC110006319		not specified	Uncertain significance(Last reviewed: Nov 27, 2017)	criteria provided, single submitter	VCV000633261	11	5247058	11	5225828	633261	621811	rs1468940510	NC_000011.10:5225827:G:T
NM_000518.5(HBB):c.316-106C>G	HBB|LOC107133510|LOC110006319		alpha Thalassemia|Susceptibility to malaria|Erythrocytosis 6, familial|Heinz body anemia|Methemoglobinemia, beta-globin type|Fetal hemoglobin quantitative trait locus 1|beta Thalassemia|Beta-thalassemia, dominant inclusion body type|Hb SS disease|not provided|beta Thalassemia|not specified|Hb SS disease|Beta-plus-thalassemia	Pathogenic(Last reviewed: Dec 10, 2019)	criteria provided, multiple submitters, no conflicts	VCV000015457	11	5247062	11	5225832	15457	30496	rs34690599	NC_000011.10:5225831:G:C
NM_000518.5(HBB):c.316-107G>C	HBB|LOC107133510|LOC110006319		not specified	Uncertain significance(Last reviewed: Dec 14, 2016)	criteria provided, single submitter	VCV000439148	11	5247063	11	5225833	439148	432676	rs930802593	NC_000011.10:5225832:C:G
NM_000518.5(HBB):c.316-109C>T	HBB|LOC107133510|LOC110006319		not provided	Uncertain significance(Last reviewed: Jun 12, 2017)	criteria provided, single submitter	VCV000495987	11	5247065	11	5225835	495987	487438	rs1554917650	NC_000011.10:5225834:G:A
NM_000518.5(HBB):c.316-114C>A	HBB|LOC107133510|LOC110006319		not specified|not provided	Uncertain significance(Last reviewed: Jul 7, 2020)	criteria provided, multiple submitters, no conflicts	VCV000632849	11	5247070	11	5225840	632849	621812	rs1003790835	NC_000011.10:5225839:G:T
NM_000518.5(HBB):c.316-114C>T	HBB|LOC107133510|LOC110006319		not provided	Uncertain significance(Last reviewed: Feb 13, 2017)	criteria provided, single submitter	VCV000495988	11	5247070	11	5225840	495988	487494	rs1003790835	NC_000011.10:5225839:G:A
NM_000518.5(HBB):c.316-120C>G	HBB|LOC107133510|LOC110006319		not provided	Likely benign(Last reviewed: Dec 13, 2018)	criteria provided, single submitter	VCV000796911	11	5247076	11	5225846	796911	787678	rs1589891720	NC_000011.10:5225845:G:C
NM_000518.5(HBB):c.316-124A>T	HBB|LOC107133510|LOC110006319		not provided	Uncertain significance(Last reviewed: Mar 12, 2019)	criteria provided, single submitter	VCV000801187	11	5247080	11	5225850	801187	789680	rs1184042209	NC_000011.10:5225849:T:A
NM_000518.5(HBB):c.316-125A>G	LOC110006319|HBB|LOC107133510		not provided|beta Thalassemia	Conflicting interpretations of pathogenicity(Last reviewed: Dec 31, 2019)	criteria provided, conflicting interpretations	VCV000439149	11	5247081	11	5225851	439149	432677	rs63751175	NC_000011.10:5225850:T:C
NM_000518.5(HBB):c.316-128G>C	HBB|LOC107133510|LOC110006319		not provided	Uncertain significance(Last reviewed: Dec 13, 2016)	criteria provided, single submitter	VCV000495989	11	5247084	11	5225854	495989	487498	rs1291160651	NC_000011.10:5225853:C:G
NM_000518.5(HBB):c.316-130T>C	HBB|LOC107133510|LOC110006319		not specified	Uncertain significance(Last reviewed: Jan 18, 2020)	criteria provided, single submitter	VCV000495990	11	5247086	11	5225856	495990	487528	rs956857115	NC_000011.10:5225855:A:G
NM_000518.5(HBB):c.316-138G>T	HBB|LOC107133510|LOC110006319		not provided	Likely benign(Last reviewed: Feb 14, 2019)	criteria provided, single submitter	VCV000801188	11	5247094	11	5225864	801188	789681	rs1444028845	NC_000011.10:5225863:C:A
NM_000518.5(HBB):c.316-138G>A	HBB|LOC107133510|LOC110006319		not provided	Uncertain significance(Last reviewed: Jul 10, 2019)	criteria provided, multiple submitters, no conflicts	VCV000495991	11	5247094	11	5225864	495991	487530	rs1444028845	NC_000011.10:5225863:C:T
NM_000518.5(HBB):c.316-145G>A	HBB|LOC107133510|LOC110006319		not specified	Uncertain significance(Last reviewed: Aug 15, 2018)	criteria provided, single submitter	VCV000632848	11	5247101	11	5225871	632848	621813	rs1005042281	NC_000011.10:5225870:C:T
NM_000518.5(HBB):c.316-146T>C	HBB|LOC107133510|LOC110006319		not specified	Likely benign	criteria provided, single submitter	VCV000256346	11	5247102	11	5225872	256346	254204	rs35328027	NC_000011.10:5225871:A:G
NM_000518.5(HBB):c.316-146T>G	HBB|LOC107133510|LOC110006319		not provided|beta Thalassemia|not specified|Beta-plus-thalassemia	Pathogenic(Last reviewed: May 10, 2019)	criteria provided, multiple submitters, no conflicts	VCV000036312	11	5247102	11	5225872	36312	44976	rs35328027	NC_000011.10:5225871:A:C
NM_000518.5(HBB):c.316-147A>C	HBB|LOC107133510|LOC110006319		not provided	Likely benign(Last reviewed: Nov 8, 2018)	criteria provided, single submitter	VCV000792476	11	5247103	11	5225873	792476	787680	rs1415697390	NC_000011.10:5225872:T:G
NM_000518.5(HBB):c.316-150C>A	HBB|LOC107133510|LOC110006319		not provided	Likely benign(Last reviewed: Oct 18, 2018)	criteria provided, single submitter	VCV000793229	11	5247106	11	5225876	793229	787954	rs193922556	NC_000011.10:5225875:G:T
NM_000518.5(HBB):c.316-150C>G	HBB|LOC107133510|LOC110006319		beta Thalassemia	Likely benign(Last reviewed: Aug 18, 2011)	criteria provided, single submitter	VCV000036314	11	5247106	11	5225876	36314	44978	rs193922556	NC_000011.10:5225875:G:C
NM_000518.5(HBB):c.316-152A>T	HBB|LOC107133510|LOC110006319		not provided	Likely benign(Last reviewed: Oct 18, 2018)	criteria provided, single submitter	VCV000793230	11	5247108	11	5225878	793230	787960	rs1589891751	NC_000011.10:5225877:T:A
NM_000518.5(HBB):c.316-156T>C	LOC107133510|LOC110006319|HBB		not specified	Uncertain significance(Last reviewed: Jan 25, 2017)	criteria provided, single submitter	VCV000439150	11	5247112	11	5225882	439150	432678	rs1164871363	NC_000011.10:5225881:A:G
NM_000518.5(HBB):c.316-177A>C	HBB|LOC107133510|LOC110006319		not provided	Likely benign(Last reviewed: Dec 31, 2019)	criteria provided, single submitter	VCV000797803	11	5247133	11	5225903	797803	787755	rs964085975	NC_000011.10:5225902:T:G
NM_000518.5(HBB):c.316-177A>G	HBB|LOC107133510|LOC110006319		not specified	Uncertain significance(Last reviewed: Jun 20, 2017)	criteria provided, single submitter	VCV000439151	11	5247133	11	5225903	439151	432679	rs964085975	NC_000011.10:5225902:T:C
NM_000518.5(HBB):c.316-179A>C	HBB|LOC107133510|LOC110006319		not specified|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Dec 31, 2019)	criteria provided, conflicting interpretations	VCV000632851	11	5247135	11	5225905	632851	621815	rs185607297	NC_000011.10:5225904:T:G
NM_000518.5(HBB):c.316-184T>C	HBB|LOC107133510|LOC110006319		beta Thalassemia|not specified|not provided	Likely benign(Last reviewed: Jan 3, 2018)	criteria provided, multiple submitters, no conflicts	VCV000036315	11	5247140	11	5225910	36315	44979	rs193922557	NC_000011.10:5225909:A:G
NM_000518.5(HBB):c.316-185C>T	HBB|LOC107133510|LOC110006319		not provided|not specified|beta Thalassemia	Benign(Last reviewed: Dec 31, 2019)	criteria provided, multiple submitters, no conflicts	VCV000036316	11	5247141	11	5225911	36316	44980	rs1609812	NC_000011.10:5225910:G:A
NM_000518.5(HBB):c.316-188T>C	HBB|LOC107133510|LOC110006319		not provided	Likely benign(Last reviewed: Dec 21, 2018)	criteria provided, single submitter	VCV000751267	11	5247144	11	5225914	751267	775868	rs1589891780	NC_000011.10:5225913:A:G
NM_000518.5(HBB):c.316-189A>G	HBB|LOC107133510|LOC110006319		not provided|not specified	Conflicting interpretations of pathogenicity(Last reviewed: Sep 23, 2020)	criteria provided, conflicting interpretations	VCV000495992	11	5247145	11	5225915	495992	487439	rs1034207896	NC_000011.10:5225914:T:C
NM_000518.5(HBB):c.316-192G>A	HBB|LOC107133510|LOC110006319		not specified	Uncertain significance(Last reviewed: Nov 20, 2018)	criteria provided, single submitter	VCV000632852	11	5247148	11	5225918	632852	621816	rs1564874512	NC_000011.10:5225917:C:T
NM_000518.5(HBB):c.316-197C>T	HBB|LOC107133510|LOC110006319		not provided|Beta thalassemia major|not specified|beta Thalassemia|beta^0^ Thalassemia|Hb SS disease	Pathogenic(Last reviewed: Dec 27, 2019)	criteria provided, multiple submitters, no conflicts	VCV000015458	11	5247153	11	5225923	15458	30497	rs34451549	NC_000011.10:5225922:G:A
NM_000518.5(HBB):c.316-198G>A	HBB|LOC107133510|LOC110006319		not specified	Uncertain significance(Last reviewed: Sep 30, 2020)	criteria provided, single submitter	VCV000981074	11	5247154	11	5225924	981074	969171		NC_000011.10:5225923:C:T
NM_000518.5(HBB):c.316-208C>G	HBB|LOC107133510|LOC110006319		beta Thalassemia	Benign(Last reviewed: Nov 25, 2019)	no assertion criteria provided	VCV000869237	11	5247164	11	5225934	869237	857560		NC_000011.10:5225933:G:C
NM_000518.5(HBB):c.316-217T>C	HBB|LOC107133510|LOC110006319		not provided	Likely benign(Last reviewed: Dec 4, 2018)	criteria provided, single submitter	VCV000798416	11	5247173	11	5225943	798416	787979	rs1589891794	NC_000011.10:5225942:A:G
NM_000518.5(HBB):c.316-238C>T	HBB|LOC107133510|LOC110006319		beta Thalassemia|not specified|not provided	Likely benign(Last reviewed: Dec 31, 2019)	criteria provided, multiple submitters, no conflicts	VCV000256347	11	5247194	11	5225964	256347	254205	rs558554234	NC_000011.10:5225963:G:A
NM_000518.5(HBB):c.316-246C>T	HBB|LOC107133510|LOC110006319		not provided	Likely benign(Last reviewed: Oct 29, 2018)	criteria provided, single submitter	VCV000793871	11	5247202	11	5225972	793871	787682	rs1589891810	NC_000011.10:5225971:G:A
NM_000518.5(HBB):c.316-272G>T	LOC107133510|LOC110006319|HBB		beta Thalassemia	Benign(Last reviewed: Nov 25, 2019)	no assertion criteria provided	VCV000869238	11	5247228	11	5225998	869238	857561		NC_000011.10:5225997:C:A
NM_000518.5(HBB):c.316-272G>C	HBB|LOC107133510|LOC110006319		beta Thalassemia|not provided	Likely benign(Last reviewed: Dec 31, 2019)	criteria provided, single submitter	VCV000795281	11	5247228	11	5225998	795281	787983	rs773343845	NC_000011.10:5225997:C:G
NM_000518.5(HBB):c.316-295C>T	HBB|LOC107133510|LOC110006319		not provided	Likely benign(Last reviewed: Dec 31, 2019)	criteria provided, single submitter	VCV000764715	11	5247251	11	5226021	764715	775697	rs569636767	NC_000011.10:5226020:G:A
NM_000518.5(HBB):c.316-323T>C	HBB|LOC107133510|LOC110006319		not provided	Likely benign(Last reviewed: Oct 11, 2018)	criteria provided, single submitter	VCV000755510	11	5247279	11	5226049	755510	775883	rs1589891857	NC_000011.10:5226048:A:G
NM_000518.5(HBB):c.316-341T>C	HBB|LOC107133510|LOC110006319		not provided	Likely benign(Last reviewed: Dec 5, 2018)	criteria provided, single submitter	VCV000796407	11	5247297	11	5226067	796407	787759	rs1200755137	NC_000011.10:5226066:A:G
NM_000518.5(HBB):c.316-368T>G	HBB|LOC107133510|LOC110006319		not provided	Likely benign(Last reviewed: Dec 31, 2019)	criteria provided, single submitter	VCV000766475	11	5247324	11	5226094	766475	775887	rs1589891884	NC_000011.10:5226093:A:C
NM_000518.5(HBB):c.316-369G>A	HBB|LOC107133510|LOC110006319		beta Thalassemia	Uncertain significance(Last reviewed: Sep 24, 2019)	no assertion criteria provided	VCV000830005	11	5247325	11	5226095	830005	818290	rs1589891886	NC_000011.10:5226094:C:T
NM_000518.5(HBB):c.316-373C>A	HBB|LOC107133510|LOC110006319		beta Thalassemia|not provided	Benign(Last reviewed: Dec 31, 2019)	criteria provided, single submitter	VCV000695343	11	5247329	11	5226099	695343	685287	rs78815705	NC_000011.10:5226098:G:T
NM_000518.5(HBB):c.316-381G>A	HBB|LOC107133510|LOC110006319		not provided	Likely benign(Last reviewed: Dec 31, 2019)	criteria provided, single submitter	VCV000774507	11	5247337	11	5226107	774507	778143	rs1045462228	NC_000011.10:5226106:C:T
NM_000518.5(HBB):c.315+425T>C	HBB|LOC107133510|LOC110006319		not provided	Likely benign(Last reviewed: Sep 20, 2018)	criteria provided, single submitter	VCV000751959	11	5247382	11	5226152	751959	775686	rs922176223	NC_000011.10:5226151:A:G
NM_000518.5(HBB):c.315+421T>C	HBB|LOC107133510|LOC110006319		not provided	Likely benign(Last reviewed: Dec 31, 2019)	criteria provided, single submitter	VCV000798809	11	5247386	11	5226156	798809	787770	rs1250042245	NC_000011.10:5226155:A:G
NM_000518.5(HBB):c.315+408T>C	HBB|LOC107133510|LOC110006319		not provided	Likely benign(Last reviewed: Dec 31, 2019)	criteria provided, single submitter	VCV000702712	11	5247399	11	5226169	702712	695524	rs1323342312	NC_000011.10:5226168:A:G
NM_000518.5(HBB):c.315+380T>C	HBB|LOC107133510|LOC110006319		not provided	Benign(Last reviewed: Dec 31, 2019)	criteria provided, single submitter	VCV000695384	11	5247427	11	5226197	695384	685288	rs190369729	NC_000011.10:5226196:A:G
NM_000518.5(HBB):c.315+377C>T	HBB|LOC107133510|LOC110006319		not provided	Likely benign(Last reviewed: Dec 31, 2019)	criteria provided, single submitter	VCV000762977	11	5247430	11	5226200	762977	775698	rs182729393	NC_000011.10:5226199:G:A
NM_000518.5(HBB):c.315+362G>A	HBB|LOC107133510|LOC110006319		not provided	Likely benign(Last reviewed: Dec 8, 2018)	criteria provided, single submitter	VCV000798571	11	5247445	11	5226215	798571	787772	rs1589891959	NC_000011.10:5226214:C:T
NM_000518.5(HBB):c.315+337A>G	HBB|LOC107133510|LOC110006319		not provided	Likely benign(Last reviewed: Dec 31, 2019)	criteria provided, single submitter	VCV000754485	11	5247470	11	5226240	754485	775699	rs561258571	NC_000011.10:5226239:T:C
NM_000518.5(HBB):c.315+335C>G	HBB|LOC107133510|LOC110006319		not provided	Likely benign(Last reviewed: Dec 31, 2019)	criteria provided, single submitter	VCV000765568	11	5247472	11	5226242	765568	775688	rs1589891972	NC_000011.10:5226241:G:C
NM_000518.5(HBB):c.315+334A>C	HBB|LOC107133510|LOC110006319		not provided	Likely benign(Last reviewed: Dec 31, 2019)	criteria provided, single submitter	VCV000765167	11	5247473	11	5226243	765167	775694	rs1055395965	NC_000011.10:5226242:T:G
NM_000518.5(HBB):c.315+332T>G	HBB|LOC107133510|LOC110006319		not provided	Likely benign(Last reviewed: Dec 31, 2019)	criteria provided, single submitter	VCV000794095	11	5247475	11	5226245	794095	787686	rs531567967	NC_000011.10:5226244:A:C
NM_000518.5(HBB):c.315+293G>A	HBB|LOC107133510|LOC110006319		not provided	Likely benign(Last reviewed: Oct 13, 2018)	criteria provided, single submitter	VCV000755422	11	5247514	11	5226284	755422	775839	rs1320832744	NC_000011.10:5226283:C:T
NM_000518.5(HBB):c.315+272A>G	HBB|LOC107133510|LOC110006319		not provided	Likely benign(Last reviewed: Dec 31, 2019)	criteria provided, single submitter	VCV000797671	11	5247535	11	5226305	797671	787690	rs1589892008	NC_000011.10:5226304:T:C
NM_000518.5(HBB):c.315+260A>G	HBB|LOC107133510|LOC110006319		not provided	Likely benign(Last reviewed: Dec 31, 2019)	criteria provided, single submitter	VCV000750903	11	5247547	11	5226317	750903	775846	rs111415391	NC_000011.10:5226316:T:C
NM_000518.5(HBB):c.315+255T>C	HBB|LOC107133510|LOC110006319		beta Thalassemia	Benign(Last reviewed: Nov 25, 2019)	no assertion criteria provided	VCV000869354	11	5247552	11	5226322	869354	857563		NC_000011.10:5226321:A:G
NM_000518.5(HBB):c.315+221G>A	HBB|LOC107133510|LOC110006319		not provided	Likely benign(Last reviewed: Dec 31, 2019)	criteria provided, single submitter	VCV000763631	11	5247586	11	5226356	763631	775904	rs753003330	NC_000011.10:5226355:C:T
NM_000518.5(HBB):c.315+220C>T	HBB|LOC107133510|LOC110006319		not provided	Benign(Last reviewed: Dec 31, 2019)	criteria provided, single submitter	VCV000707768	11	5247587	11	5226357	707768	695525	rs113152027	NC_000011.10:5226356:G:A
NM_000518.5(HBB):c.315+207T>A	LOC110006319|HBB|LOC107133510		not provided	Likely benign(Last reviewed: Dec 10, 2018)	criteria provided, single submitter	VCV000793209	11	5247600	11	5226370	793209	787692	rs1589892074	NC_000011.10:5226369:A:T
NM_000518.5(HBB):c.315+205T>G	HBB|LOC107133510|LOC110006319		not provided	Likely benign(Last reviewed: Nov 28, 2018)	criteria provided, single submitter	VCV000796030	11	5247602	11	5226372	796030	787985	rs1589892081	NC_000011.10:5226371:A:C
NM_000518.5(HBB):c.315+203T>C	HBB|LOC107133510|LOC110006319		not provided	Likely benign(Last reviewed: Nov 8, 2018)	criteria provided, single submitter	VCV000763383	11	5247604	11	5226374	763383	775848	rs1042051118	NC_000011.10:5226373:A:G
NM_000518.5(HBB):c.315+189T>C	HBB|LOC107133510|LOC110006319		not provided	Likely benign(Last reviewed: Oct 1, 2018)	criteria provided, single submitter	VCV000751288	11	5247618	11	5226388	751288	775851	rs1589892094	NC_000011.10:5226387:A:G
NM_000518.5(HBB):c.315+180T>C	HBB|LOC107133510|LOC110006319		not provided	Benign(Last reviewed: Dec 31, 2019)	criteria provided, single submitter	VCV000695498	11	5247627	11	5226397	695498	685289	rs529931134	NC_000011.10:5226396:A:G
NM_000518.5(HBB):c.315+175A>T	HBB|LOC107133510|LOC110006319		not provided	Likely benign(Last reviewed: Dec 31, 2019)	criteria provided, single submitter	VCV000766521	11	5247632	11	5226402	766521	775712	rs973955533	NC_000011.10:5226401:T:A
NM_000518.5(HBB):c.315+171A>G	LOC110006319|HBB|LOC107133510		not provided	Likely benign(Last reviewed: Dec 31, 2019)	criteria provided, single submitter	VCV000703455	11	5247636	11	5226406	703455	695526	rs996301151	NC_000011.10:5226405:T:C
NM_000518.5(HBB):c.315+156T>C	HBB|LOC107133510|LOC110006319		not provided	Likely benign(Last reviewed: Dec 31, 2019)	criteria provided, single submitter	VCV000797626	11	5247651	11	5226421	797626	787694	rs981149711	NC_000011.10:5226420:A:G
NM_000518.5(HBB):c.315+142C>T	HBB|LOC107133510|LOC110006319		not provided	Likely benign(Last reviewed: Dec 31, 2019)	criteria provided, single submitter	VCV000797670	11	5247665	11	5226435	797670	787761	rs934286084	NC_000011.10:5226434:G:A
NM_000518.5(HBB):c.315+139G>A	HBB|LOC107133510|LOC110006319		not provided	Likely benign(Last reviewed: Aug 29, 2018)	criteria provided, single submitter	VCV000766523	11	5247668	11	5226438	766523	775717	rs1589892116	NC_000011.10:5226437:C:T
NM_000518.5(HBB):c.315+132G>C	HBB|LOC107133510|LOC110006319		not provided	Likely benign(Last reviewed: Nov 20, 2018)	criteria provided, single submitter	VCV000795422	11	5247675	11	5226445	795422	787986	rs1329253876	NC_000011.10:5226444:C:G
NM_000518.5(HBB):c.315+125T>C	HBB|LOC107133510|LOC110006319		not provided	Likely benign(Last reviewed: Dec 31, 2019)	criteria provided, single submitter	VCV000800025	11	5247682	11	5226452	800025	787696	rs1053188095	NC_000011.10:5226451:A:G
NM_000518.5(HBB):c.315+118G>C	HBB|LOC107133510|LOC110006319		not provided	Likely benign(Last reviewed: Nov 27, 2018)	criteria provided, single submitter	VCV000796185	11	5247689	11	5226459	796185	787774	rs1302097141	NC_000011.10:5226458:C:G
NM_000518.5(HBB):c.315+109C>T	HBB|LOC107133510|LOC110006319		not provided	Likely benign(Last reviewed: Dec 31, 2019)	criteria provided, single submitter	VCV000706923	11	5247698	11	5226468	706923	695527	rs543925348	NC_000011.10:5226467:G:A
NM_000518.5(HBB):c.315+81C>T	HBB|LOC107133510|LOC110006319		not specified|not provided|beta Thalassemia	Benign(Last reviewed: Dec 31, 2019)	criteria provided, multiple submitters, no conflicts	VCV000439774	11	5247726	11	5226496	439774	433082	rs7946748	NC_000011.10:5226495:G:A
NM_000518.5(HBB):c.315+80A>T	HBB|LOC107133510|LOC110006319		not provided	Likely benign(Last reviewed: Nov 26, 2018)	criteria provided, single submitter	VCV000795403	11	5247727	11	5226497	795403	787766	rs1589892172	NC_000011.10:5226496:T:A
NM_000518.5(HBB):c.315+74T>G	LOC107133510|HBB|LOC110006319		not specified|beta Thalassemia|not provided	Benign(Last reviewed: Dec 31, 2019)	criteria provided, multiple submitters, no conflicts	VCV000439775	11	5247733	11	5226503	439775	433083	rs7480526	NC_000011.10:5226502:A:C
NM_000518.5(HBB):c.315+70G>C	HBB|LOC107133510|LOC110006319		not specified|not provided	Benign/Likely benign(Last reviewed: Dec 31, 2019)	criteria provided, multiple submitters, no conflicts	VCV000764666	11	5247737	11	5226507	764666	775852	rs373152208	NC_000011.10:5226506:C:G
NM_000518.5(HBB):c.315+34C>T	HBB|LOC107133510|LOC110006319		not provided	Likely benign(Last reviewed: Oct 5, 2018)	criteria provided, single submitter	VCV000755397	11	5247773	11	5226543	755397	775909	rs759795721	NC_000011.10:5226542:G:A
NM_000518.5(HBB):c.315+26T>G	HBB|LOC107133510|LOC110006319		not specified|not provided	Benign(Last reviewed: Dec 31, 2019)	criteria provided, multiple submitters, no conflicts	VCV000439776	11	5247781	11	5226551	439776	433084	rs368604295	NC_000011.10:5226550:A:C
NM_000518.5(HBB):c.315+16G>C	HBB|LOC107133510|LOC110006319		beta Thalassemia|not specified	Benign/Likely benign(Last reviewed: May 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000256345	11	5247791	11	5226561	256345	254206	rs10768683	NC_000011.10:5226560:C:G
NM_000518.5(HBB):c.315+15C>T	HBB|LOC107133510|LOC110006319		not provided	Likely benign(Last reviewed: Dec 31, 2019)	criteria provided, single submitter	VCV000763094	11	5247792	11	5226562	763094	775724	rs756567448	NC_000011.10:5226561:G:A
NM_000518.5(HBB):c.315+9A>G	HBB|LOC107133510|LOC110006319		not specified	Uncertain significance(Last reviewed: Mar 28, 2019)	criteria provided, single submitter	VCV000929230	11	5247798	11	5226568	929230	917486		NC_000011.10:5226567:T:C
NM_000518.5(HBB):c.315+5G>C	HBB|LOC106099062|LOC107133510|LOC110006319		beta Thalassemia	Pathogenic(Last reviewed: Nov 25, 2019)	no assertion criteria provided	VCV000869356	11	5247802	11	5226572	869356	857565		NC_000011.10:5226571:C:G
NM_000518.5(HBB):c.315+3G>C	HBB|LOC106099062|LOC107133510|LOC110006319		not specified	Uncertain significance(Last reviewed: Jun 2, 2017)	criteria provided, single submitter	VCV000439147	11	5247804	11	5226574	439147	432680	rs754412212	NC_000011.10:5226573:C:G
NM_000518.5(HBB):c.315+2T>C	HBB|LOC106099062|LOC107133510|LOC110006319		beta^0^ Thalassemia|beta Thalassemia	Pathogenic(Last reviewed: Nov 25, 2019)	no assertion criteria provided	VCV000869355	11	5247805	11	5226575	869355	857566		NC_000011.10:5226574:A:G
NM_000518.5(HBB):c.315+2T>G	HBB|LOC106099062|LOC107133510|LOC110006319		not provided|beta Thalassemia	Likely pathogenic(Last reviewed: Mar 16, 2020)	criteria provided, multiple submitters, no conflicts	VCV000439146	11	5247805	11	5226575	439146	432681	rs63750283	NC_000011.10:5226574:A:C
NM_000518.5(HBB):c.315+1G>T	HBB|LOC106099062|LOC107133510|LOC110006319		not provided|beta Thalassemia	Pathogenic(Last reviewed: May 3, 2020)	criteria provided, multiple submitters, no conflicts	VCV000619686	11	5247806	11	5226576	619686	611304	rs33945777	NC_000011.10:5226575:C:A
NM_000518.5(HBB):c.315+1G>C	HBB|LOC106099062|LOC107133510|LOC110006319		beta Thalassemia	Likely pathogenic(Last reviewed: Jan 15, 2015)	criteria provided, single submitter	VCV000189128	11	5247806	11	5226576	189128	186822	rs33945777	NC_000011.10:5226575:C:G
NM_000518.5(HBB):c.315+1G>A	HBB|LOC106099062|LOC107133510|LOC110006319		alpha Thalassemia|Susceptibility to malaria|Erythrocytosis 6, familial|Heinz body anemia|Methemoglobinemia, beta-globin type|Fetal hemoglobin quantitative trait locus 1|beta Thalassemia|Beta-thalassemia, dominant inclusion body type|Hb SS disease|not specified|not provided|Hb SS disease|beta^0^ Thalassemia|beta Thalassemia	Pathogenic(Last reviewed: Dec 4, 2019)	criteria provided, multiple submitters, no conflicts	VCV000015438	11	5247806	11	5226576	15438	30477	rs33945777	NC_000011.10:5226575:C:T
NM_000518.4(HBB):c.[278A>C;315G>Y]	LOC110006319|HBB|LOC106099062|LOC107133510	R105S, H93P	HEMOGLOBIN DUINO	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000446742	11|11	5247807	11|11	5226577	446742	30169|30326	rs33914944|rs33974325	NC_000011.10:5226576:C:R|NC_000011.10:5226613:T:G
NM_000518.5(HBB):c.315G>T (p.Arg105Ser)	HBB|LOC106099062|LOC107133510|LOC110006319	R105S	not specified	Uncertain significance(Last reviewed: Nov 15, 2016)	criteria provided, single submitter	VCV000439779	11	5247807	11	5226577	439779	433085	rs33914944	NC_000011.10:5226576:C:A
NM_000518.5(HBB):c.315G>C (p.Arg105Ser)	HBB|LOC106099062|LOC107133510|LOC110006319	R104S, R105S	Hb camperdown|not specified	Uncertain significance(Last reviewed: Nov 12, 2016)	criteria provided, single submitter	VCV000015525	11	5247807	11	5226577	15525	30564	rs33914944	NC_000011.10:5226576:C:G
NM_000518.5(HBB):c.315G>Y (p.Arg105Ser)	HBB|LOC106099062|LOC107133510|LOC110006319	R105S	HEMOGLOBIN CAMPERDOWN	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015130	11	5247807	11	5226577	15130	30169	rs33914944	NC_000011.10:5226576:C:R
NM_000518.5(HBB):c.314G>C (p.Arg105Thr)	LOC107133510|LOC110006319|HBB|LOC106099062	R105T	HEMOGLOBIN SHERWOOD FOREST|not specified	Likely benign(Last reviewed: Nov 8, 2016)	criteria provided, single submitter	VCV000015351	11	5247808	11	5226578	15351	30390	rs33911434	NC_000011.10:5226577:C:G
NM_000518.5(HBB):c.312C>G (p.Phe104Leu)	LOC106099062|LOC107133510|LOC110006319|HBB	F103L, F104L	HEMOGLOBIN HEATHROW|Erythrocytosis 6, familial	Pathogenic, other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015192	11	5247810	11	5226580	15192	30231	rs35067717	NC_000011.10:5226579:G:C
NM_000518.4(HBB):c.310T>G (p.Phe104Val)	HBB|LOC106099062|LOC107133510|LOC110006319	F103V, F104V	HEMOGLOBIN SPARTA	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015608	11	5247812	11	5226582	15608	30647	rs33921589	NC_000011.10:5226581:A:C
NM_000518.4(HBB):c.310T>A (p.Phe104Ile)	HBB|LOC106099062|LOC107133510|LOC110006319	F103I, F104I	HEMOGLOBIN SAINT NAZAIRE	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015524	11	5247812	11	5226582	15524	30563	rs33921589	NC_000011.10:5226581:A:T
NM_000518.5(HBB):c.309C>A (p.Asn103Lys)	HBB|LOC106099062|LOC107133510|LOC110006319	N103K	not specified|not provided	Uncertain significance(Last reviewed: Jun 20, 2017)	criteria provided, multiple submitters, no conflicts	VCV000036311	11	5247813	11	5226583	36311	44975	rs34227486	NC_000011.10:5226582:G:T
NM_000518.4(HBB):c.308A>C (p.Asn103Thr)	HBB|LOC106099062|LOC107133510|LOC110006319	N102T, N103T	not specified	Benign(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015235	11	5247814	11	5226584	15235	30274	rs33948057	NC_000011.10:5226583:T:G
NM_000518.4(HBB):c.308A>G (p.Asn103Ser)	HBB|LOC106099062|LOC107133510|LOC110006319	N102S, N103S	HEMOGLOBIN BETH ISRAEL	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015111	11	5247814	11	5226584	15111	30150	rs33948057	NC_000011.10:5226583:T:C
NM_000518.5(HBB):c.307A>G (p.Asn103Asp)	HBB|LOC106099062|LOC107133510|LOC110006319	N103D	not specified	Uncertain significance(Last reviewed: Dec 27, 2018)	criteria provided, single submitter	VCV000811863	11	5247815	11	5226585	811863	799650	rs33927739	NC_000011.10:5226584:T:C
NM_000518.5(HBB):c.307A>T (p.Asn103Tyr)	HBB|LOC106099062|LOC107133510|LOC110006319	N102Y, N103Y	HEMOGLOBIN ST. MANDE	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015354	11	5247815	11	5226585	15354	30393	rs33927739	NC_000011.10:5226584:T:A
NM_000518.5(HBB):c.306G>C (p.Glu102Asp)	HBB|LOC106099062|LOC107133510|LOC110006319	E101D, E102D	HEMOGLOBIN POTOMAC|Erythrocytosis 6, familial	Pathogenic, other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015317	11	5247816	11	5226586	15317	30356	rs35209591	NC_000011.10:5226585:C:G
NM_000518.5(HBB):c.305A>G (p.Glu102Gly)	LOC110006319|HBB|LOC106099062|LOC107133510	E101G, E102G	HEMOGLOBIN ALBERTA|Erythrocytosis 6, familial	Pathogenic, other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015094	11	5247817	11	5226587	15094	30133	rs33937393	NC_000011.10:5226586:T:C
NM_000518.4(HBB):c.304G>C (p.Glu102Gln)	HBB|LOC106099062|LOC107133510|LOC110006319	E101Q, E102Q	HEMOGLOBIN RUSH	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015332	11	5247818	11	5226588	15332	30371	rs33966487	NC_000011.10:5226587:C:G
NM_000518.4(HBB):c.304G>A (p.Glu102Lys)	HBB|LOC106099062|LOC107133510|LOC110006319	E101K, E102K	HEMOGLOBIN BRITISH COLUMBIA|Erythrocytosis 6, familial	Pathogenic, other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015118	11	5247818	11	5226588	15118	30157	rs33966487	NC_000011.10:5226587:C:T
NM_000518.4(HBB):c.302C>G (p.Pro101Arg)	HBB|LOC106099062|LOC107133510|LOC110006319	P100R, P101R	HEMOGLOBIN NEW MEXICO	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015285	11	5247820	11	5226590	15285	30324	rs33965000	NC_000011.10:5226589:G:C
NM_000518.4(HBB):c.302C>T (p.Pro101Leu)	LOC106099062|LOC107133510|LOC110006319|HBB	P100L, P101L	HEMOGLOBIN BRIGHAM|Erythrocytosis 6, familial	Pathogenic, other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015116	11	5247820	11	5226590	15116	30155	rs33965000	NC_000011.10:5226589:G:A
NM_000518.5(HBB):c.300T>A (p.Asp100Glu)	HBB|LOC106099062|LOC107133510	D100E	Erythrocytosis 6, familial	Pathogenic(Last reviewed: Nov 1, 2019)	criteria provided, single submitter	VCV000917854	11	5247822	11	5226592	917854	906174		NC_000011.10:5226591:A:T
NM_000518.5(HBB):c.300T>R (p.Asp100Glu)	HBB|LOC106099062|LOC107133510	D100E	HEMOGLOBIN COIMBRA	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015495	11	5247822	11	5226592	15495	30534	rs34013622	NC_000011.10:5226591:A:Y
NM_000518.4(HBB):c.299A>C (p.Asp100Ala)	HBB|LOC106099062|LOC107133510	D99A, D100A	HEMOGLOBIN RADCLIFFE|Erythrocytosis 6, familial	Pathogenic, other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015315	11	5247823	11	5226593	15315	30354	rs33971048	NC_000011.10:5226592:T:G
NM_000518.4(HBB):c.299A>G (p.Asp100Gly)	HBB|LOC106099062|LOC107133510	D99G, D100G	HEMOGLOBIN HOTEL-DIEU|Erythrocytosis 6, familial	Pathogenic, other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015204	11	5247823	11	5226593	15204	30243	rs33971048	NC_000011.10:5226592:T:C
NM_000518.4(HBB):c.299A>T (p.Asp100Val)	HBB|LOC106099062|LOC107133510	D99V, D100V	HEMOGLOBIN CHEMILLY|Erythrocytosis 6, familial	Pathogenic, other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015134	11	5247823	11	5226593	15134	30173	rs33971048	NC_000011.10:5226592:T:A
NM_000518.4(HBB):c.298G>T (p.Asp100Tyr)	HBB|LOC106099062|LOC107133510	D99Y, D100Y	HEMOGLOBIN YPSILANTI|Erythrocytosis 6, familial	Pathogenic, other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015397	11	5247824	11	5226594	15397	30436	rs33954595	NC_000011.10:5226593:C:A
NM_000518.4(HBB):c.298G>C (p.Asp100His)	HBB|LOC106099062|LOC107133510	D99H, D100H	HEMOGLOBIN YAKIMA|Erythrocytosis 6, familial	Pathogenic, other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015391	11	5247824	11	5226594	15391	30430	rs33954595	NC_000011.10:5226593:C:G
NM_000518.4(HBB):c.298G>A (p.Asp100Asn)	LOC106099062|LOC107133510|HBB	D99N, D100N	HEMOGLOBIN KEMPSEY|Erythrocytosis 6, familial	Pathogenic, other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015236	11	5247824	11	5226594	15236	30275	rs33954595	NC_000011.10:5226593:C:T
NM_000518.4(HBB):c.296T>G (p.Val99Gly)	HBB|LOC106099062|LOC107133510	V98G, V99G	HEMOGLOBIN NOTTINGHAM	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015291	11	5247826	11	5226596	15291	30330	rs33985510	NC_000011.10:5226595:A:C
NM_000518.4(HBB):c.296T>C (p.Val99Ala)	HBB|LOC106099062|LOC107133510	V98A, V99A	HEMOGLOBIN DJELFA	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015158	11	5247826	11	5226596	15158	30197	rs33985510	NC_000011.10:5226595:A:G
NM_000518.4(HBB):c.[295G>A;98T>A]	LOC107133510|HBB|LOC106099062	V99M, L33Q		other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000446743	11|11	5247827	11|11	5226597	446743	30280|30572	rs33933298|rs33948578	NC_000011.10:5226596:C:T|NC_000011.10:5226793:A:T
NM_000518.5(HBB):c.295G>A (p.Val99Met)	HBB|LOC106099062|LOC107133510	V99M	Heinz body anemia|Hemoglobinopathy|not provided	Pathogenic(Last reviewed: Oct 4, 2019)	criteria provided, multiple submitters, no conflicts	VCV000015241	11	5247827	11	5226597	15241	30280	rs33933298	NC_000011.10:5226596:C:T
NM_000518.5(HBB):c.294C>G (p.His98Gln)	HBB|LOC106099062|LOC107133510	H98Q	not specified|not provided	Pathogenic(Last reviewed: Jan 31, 2019)	criteria provided, multiple submitters, no conflicts	VCV000801186	11	5247828	11	5226598	801186	789498	rs34515413	NC_000011.10:5226597:G:C
NM_000518.5(HBB):c.294C>T (p.His98=)	HBB|LOC106099062|LOC107133510		not specified|beta Thalassemia|Hemoglobin E|Fetal hemoglobin quantitative trait locus 1|Hb SS disease|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Dec 31, 2019)	criteria provided, conflicting interpretations	VCV000439783	11	5247828	11	5226598	439783	433086	rs34515413	NC_000011.10:5226597:G:A
NM_000518.5(HBB):c.294C>R (p.His98Gln)	HBB|LOC106099062|LOC107133510	H98Q	Erythrocytosis 6, familial|HEMOGLOBIN MALMO	Pathogenic, other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015259	11	5247828	11	5226598	15259	30298	rs34515413	NC_000011.10:5226597:G:Y
NM_000518.4(HBB):c.293A>T (p.His98Leu)	HBB|LOC106099062|LOC107133510	H97L, H98L	HEMOGLOBIN WOOD|Erythrocytosis 6, familial	Pathogenic, other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015390	11	5247829	11	5226599	15390	30429	rs33951978	NC_000011.10:5226598:T:A
NM_000518.4(HBB):c.293A>C (p.His98Pro)	HBB|LOC106099062|LOC107133510	H97P, H98P	HEMOGLOBIN NAGOYA	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015283	11	5247829	11	5226599	15283	30322	rs33951978	NC_000011.10:5226598:T:G
NM_000518.4(HBB):c.292C>A (p.His98Asn)	HBB|LOC106099062|LOC107133510	H97N, H98N	HEMOGLOBIN SANTA CLARA	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015607	11	5247830	11	5226600	15607	30646	rs33950993	NC_000011.10:5226599:G:T
NM_000518.4(HBB):c.292C>T (p.His98Tyr)	HBB|LOC106099062|LOC107133510	H97Y, H98Y	HEMOGLOBIN MORIGUCHI	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015274	11	5247830	11	5226600	15274	30313	rs33950993	NC_000011.10:5226599:G:A
NM_000518.5(HBB):c.290T>C (p.Leu97Pro)	HBB|LOC106099062|LOC107133510	L96P, L97P	HEMOGLOBIN DEBROUSSE	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015550	11	5247832	11	5226602	15550	30589	rs36081208	NC_000011.10:5226601:A:G
NM_000518.5(HBB):c.289C>G (p.Leu97Val)	HBB|LOC106099062|LOC107133510	L96V, L97V	HEMOGLOBIN REGINA	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015325	11	5247833	11	5226603	15325	30364	rs34665886	NC_000011.10:5226602:G:C
NM_000518.5(HBB):c.288G>A (p.Lys96=)	HBB|LOC106099062|LOC107133510		not provided|not specified	Likely benign(Last reviewed: Aug 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000256344	11	5247834	11	5226604	256344	254207	rs36038739	NC_000011.10:5226603:C:T
NM_000518.5(HBB):c.288G>C (p.Lys96Asn)	HBB|LOC106099062|LOC107133510	K95N, K96N	HEMOGLOBIN DETROIT	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015157	11	5247834	11	5226604	15157	30196	rs36038739	NC_000011.10:5226603:C:G
NM_000518.5(HBB):c.287A>T (p.Lys96Met)	HBB|LOC106099062|LOC107133510	K95M, K96M	HEMOGLOBIN J (CORDOBA)	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015218	11	5247835	11	5226605	15218	30257	rs35204496	NC_000011.10:5226604:T:A
NM_000518.5(HBB):c.286A>G (p.Lys96Glu)	HBB|LOC106099062|LOC107133510	K96E	not specified|not provided|HEMOGLOBIN N (JENKINS)|HEMOGLOBIN JENKINS|HEMOGLOBIN HOPKINS 1|HEMOGLOBIN KENWOOD|HEMOGLOBIN N (BALTIMORE)	Likely benign(Last reviewed: Jun 21, 2019)	criteria provided, multiple submitters, no conflicts	VCV000015278	11	5247836	11	5226606	15278	30317	rs33914359	NC_000011.10:5226605:T:C
NM_000518.5(HBB):c.284A>G (p.Asp95Gly)	HBB|LOC106099062|LOC107133510	D94G, D95G	HEMOGLOBIN CHANDIGARH	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015133	11	5247838	11	5226608	15133	30172	rs34579351	NC_000011.10:5226607:T:C
NM_000518.4(HBB):c.283G>T (p.Asp95Tyr)	HBB|LOC106099062|LOC107133510	D94Y, D95Y	HEMOGLOBIN GELDROP ST. ANNA	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015620	11	5247839	11	5226609	15620	30659	rs33959340	NC_000011.10:5226608:C:A
NM_000518.4(HBB):c.283G>A (p.Asp95Asn)	HBB|LOC106099062|LOC107133510	D94N, D95N	not provided|HEMOGLOBIN BUNBURY	Uncertain significance(Last reviewed: Oct 31, 2018)	criteria provided, single submitter	VCV000015123	11	5247839	11	5226609	15123	30162	rs33959340	NC_000011.10:5226608:C:T
NM_000518.4(HBB):c.283G>C (p.Asp95His)	HBB|LOC106099062|LOC107133510	D94H, D95H	HEMOGLOBIN BARCELONA|Erythrocytosis 6, familial	Pathogenic, other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015104	11	5247839	11	5226609	15104	30143	rs33959340	NC_000011.10:5226608:C:G
NM_000518.5(HBB):c.280T>C (p.Cys94Arg)	HBB|LOC106099062|LOC107133510	C94R	HEMOGLOBIN OKAZAKI	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015297	11	5247842	11	5226612	15297	30336	rs33972927	NC_000011.10:5226611:A:G
NM_000518.5(HBB):c.279C>A (p.His93Gln)	HBB|LOC106099062|LOC107133510	H93Q	not specified	Pathogenic(Last reviewed: Dec 12, 2018)	criteria provided, single submitter	VCV000811500	11	5247843	11	5226613	811500	799651	rs34083951	NC_000011.10:5226612:G:T
NM_000518.5(HBB):c.279C>R (p.His93Gln)	HBB|LOC106099062|LOC107133510	H93Q	HEMOGLOBIN SAINT ETIENNE	Pathogenic(Last reviewed: Jun 1, 1985)	no assertion criteria provided	VCV000015208	11	5247843	11	5226613	15208	30247	rs34083951	NC_000011.10:5226612:G:Y
NM_000518.4(HBB):c.278A>C (p.His93Pro)	HBB|LOC106099062|LOC107133510	H93P	HEMOGLOBIN NEWCASTLE	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015287	11	5247844	11	5226614	15287	30326	rs33974325	NC_000011.10:5226613:T:G
NM_000518.4(HBB):c.278A>G (p.His93Arg)	HBB|LOC106099062|LOC107133510	H92R, H93R	HEMOGLOBIN MOZHAISK	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015276	11	5247844	11	5226614	15276	30315	rs33974325	NC_000011.10:5226613:T:C
NM_000518.4(HBB):c.277C>A (p.His93Asn)	HBB|LOC106099062|LOC107133510	H93N, H92N	Hemoglobinopathy	Pathogenic(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015494	11	5247845	11	5226615	15494	30533	rs33924775	NC_000011.10:5226614:G:T
NM_000518.4(HBB):c.277C>T (p.His93Tyr)	HBB|LOC106099062|LOC107133510	H92Y, H93Y	HEMOGLOBIN M (HYDE PARK)|HEMOGLOBIN M (AKITA)|HEMOGLOBIN M (MILWAUKEE 2)|Methemoglobinemia, beta-globin type	Pathogenic, other(Last reviewed: May 10, 2018)	no assertion criteria provided	VCV000015255	11	5247845	11	5226615	15255	30294	rs33924775	NC_000011.10:5226614:G:A
NM_000518.4(HBB):c.277C>G (p.His93Asp)	HBB|LOC106099062|LOC107133510	H92D, H93D	HEMOGLOBIN J (ALTGELD GARDENS)	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015209	11	5247845	11	5226615	15209	30248	rs33924775	NC_000011.10:5226614:G:C
NM_000518.4(HBB):c.275T>C (p.Leu92Pro)	HBB|LOC106099062|LOC107133510	L92P	HEMOGLOBIN SABINE|not specified	Pathogenic(Last reviewed: Jan 18, 2017)	criteria provided, single submitter	VCV000015338	11	5247847	11	5226617	15338	30377	rs33917785	NC_000011.10:5226616:A:G
NM_000518.4(HBB):c.275T>G (p.Leu92Arg)	HBB|LOC106099062|LOC107133510	L91R, L92R	HEMOGLOBIN CARIBBEAN	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015131	11	5247847	11	5226617	15131	30170	rs33917785	NC_000011.10:5226616:A:C
NM_000518.5(HBB):c.274C>T (p.Leu92=)	HBB|LOC106099062|LOC107133510		not provided|beta Thalassemia|Hemoglobin E|Fetal hemoglobin quantitative trait locus 1|Hb SS disease|not specified	Conflicting interpretations of pathogenicity(Last reviewed: Dec 31, 2019)	criteria provided, conflicting interpretations	VCV000439144	11	5247848	11	5226618	439144	432683	rs769583496	NC_000011.10:5226617:G:A
NM_000518.5(HBB):c.273G>C (p.Glu91Asp)	HBB|LOC106099062|LOC107133510	E90D, E91D	HEMOGLOBIN PIERRE-BENITE	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015311	11	5247849	11	5226619	15311	30350	rs35002698	NC_000011.10:5226618:C:G
NM_000518.5(HBB):c.272A>G (p.Glu91Gly)	HBB|LOC106099062|LOC107133510	E90G, E91G	HEMOGLOBIN ROSEAU-POINTE A PITRE	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015330	11	5247850	11	5226620	15330	30369	rs35068498	NC_000011.10:5226619:T:C
NM_000518.4(HBB):c.[20A>T;271G>A]	HBB|LOC106099062|LOC107133510	E91K, E7V	HEMOGLOBIN S (CAMEROON)	Pathogenic(Last reviewed: May 1, 2004)	no assertion criteria provided	VCV000446747	11|11	5247851	11|11	5226621	446747	30130|30372	rs33913712|rs334	NC_000011.10:5226620:C:T|NC_000011.10:5227001:T:A
NM_000518.5(HBB):c.271G>T (p.Glu91Ter)	HBB|LOC106099062|LOC107133510	E91*	beta^0^ Thalassemia|beta Thalassemia	Pathogenic(Last reviewed: Nov 25, 2019)	no assertion criteria provided	VCV000015504	11	5247851	11	5226621	15504	30543	rs33913712	NC_000011.10:5226620:C:A
NM_000518.4(HBB):c.271G>A (p.Glu91Lys)	HBB|LOC106099062|LOC107133510	E91K	HEMOGLOBIN AGENOGI|not provided	Uncertain significance(Last reviewed: Nov 6, 2017)	criteria provided, single submitter	VCV000015091	11	5247851	11	5226621	15091	30130	rs33913712	NC_000011.10:5226620:C:T
NM_000518.5(HBB):c.270T>C (p.Ser90=)	HBB|LOC106099062|LOC107133510		not specified	Likely benign(Last reviewed: Aug 28, 2019)	criteria provided, single submitter	VCV000495984	11	5247852	11	5226622	495984	487502	rs1554917814	NC_000011.10:5226621:A:G
NM_000518.4(HBB):c.269G>C (p.Ser90Thr)	HBB|LOC106099062|LOC107133510	S89T, S90T	HEMOGLOBIN VILLAVERDE	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015528	11	5247853	11	5226623	15528	30567	rs33917628	NC_000011.10:5226622:C:G
NM_000518.4(HBB):c.269G>A (p.Ser90Asn)	HBB|LOC106099062|LOC107133510	S89N, S90N	HEMOGLOBIN CRETEIL|Erythrocytosis 6, familial	Pathogenic, other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015147	11	5247853	11	5226623	15147	30186	rs33917628	NC_000011.10:5226622:C:T
NM_000518.5(HBB):c.268A>C (p.Ser90Arg)	HBB|LOC106099062|LOC107133510	S89R, S90R	HEMOGLOBIN VANDERBILT|Erythrocytosis 6, familial	Pathogenic, other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015383	11	5247854	11	5226624	15383	30422	rs35351128	NC_000011.10:5226623:T:G
NM_000518.4(HBB):c.266T>C (p.Leu89Pro)	HBB|LOC106099062|LOC107133510	L89P	HEMOGLOBIN SANTA ANA|not provided	Pathogenic(Last reviewed: Oct 1, 2017)	criteria provided, single submitter	VCV000015343	11	5247856	11	5226626	15343	30382	rs33940204	NC_000011.10:5226625:A:G
NM_000518.4(HBB):c.266T>G (p.Leu89Arg)	HBB|LOC106099062|LOC107133510	L88R, L89R	HEMOGLOBIN BORAS	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015108	11	5247856	11	5226626	15108	30147	rs33940204	NC_000011.10:5226625:A:C
NM_000518.4(HBB):c.263C>T (p.Thr88Ile)	HBB|LOC106099062|LOC107133510	T87I, T88I	not specified	Benign(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015493	11	5247859	11	5226629	15493	30532	rs33993568	NC_000011.10:5226628:G:A
NM_000518.4(HBB):c.263C>A (p.Thr88Lys)	HBB|LOC106099062|LOC107133510	T87K, T88K	not specified|HEMOGLOBIN D (IBADAN)	Likely benign(Last reviewed: Jan 20, 2017)	criteria provided, single submitter	VCV000015150	11	5247859	11	5226629	15150	30189	rs33993568	NC_000011.10:5226628:G:T
NM_000518.5(HBB):c.262A>C (p.Thr88Pro)	HBB|LOC106099062|LOC107133510	T88P	not specified|beta Thalassemia|HEMOGLOBIN VALLETTA	Benign/Likely benign(Last reviewed: Nov 22, 2019)	criteria provided, multiple submitters, no conflicts	VCV000015489	11	5247860	11	5226630	15489	30528	rs35553496	NC_000011.10:5226629:T:G
NM_000518.5(HBB):c.260C>A (p.Ala87Asp)	HBB|LOC106099062|LOC107133510	A86D, A87D	HEMOGLOBIN OLOMOUC	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015299	11	5247862	11	5226632	15299	30338	rs35819837	NC_000011.10:5226631:G:T
NM_000518.5(HBB):c.259G>C (p.Ala87Pro)	HBB|LOC106099062|LOC107133510	A87P	HEMOGLOBIN CARDARELLI	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015611	11	5247863	11	5226633	15611	30650	rs33952147	NC_000011.10:5226632:C:G
NM_000518.5(HBB):c.257T>C (p.Phe86Ser)	HBB|LOC106099062|LOC107133510	F85S, F86S	Hemoglobinopathy	Pathogenic(Last reviewed: Sep 29, 1967)	no assertion criteria provided	VCV000015122	11	5247865	11	5226635	15122	30161	rs35693898	NC_000011.10:5226634:A:G
NM_000518.5(HBB):c.254C>T (p.Thr85Ile)	HBB|LOC106099062|LOC107133510	T84I, T85I	HEMOGLOBIN KOFU	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015240	11	5247868	11	5226638	15240	30279	rs35914488	NC_000011.10:5226637:G:A
NM_000518.5(HBB):c.253A>G (p.Thr85Ala)	HBB|LOC106099062|LOC107133510	T84A, T85A	HEMOGLOBIN SAALE|not provided	Uncertain significance(Last reviewed: Feb 16, 2018)	criteria provided, single submitter	VCV000015579	11	5247869	11	5226639	15579	30618	rs35960772	NC_000011.10:5226638:T:C
NM_000518.5(HBB):c.251G>A (p.Gly84Asp)	HBB|LOC106099062|LOC107133510	G84D	not specified|HEMOGLOBIN PYRGOS	Likely benign(Last reviewed: Nov 7, 2018)	criteria provided, single submitter	VCV000015320	11	5247871	11	5226641	15320	30359	rs1803195	NC_000011.10:5226640:C:T
NM_000518.5(HBB):c.250G>C (p.Gly84Arg)	HBB|LOC106099062|LOC107133510	G84R	HEMOGLOBIN MUSKEGON	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015521	11	5247872	11	5226642	15521	30560	rs33930385	NC_000011.10:5226641:C:G
NM_000518.5(HBB):c.250G>T (p.Gly84Cys)	HBB|LOC106099062|LOC107133510	G83C, G84C	not provided|HEMOGLOBIN TA-LI	Uncertain significance(Last reviewed: Jul 18, 2019)	criteria provided, single submitter	VCV000015367	11	5247872	11	5226642	15367	30406	rs33930385	NC_000011.10:5226641:C:A
NM_000518.5(HBB):c.249G>C (p.Lys83Asn)	HBB|LOC106099062|LOC107133510	K83N	not provided	Likely pathogenic(Last reviewed: Jun 27, 2018)	criteria provided, single submitter	VCV000618675	11	5247873	11	5226643	618675	609790	rs33991993	NC_000011.10:5226642:C:G
NM_000518.4(HBB):c.[20A>T;249G>Y]	HBB|LOC106099062|LOC107133510	K83N, E7V	HEMOGLOBIN S (PROVIDENCE)	Pathogenic(Last reviewed: Oct 1, 1988)	no assertion criteria provided	VCV000446737	11|11	5247873	11|11	5226643	446737	30358|30372	rs33991993|rs334	NC_000011.10:5226642:C:R|NC_000011.10:5227001:T:A
NM_000518.5(HBB):c.249G>Y (p.Lys83Asn)	HBB|LOC106099062|LOC107133510	K83N	Erythrocytosis 6, familial|HEMOGLOBIN PROVIDENCE	Pathogenic, other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015319	11	5247873	11	5226643	15319	30358	rs33991993	NC_000011.10:5226642:C:R
NM_000518.4(HBB):c.248A>C (p.Lys83Thr)	HBB|LOC106099062|LOC107133510	K82T, K83T	HEMOGLOBIN RAHERE|Erythrocytosis 6, familial	Pathogenic, other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015321	11	5247874	11	5226644	15321	30360	rs33987903	NC_000011.10:5226643:T:G
NM_000518.4(HBB):c.248A>T (p.Lys83Met)	HBB|LOC106099062|LOC107133510	K82M, K83M	HEMOGLOBIN HELSINKI|Erythrocytosis 6, familial	Pathogenic, other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015193	11	5247874	11	5226644	15193	30232	rs33987903	NC_000011.10:5226643:T:A
NM_000518.4(HBB):c.247A>G (p.Lys83Glu)	HBB|LOC106099062|LOC107133510	K82E, K83E	Hb gambara	Pathogenic(Last reviewed: Jul 1, 1997)	no assertion criteria provided	VCV000015561	11	5247875	11	5226645	15561	30600	rs33940051	NC_000011.10:5226644:T:C
NM_000518.4(HBB):c.247A>C (p.Lys83Gln)	HBB|LOC106099062|LOC107133510	K82Q, K83Q	HEMOGLOBIN TSURUMAI	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015552	11	5247875	11	5226645	15552	30591	rs33940051	NC_000011.10:5226644:T:G
NM_000518.5(HBB):c.246C>A (p.Leu82=)	HBB|LOC106099062|LOC107133510		not specified|beta Thalassemia|Hemoglobin E|Fetal hemoglobin quantitative trait locus 1|Hb SS disease|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Dec 31, 2019)	criteria provided, conflicting interpretations	VCV000439778	11	5247876	11	5226646	439778	433087	rs145669504	NC_000011.10:5226645:G:T
NM_000518.5(HBB):c.246C>G (p.Leu82=)	HBB|LOC106099062|LOC107133510		not provided|beta Thalassemia	Likely benign(Last reviewed: Dec 20, 2018)	criteria provided, multiple submitters, no conflicts	VCV000036305	11	5247876	11	5226646	36305	44969	rs145669504	NC_000011.10:5226645:G:C
NM_000518.4(HBB):c.245T>A (p.Leu82His)	HBB|LOC106099062|LOC107133510	L81H, L82H	HEMOGLOBIN LA ROCHE-SUR-YON	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015570	11	5247877	11	5226647	15570	30609	rs33936967	NC_000011.10:5226646:A:T
NM_000518.4(HBB):c.245T>G (p.Leu82Arg)	HBB|LOC106099062|LOC107133510	L81R, L82R	HEMOGLOBIN BAYLOR	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015105	11	5247877	11	5226647	15105	30144	rs33936967	NC_000011.10:5226646:A:C
NM_000518.5(HBB):c.244C>T (p.Leu82Phe)	LOC106099062|LOC107133510|HBB	L82F	not provided	Uncertain significance(Last reviewed: Feb 28, 2018)	criteria provided, single submitter	VCV000619857	11	5247878	11	5226648	619857	611096	rs11549406	NC_000011.10:5226647:G:A
NM_000518.5(HBB):c.243C>A (p.Asn81Lys)	HBB|LOC106099062|LOC107133510	N80K, N81K	HEMOGLOBIN G (SZUHU)|HEMOGLOBIN GIFU	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015177	11	5247879	11	5226649	15177	30216	rs35890380	NC_000011.10:5226648:G:T
NM_000518.5(HBB):c.239A>G (p.Asp80Gly)	HBB|LOC106099062|LOC107133510	D79G, D80G	HEMOGLOBIN G (HSI-TSOU)	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015174	11	5247883	11	5226653	15174	30213	rs34173382	NC_000011.10:5226652:T:C
NM_000518.4(HBB):c.238G>C (p.Asp80His)	HBB|LOC106099062|LOC107133510	D80H	HEMOGLOBIN TIGRAYE|not specified	Uncertain significance(Last reviewed: Apr 10, 2019)	criteria provided, single submitter	VCV000015522	11	5247884	11	5226654	15522	30561	rs33990858	NC_000011.10:5226653:C:G
NM_000518.4(HBB):c.238G>T (p.Asp80Tyr)	HBB|LOC106099062|LOC107133510	D80Y	not specified|HEMOGLOBIN TAMPA	Likely benign(Last reviewed: Nov 28, 2018)	criteria provided, single submitter	VCV000015371	11	5247884	11	5226654	15371	30410	rs33990858	NC_000011.10:5226653:C:A
NM_000518.4(HBB):c.238G>A (p.Asp80Asn)	HBB|LOC107133510|LOC106099062	D80N	HEMOGLOBIN YAIZU|not specified|HEMOGLOBIN G (ACCRA)	Uncertain significance(Last reviewed: Dec 13, 2016)	criteria provided, single submitter	VCV000015169	11	5247884	11	5226654	15169	30208	rs33990858	NC_000011.10:5226653:C:T
NM_000518.5(HBB):c.236T>G (p.Leu79Arg)	HBB|LOC106099062|LOC107133510	L78R, L79R	HEMOGLOBIN QUIN-HAI	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015314	11	5247886	11	5226656	15314	30353	rs34870172	NC_000011.10:5226655:A:C
NM_000518.5(HBB):c.233A>G (p.His78Arg)	HBB|LOC106099062|LOC107133510	H77R, H78R	HEMOGLOBIN COSTA RICA	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015556	11	5247889	11	5226659	15556	30595	rs33952543	NC_000011.10:5226658:T:C
NM_000518.4(HBB):c.232C>G (p.His78Asp)	HBB|LOC106099062|LOC107133510	H77D, H78D	not provided|HEMOGLOBIN J (IRAN)	Uncertain significance(Last reviewed: Sep 14, 2018)	criteria provided, single submitter	VCV000015221	11	5247890	11	5226660	15221	30260	rs33991294	NC_000011.10:5226659:G:C
NM_000518.4(HBB):c.232C>T (p.His78Tyr)	HBB|LOC106099062|LOC107133510	H77Y, H78Y	HEMOGLOBIN FUKUYAMA	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015168	11	5247890	11	5226660	15168	30207	rs33991294	NC_000011.10:5226659:G:A
NM_000518.5(HBB):c.230C>A (p.Ala77Asp)	HBB|LOC106099062|LOC107133510	A76D, A77D	HEMOGLOBIN J (CHICAGO)	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015217	11	5247892	11	5226662	15217	30256	rs33985847	NC_000011.10:5226661:G:T
NM_000518.5(HBB):c.229G>C (p.Ala77Pro)	HBB|LOC106099062|LOC107133510	A76P, A77P	HEMOGLOBIN CALAIS	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015482	11	5247893	11	5226663	15482	30521	rs35286210	NC_000011.10:5226662:C:G
NM_000518.4(HBB):c.227T>G (p.Leu76Arg)	HBB|LOC106099062|LOC107133510	L75R, L76R	HEMOGLOBIN PASADENA	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015307	11	5247895	11	5226665	15307	30346	rs33950542	NC_000011.10:5226664:A:C
NM_000518.4(HBB):c.227T>C (p.Leu76Pro)	HBB|LOC106099062|LOC107133510	L75P, L76P	HEMOGLOBIN ATLANTA|HEMOGLOBIN ATLANTA-COVENTRY	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015100	11	5247895	11	5226665	15100	30139	rs33950542	NC_000011.10:5226664:A:G
NM_000518.4(HBB):c.224G>A (p.Gly75Asp)	HBB|LOC106099062|LOC107133510	G74D, G75D	HEMOGLOBIN SHEPHERDS BUSH	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015350	11	5247898	11	5226668	15350	30389	rs33976006	NC_000011.10:5226667:C:T
NM_000518.4(HBB):c.224G>T (p.Gly75Val)	HBB|LOC106099062|LOC107133510	G74V, G75V	HEMOGLOBIN BUSHWICK	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015125	11	5247898	11	5226668	15125	30164	rs33976006	NC_000011.10:5226667:C:A
NM_000518.5(HBB):c.223G>A (p.Gly75Ser)	HBB|LOC106099062|LOC107133510	G75S	not specified	Uncertain significance(Last reviewed: Sep 9, 2019)	criteria provided, single submitter	VCV000495982	11	5247899	11	5226669	495982	487446	rs33916541	NC_000011.10:5226668:C:T
NM_000518.5(HBB):c.223G>C (p.Gly75Arg)	HBB|LOC106099062|LOC107133510	G74R, G75R	HEMOGLOBIN AALBORG	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015089	11	5247899	11	5226669	15089	30128	rs33916541	NC_000011.10:5226668:C:G
NM_000518.4(HBB):c.221A>G (p.Asp74Gly)	HBB|LOC106099062|LOC107133510	D73G, D74G	HEMOGLOBIN TILBURG	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015373	11	5247901	11	5226671	15373	30412	rs33967755	NC_000011.10:5226670:T:C
NM_000518.4(HBB):c.221A>T (p.Asp74Val)	HBB|LOC106099062|LOC107133510	D73V, D74V	HEMOGLOBIN MOBILE	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015273	11	5247901	11	5226671	15273	30312	rs33967755	NC_000011.10:5226670:T:A
NM_000518.4(HBB):c.[20A>T;220G>A]	HBB|LOC106099062|LOC107133510	D74N, E7V	HEMOGLOBIN ZIGUINCHOR	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000446730	11|11	5247902	11|11	5226672	446730	30283|30372	rs33945705|rs334	NC_000011.10:5226671:C:T|NC_000011.10:5227001:T:A
NM_000518.4(HBB):c.220G>T (p.Asp74Tyr)	HBB|LOC106099062|LOC107133510	D73Y, D74Y	HEMOGLOBIN VANCOUVER	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015382	11	5247902	11	5226672	15382	30421	rs33945705	NC_000011.10:5226671:C:A
NM_000518.4(HBB):c.220G>A (p.Asp74Asn)	HBB|LOC106099062|LOC107133510	D74N	not specified|HEMOGLOBIN KORLE-BU|not provided	Likely benign(Last reviewed: Aug 7, 2020)	criteria provided, multiple submitters, no conflicts	VCV000015244	11	5247902	11	5226672	15244	30283	rs33945705	NC_000011.10:5226671:C:T
NM_000518.5(HBB):c.216T>A (p.Phe72Leu)	HBB|LOC106099062|LOC107133510	F72L	not provided	Uncertain significance(Last reviewed: Oct 24, 2018)	criteria provided, single submitter	VCV000801185	11	5247906	11	5226676	801185	789499	rs754481448	NC_000011.10:5226675:A:T
NM_000518.5(HBB):c.215T>C (p.Phe72Ser)	HBB|LOC106099062|LOC107133510	F71S, F72S	HEMOGLOBIN CHRISTCHURCH	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015137	11	5247907	11	5226677	15137	30176	rs34362537	NC_000011.10:5226676:A:G
NM_000518.4(HBB):c.212C>T (p.Ala71Val)	HBB|LOC106099062|LOC107133510	A70V, A71V	HEMOGLOBIN MARINEO	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015621	11	5247910	11	5226680	15621	30660	rs33946401	NC_000011.10:5226679:G:A
NM_000518.4(HBB):c.212C>A (p.Ala71Asp)	HBB|LOC106099062|LOC107133510	A70D, A71D	HEMOGLOBIN SEATTLE	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015346	11	5247910	11	5226680	15346	30385	rs33946401	NC_000011.10:5226679:G:T
NM_000518.5(HBB):c.209G>A (p.Gly70Asp)	HBB|LOC106099062|LOC107133510	G70D	not specified|not provided	Likely benign(Last reviewed: May 23, 2017)	criteria provided, single submitter	VCV000015226	11	5247913	11	5226683	15226	30265	rs34718174	NC_000011.10:5226682:C:T
NM_000518.4(HBB):c.208G>C (p.Gly70Arg)	HBB|LOC106099062|LOC107133510	G69R, G70R	HEMOGLOBIN KENITRA	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015237	11	5247914	11	5226684	15237	30276	rs33947415	NC_000011.10:5226683:C:G
NM_000518.4(HBB):c.208G>A (p.Gly70Ser)	HBB|LOC106099062|LOC107133510	G70S	not provided|Fetal hemoglobin quantitative trait locus 1|beta Thalassemia|Beta-thalassemia, dominant inclusion body type|Hb SS disease|beta Thalassemia|not specified|Hemoglobin E|HEMOGLOBIN CITY OF HOPE|Fetal hemoglobin quantitative trait locus 1|Hb SS disease	Conflicting interpretations of pathogenicity(Last reviewed: Dec 27, 2019)	criteria provided, conflicting interpretations	VCV000015138	11	5247914	11	5226684	15138	30177	rs33947415	NC_000011.10:5226683:C:T
NM_000518.5(HBB):c.207C>T (p.Leu69=)	HBB|LOC106099062|LOC107133510		not specified|not provided	Likely benign(Last reviewed: Dec 31, 2019)	criteria provided, multiple submitters, no conflicts	VCV000439141	11	5247915	11	5226685	439141	432686	rs112287010	NC_000011.10:5226684:G:A
NM_000518.4(HBB):c.206T>C (p.Leu69Pro)	HBB|LOC106099062|LOC107133510	L68P, L69P	HEMOGLOBIN MIZUHO	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015271	11	5247916	11	5226686	15271	30310	rs33972593	NC_000011.10:5226685:A:G
NM_000518.4(HBB):c.206T>A (p.Leu69His)	HBB|LOC106099062|LOC107133510	L68H, L69H	HEMOGLOBIN BRISBANE|HEMOGLOBIN GREAT LAKES|Erythrocytosis 6, familial	Pathogenic, other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015117	11	5247916	11	5226686	15117	30156	rs33972593	NC_000011.10:5226685:A:T
NM_000518.5(HBB):c.205C>T (p.Leu69Phe)	HBB|LOC106099062|LOC107133510	L69F	HEMOGLOBIN ROCKFORD	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015613	11	5247917	11	5226687	15613	30652	rs33961459	NC_000011.10:5226686:G:A
NM_000518.4(HBB):c.203T>G (p.Val68Gly)	HBB|LOC106099062|LOC107133510	V67G, V68G	HEMOGLOBIN MANUKAU	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015527	11	5247919	11	5226689	15527	30566	rs33918343	NC_000011.10:5226688:A:C
NM_000518.4(HBB):c.203T>C (p.Val68Ala)	HBB|LOC106099062|LOC107133510	V67A, V68A	HEMOGLOBIN SYDNEY	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015364	11	5247919	11	5226689	15364	30403	rs33918343	NC_000011.10:5226688:A:G
NM_000518.4(HBB):c.203T>A (p.Val68Glu)	LOC107133510|HBB|LOC106099062	V67E, V68E	HEMOGLOBIN M (MILWAUKEE 1)|Methemoglobinemia, beta-globin type	Pathogenic, other(Last reviewed: May 10, 2018)	no assertion criteria provided	VCV000015254	11	5247919	11	5226689	15254	30293	rs33918343	NC_000011.10:5226688:A:T
NM_000518.4(HBB):c.202G>A (p.Val68Met)	HBB|LOC106099062|LOC107133510	V68M	HEMOGLOBIN ALESHA|HEMOGLOBIN BRISTOL	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015536	11	5247920	11	5226690	15536	30575	rs36008922	NC_000011.10:5226689:C:T
NM_000518.5(HBB):c.201A>G (p.Lys67=)	LOC107133510|HBB|LOC106099062		not provided	Uncertain significance(Last reviewed: Feb 18, 2018)	criteria provided, single submitter	VCV000619855	11	5247921	11	5226691	619855	611098	rs36092904	NC_000011.10:5226690:T:C
NM_000518.5(HBB):c.200A>C (p.Lys67Thr)	HBB|LOC106099062|LOC107133510	K67T	not specified|HEMOGLOBIN CHICO	Uncertain significance(Last reviewed: Aug 9, 2016)	criteria provided, single submitter	VCV000015136	11	5247922	11	5226692	15136	30175	rs35939489	NC_000011.10:5226691:T:G
NM_000518.5(HBB):c.199A>T (p.Lys67Ter)	HBB|LOC106099062|LOC107133510	K67*	beta Thalassemia	Pathogenic(Last reviewed: Nov 25, 2019)	no assertion criteria provided	VCV000869229	11	5247923	11	5226693	869229	857466		NC_000011.10:5226692:T:A
NM_000518.5(HBB):c.199A>G (p.Lys67Glu)	HBB|LOC106099062|LOC107133510	K66E, K67E	not provided|Hemoglobinopathy	Likely pathogenic(Last reviewed: Oct 9, 2018)	criteria provided, single submitter	VCV000015206	11	5247923	11	5226693	15206	30245	rs34165323	NC_000011.10:5226692:T:C
NM_000518.5(HBB):c.198G>C (p.Lys66Asn)	HBB|LOC106099062|LOC107133510	K65N, K66N	HEMOGLOBIN J (SICILIA)	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015227	11	5247924	11	5226694	15227	30266	rs35747961	NC_000011.10:5226693:C:G
NM_000518.4(HBB):c.[197A>T;367T>C]	LOC106099062|HBB|LOC107133510|LOC110006319	K66M, F123L	HEMOGLOBIN CASABLANCA	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000446744	11|11	5247925	11|11	5226695	446744	30250|30619	rs33932548|rs33971848	NC_000011.10:5226694:T:A|NC_000011.10:5225674:A:G
NM_000518.5(HBB):c.197A>T (p.Lys66Met)	HBB|LOC106099062|LOC107133510	K66M	HEMOGLOBIN J (ANTAKYA)	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015211	11	5247925	11	5226695	15211	30250	rs33932548	NC_000011.10:5226694:T:A
NM_000518.5(HBB):c.196A>C (p.Lys66Gln)	HBB|LOC106099062|LOC107133510	K65Q, K66Q	HEMOGLOBIN J (CAIRO)	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015215	11	5247926	11	5226696	15215	30254	rs35353749	NC_000011.10:5226695:T:G
NM_000518.4(HBB):c.194G>C (p.Gly65Ala)	HBB|LOC106099062|LOC107133510	G64A, G65A	HEMOGLOBIN AUBAGNE	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015599	11	5247928	11	5226698	15599	30638	rs33922018	NC_000011.10:5226697:C:G
NM_000518.4(HBB):c.194G>A (p.Gly65Asp)	HBB|LOC106099062|LOC107133510	G64D, G65D	HEMOGLOBIN J (BARI)|HEMOGLOBIN J (CALABRIA)|HEMOGLOBIN J (COSENZA)	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015216	11	5247928	11	5226698	15216	30255	rs33922018	NC_000011.10:5226697:C:T
NM_000518.4(HBB):c.191A>G (p.His64Arg)	HBB|LOC106099062|LOC107133510	H63R, H64R	Hemoglobin Zurich	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015400	11	5247931	11	5226701	15400	30439	rs33985544	NC_000011.10:5226700:T:C
NM_000518.4(HBB):c.191A>C (p.His64Pro)	HBB|LOC106099062|LOC107133510	H63P, H64P	HEMOGLOBIN BICETRE	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015113	11	5247931	11	5226701	15113	30152	rs33985544	NC_000011.10:5226700:T:G
NM_000518.5(HBB):c.190C>T (p.His64Tyr)	HBB|LOC106099062|LOC107133510	H64Y	HEMOGLOBIN M (RADOM) METHEMOGLOBINEMIA, BETA TYPE|beta Thalassemia|HEMOGLOBIN M (SASKATOON)	Pathogenic(Last reviewed: Jul 2, 2019)	criteria provided, multiple submitters, no conflicts	VCV000015256	11	5247932	11	5226702	15256	30295	rs33922873	NC_000011.10:5226701:G:A
NM_000518.5(HBB):c.188C>A (p.Ala63Asp)	HBB|LOC106099062|LOC107133510	A62D, A63D	HEMOGLOBIN J (EUROPA)	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015553	11	5247934	11	5226704	15553	30592	rs34151786	NC_000011.10:5226703:G:T
NM_000518.5(HBB):c.187G>C (p.Ala63Pro)	HBB|LOC106099062|LOC107133510	A62P, A63P	HEMOGLOBIN DUARTE	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015160	11	5247935	11	5226705	15160	30199	rs34933455	NC_000011.10:5226704:C:G
NM_000518.5(HBB):c.186G>C (p.Lys62Asn)	HBB|LOC106099062|LOC107133510	K62N	not specified|HEMOGLOBIN HIKARI	Likely benign(Last reviewed: May 2, 2019)	criteria provided, single submitter	VCV000015196	11	5247936	11	5226706	15196	30235	rs34446260	NC_000011.10:5226705:C:G
NM_000518.5(HBB):c.185A>T (p.Lys62Met)	HBB|LOC106099062|LOC107133510	K61M, K62M	HEMOGLOBIN BOLOGNA	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015114	11	5247937	11	5226707	15114	30153	rs34974709	NC_000011.10:5226706:T:A
NM_000518.4(HBB):c.184A>C (p.Lys62Gln)	HBB|LOC106099062|LOC107133510	K61Q, K62Q	HEMOGLOBIN POCOS DE CALDAS	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015603	11	5247938	11	5226708	15603	30642	rs33995148	NC_000011.10:5226707:T:G
NM_000518.5(HBB):c.184A>T (p.Lys62Ter)	HBB|LOC106099062|LOC107133510	K62*	not provided|beta^0^ Thalassemia|beta Thalassemia	Pathogenic(Last reviewed: Feb 17, 2020)	criteria provided, multiple submitters, no conflicts	VCV000015407	11	5247938	11	5226708	15407	30446	rs33995148	NC_000011.10:5226707:T:A
NM_000518.4(HBB):c.184A>G (p.Lys62Glu)	HBB|LOC106099062|LOC107133510	K62E	not specified|HEMOGLOBIN N (SEATTLE)	Uncertain significance(Last reviewed: May 25, 2019)	criteria provided, single submitter	VCV000015280	11	5247938	11	5226708	15280	30319	rs33995148	NC_000011.10:5226707:T:C
NM_000518.4(HBB):c.182T>A (p.Val61Glu)	HBB|LOC106099062|LOC107133510	V60E, V61E	HEMOGLOBIN CAGLIARI|Beta-plus-thalassemia	Pathogenic, other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015411	11	5247940	11	5226710	15411	30450	rs33931779	NC_000011.10:5226709:A:T
NM_000518.4(HBB):c.182T>C (p.Val61Ala)	HBB|LOC106099062|LOC107133510	V60A, V61A	HEMOGLOBIN COLLINGWOOD	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015141	11	5247940	11	5226710	15141	30180	rs33931779	NC_000011.10:5226709:A:G
NM_000518.5(HBB):c.181G>C (p.Val61Leu)	HBB|LOC106099062|LOC107133510	V60L, V61L	HEMOGLOBIN YATSUSHIRO	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015393	11	5247941	11	5226711	15393	30432	rs33990253	NC_000011.10:5226710:C:G
NM_000518.5(HBB):c.180G>A (p.Lys60=)	HBB|LOC106099062|LOC107133510		not provided|not specified	Likely benign(Last reviewed: Feb 29, 2020)	criteria provided, multiple submitters, no conflicts	VCV000439139	11	5247942	11	5226712	439139	432687	rs34621955	NC_000011.10:5226711:C:T
NM_000518.5(HBB):c.180G>C (p.Lys60Asn)	HBB|LOC106099062|LOC107133510	K60N	not specified|HEMOGLOBIN J (LOME)	Uncertain significance(Last reviewed: Sep 13, 2018)	criteria provided, single submitter	VCV000015224	11	5247942	11	5226712	15224	30263	rs34621955	NC_000011.10:5226711:C:G
NM_000518.5(HBB):c.179A>C (p.Lys60Thr)	HBB|LOC106099062|LOC107133510	K60T	not specified	Uncertain significance(Last reviewed: Mar 29, 2019)	criteria provided, single submitter	VCV000015222	11	5247943	11	5226713	15222	30261	rs35537181	NC_000011.10:5226712:T:G
NM_000518.5(HBB):c.178A>T (p.Lys60Ter)	HBB|LOC106099062|LOC107133510	K60*	beta Thalassemia	Pathogenic(Last reviewed: Nov 25, 2019)	no assertion criteria provided	VCV000869224	11	5247944	11	5226714	869224	857469		NC_000011.10:5226713:T:A
NM_000518.5(HBB):c.178A>G (p.Lys60Glu)	HBB|LOC106099062|LOC107133510	K59E, K60E	HEMOGLOBIN I (HIGH WYCOMBE)	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015205	11	5247944	11	5226714	15205	30244	rs33969400	NC_000011.10:5226713:T:C
NM_000518.5(HBB):c.176C>G (p.Pro59Arg)	HBB|LOC106099062|LOC107133510	P59R	Hemoglobinopathy	Pathogenic(Last reviewed: Sep 10, 1968)	no assertion criteria provided	VCV000015398	11	5247946	11	5226716	15398	30437	rs33991472	NC_000011.10:5226715:G:C
NM_000518.5(HBB):c.174C>T (p.Asn58=)	HBB|LOC106099062|LOC107133510		not specified	Likely benign(Last reviewed: Aug 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000439138	11	5247948	11	5226718	439138	432688	rs35278874	NC_000011.10:5226717:G:A
NM_000518.5(HBB):c.174C>A (p.Asn58Lys)	HBB|LOC106099062|LOC107133510	N58K	not specified|HEMOGLOBIN G (FERRARA)	Uncertain significance(Last reviewed: Dec 19, 2016)	criteria provided, single submitter	VCV000015172	11	5247948	11	5226718	15172	30211	rs35278874	NC_000011.10:5226717:G:T
NM_000518.5(HBB):c.172A>G (p.Asn58Asp)	HBB|LOC106099062|LOC107133510	N57D, N58D	HEMOGLOBIN J (DALOA)	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015219	11	5247950	11	5226720	15219	30258	rs33988732	NC_000011.10:5226719:T:C
NM_000518.5(HBB):c.171C>T (p.Gly57=)	HBB|LOC106099062|LOC107133510		not provided|not specified	Likely benign(Last reviewed: Nov 14, 2019)	criteria provided, multiple submitters, no conflicts	VCV000036300	11	5247951	11	5226721	36300	44964	rs193922551	NC_000011.10:5226720:G:A
NM_000518.5(HBB):c.170G>A (p.Gly57Asp)	HBB|LOC106099062|LOC107133510	G57D	not specified	Likely benign(Last reviewed: Jan 8, 2019)	criteria provided, single submitter	VCV000015214	11	5247952	11	5226722	15214	30253	rs34439278	NC_000011.10:5226721:C:T
NM_000518.5(HBB):c.169G>A (p.Gly57Ser)	HBB|LOC106099062|LOC107133510	G57S	not provided	Uncertain significance(Last reviewed: Jan 8, 2018)	criteria provided, single submitter	VCV000619854	11	5247953	11	5226723	619854	611099	rs33935983	NC_000011.10:5226722:C:T
NM_000518.4(HBB):c.[169G>C;259G>C]	HBB|LOC106099062|LOC107133510	G57R, A87P	HEMOGLOBIN POISSY	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000446734	11|11	5247953	11|11	5226723	446734	30227|30650	rs33935983|rs33952147	NC_000011.10:5226722:C:G|NC_000011.10:5226632:C:G
NM_000518.5(HBB):c.169G>C (p.Gly57Arg)	HBB|LOC106099062|LOC107133510	G57R	HEMOGLOBIN HAMADAN	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015188	11	5247953	11	5226723	15188	30227	rs33935983	NC_000011.10:5226722:C:G
NM_000518.5(HBB):c.167T>C (p.Met56Thr)	HBB|LOC106099062|LOC107133510	M56T	not specified	Uncertain significance(Last reviewed: Dec 16, 2019)	criteria provided, single submitter	VCV000928761	11	5247955	11	5226725	928761	917087		NC_000011.10:5226724:A:G
NM_000518.5(HBB):c.167T>A (p.Met56Lys)	HBB|LOC106099062|LOC107133510	M55K, M56K	HEMOGLOBIN MATERA	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015263	11	5247955	11	5226725	15263	30302	rs35094013	NC_000011.10:5226724:A:T
NM_000518.5(HBB):c.165T>C (p.Val55=)	HBB|LOC106099062|LOC107133510		not provided	Likely benign(Last reviewed: Dec 26, 2018)	criteria provided, single submitter	VCV000799058	11	5247957	11	5226727	799058	784025	rs760975738	NC_000011.10:5226726:A:G
NM_000518.5(HBB):c.164T>A (p.Val55Asp)	HBB|LOC106099062|LOC107133510	V54D, V55D	HEMOGLOBIN JACKSONVILLE	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015490	11	5247958	11	5226728	15490	30529	rs34037627	NC_000011.10:5226727:A:T
NM_000518.5(HBB):c.158A>T (p.Asp53Val)	HBB|LOC106099062|LOC107133510	D53V	not provided	Uncertain significance(Last reviewed: Jun 28, 2018)	criteria provided, single submitter	VCV000618676	11	5247964	11	5226734	618676	609792	rs33919924	NC_000011.10:5226733:T:A
NM_000518.4(HBB):c.158A>G (p.Asp53Gly)	HBB|LOC106099062|LOC107133510	D52G, D53G	HEMOGLOBIN HOKUSETSU	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015559	11	5247964	11	5226734	15559	30598	rs33919924	NC_000011.10:5226733:T:C
NM_000518.4(HBB):c.158A>C (p.Asp53Ala)	HBB|LOC106099062|LOC107133510	D52A, D53A	HEMOGLOBIN OCHO RIOS	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015293	11	5247964	11	5226734	15293	30332	rs33919924	NC_000011.10:5226733:T:G
NM_000518.4(HBB):c.[154C>T;157G>A]	LOC107133510|HBB|LOC106099062	D53N, P52S	HEMOGLOBIN GRENOBLE	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000446741	11|11	5247965	11|11	5226735	446741	30341|30536	rs33961886|rs281864894	NC_000011.10:5226734:C:T|NC_000011.10:5226737:G:A
NM_000518.4(HBB):c.157G>C (p.Asp53His)	HBB|LOC106099062|LOC107133510	D53H	not specified|HEMOGLOBIN SUMMER HILL	Uncertain significance(Last reviewed: Oct 11, 2018)	criteria provided, single submitter	VCV000015362	11	5247965	11	5226735	15362	30401	rs33961886	NC_000011.10:5226734:C:G
NM_000518.4(HBB):c.157G>A (p.Asp53Asn)	HBB|LOC106099062|LOC107133510	D53N	not provided|beta Thalassemia|not specified	Conflicting interpretations of pathogenicity(Last reviewed: May 28, 2019)	criteria provided, conflicting interpretations	VCV000015302	11	5247965	11	5226735	15302	30341	rs33961886	NC_000011.10:5226734:C:T
NM_000518.5(HBB):c.155C>G (p.Pro52Arg)	HBB|LOC106099062|LOC107133510	P51R, P52R	HEMOGLOBIN WILLAMETTE	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015377	11	5247967	11	5226737	15377	30416	rs33969727	NC_000011.10:5226736:G:C
NM_000518.5(HBB):c.154C>T (p.Pro52Ser)	LOC107133510|HBB|LOC106099062	P52S		no interpretation for the single variant	no interpretation for the single variant	VCV000478834	11	5247968	11	5226738	478834	30536	rs281864894	NC_000011.10:5226737:G:A
NM_000518.5(HBB):c.151A>T (p.Thr51Ser)	HBB|LOC106099062|LOC107133510	T51S	not specified	Uncertain significance(Last reviewed: Jul 7, 2020)	criteria provided, single submitter	VCV000495980	11	5247971	11	5226741	495980	487504	rs63750336	NC_000011.10:5226740:T:A
NM_000518.4(HBB):c.149C>G (p.Ser50Cys)	HBB|LOC106099062|LOC107133510	S49C, S50C	HEMOGLOBIN COLIMA	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015602	11	5247973	11	5226743	15602	30641	rs33960931	NC_000011.10:5226742:G:C
NM_000518.4(HBB):c.149C>T (p.Ser50Phe)	HBB|LOC106099062|LOC107133510	S49F, S50F	HEMOGLOBIN LAS PALMAS	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015246	11	5247973	11	5226743	15246	30285	rs33960931	NC_000011.10:5226742:G:A
NM_000518.4(HBB):c.146T>C (p.Leu49Pro)	HBB|LOC106099062|LOC107133510	L48P, L49P	HEMOGLOBIN BAB-SAADOUN	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015510	11	5247976	11	5226746	15510	30549	rs33952850	NC_000011.10:5226745:A:G
NM_000518.4(HBB):c.146T>G (p.Leu49Arg)	HBB|LOC106099062|LOC107133510	L48R, L49R	HEMOGLOBIN OKALOOSA	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015295	11	5247976	11	5226746	15295	30334	rs33952850	NC_000011.10:5226745:A:C
NM_000518.5(HBB):c.144T>C (p.Asp48=)	HBB|LOC106099062|LOC107133510		not specified	Likely benign(Last reviewed: Aug 28, 2019)	criteria provided, single submitter	VCV000495978	11	5247978	11	5226748	495978	487447	rs754454495	NC_000011.10:5226747:A:G
NM_000518.4(HBB):c.143A>G (p.Asp48Gly)	HBB|LOC106099062|LOC107133510	D47G, D48G	HEMOGLOBIN GAVELLO	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015181	11	5247979	11	5226749	15181	30220	rs33980484	NC_000011.10:5226748:T:C
NM_000518.4(HBB):c.143A>C (p.Asp48Ala)	HBB|LOC106099062|LOC107133510	D47A, D48A	HEMOGLOBIN AVICENNA	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015103	11	5247979	11	5226749	15103	30142	rs33980484	NC_000011.10:5226748:T:G
NM_000518.4(HBB):c.142G>T (p.Asp48Tyr)	HBB|LOC106099062|LOC107133510	D47Y, D48Y	HEMOGLOBIN MAPUTO	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015260	11	5247980	11	5226750	15260	30299	rs33932070	NC_000011.10:5226749:C:A
NM_000518.4(HBB):c.142G>A (p.Asp48Asn)	HBB|LOC106099062|LOC107133510	D47N, D48N	HEMOGLOBIN G (COPENHAGEN)	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015170	11	5247980	11	5226750	15170	30209	rs33932070	NC_000011.10:5226749:C:T
NM_000518.5(HBB):c.141G>A (p.Gly47=)	HBB|LOC106099062|LOC107133510		not specified	Likely benign(Last reviewed: Aug 28, 2019)	criteria provided, single submitter	VCV000495976	11	5247981	11	5226751	495976	487508	rs1554917961	NC_000011.10:5226750:C:T
NM_000518.5(HBB):c.140G>A (p.Gly47Glu)	HBB|LOC106099062|LOC107133510	G46E, G47E	HEMOGLOBIN K (IBADAN)	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015232	11	5247982	11	5226752	15232	30271	rs35303218	NC_000011.10:5226751:C:T
NM_000518.5(HBB):c.139G>A (p.Gly47Arg)	HBB|LOC106099062|LOC107133510	G46R, G47R	HEMOGLOBIN GAINESVILLE-GA	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015180	11	5247983	11	5226753	15180	30219	rs34743882	NC_000011.10:5226752:C:T
NM_000518.4(HBB):c.137T>G (p.Phe46Cys)	HBB|LOC106099062|LOC107133510	F45C, F46C	HEMOGLOBIN ARTA	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015546	11	5247985	11	5226755	15546	30585	rs33978338	NC_000011.10:5226754:A:C
NM_000518.4(HBB):c.137T>C (p.Phe46Ser)	LOC107133510|HBB|LOC106099062	F46S	not provided|HEMOGLOBIN CHEVERLY	Likely pathogenic(Last reviewed: Jul 30, 2017)	criteria provided, single submitter	VCV000015135	11	5247985	11	5226755	15135	30174	rs33978338	NC_000011.10:5226754:A:G
NM_000518.5(HBB):c.134C>G (p.Ser45Cys)	HBB|LOC106099062|LOC107133510	S44C, S45C	not specified	Pathogenic(Last reviewed: Nov 1, 1974)	no assertion criteria provided	VCV000015267	11	5247988	11	5226758	15267	30306	rs34868397	NC_000011.10:5226757:G:C
NM_000518.5(HBB):c.131A>G (p.Glu44Gly)	HBB|LOC106099062|LOC107133510	E44G	not provided	Uncertain significance(Last reviewed: Sep 14, 2017)	criteria provided, single submitter	VCV000619853	11	5247991	11	5226761	619853	611100	rs35262412	NC_000011.10:5226760:T:C
NM_000518.5(HBB):c.131A>C (p.Glu44Ala)	HBB|LOC106099062|LOC107133510	E44A	not specified|HEMOGLOBIN G (GALVESTON)|HEMOGLOBIN G (PORT ARTHUR)|HEMOGLOBIN G (TEXAS)	Likely benign(Last reviewed: Mar 18, 2019)	criteria provided, single submitter	VCV000015173	11	5247991	11	5226761	15173	30212	rs35262412	NC_000011.10:5226760:T:G
NM_000518.5(HBB):c.130G>T (p.Glu44Ter)	HBB|LOC106099062|LOC107133510	E44*	not provided|beta Thalassemia|beta^0^ Thalassemia|Hemoglobinopathy|Hb SS disease	Pathogenic(Last reviewed: Oct 7, 2019)	criteria provided, multiple submitters, no conflicts	VCV000015406	11	5247992	11	5226762	15406	30445	rs33922842	NC_000011.10:5226761:C:A
NM_000518.4(HBB):c.130G>C (p.Glu44Gln)	HBB|LOC106099062|LOC107133510	E43Q, E44Q	not specified	Benign(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015203	11	5247992	11	5226762	15203	30242	rs33922842	NC_000011.10:5226761:C:G
NM_000518.5(HBB):c.129T>C (p.Phe43=)	HBB|LOC106099062|LOC107133510		not specified	Likely benign(Last reviewed: Aug 28, 2019)	criteria provided, single submitter	VCV000495974	11	5247993	11	5226763	495974	487547	rs1554917971	NC_000011.10:5226762:A:G
NM_000518.5(HBB):c.128T>C (p.Phe43Ser)	HBB|LOC106099062|LOC107133510	F43S	not provided|HEMOGLOBIN CHIBA|HEMOGLOBIN HAMMERSMITH|Heinz body anemia	Pathogenic(Last reviewed: Dec 15, 2017)	criteria provided, single submitter	VCV000015190	11	5247994	11	5226764	15190	30229	rs34378160	NC_000011.10:5226763:A:G
NM_000518.4(HBB):c.127T>G (p.Phe43Val)	HBB|LOC106099062|LOC107133510	F43V	Hemolytic anemia	Pathogenic(Last reviewed: Jul 1, 1990)	no assertion criteria provided	VCV000015347	11	5247995	11	5226765	15347	30386	rs33924146	NC_000011.10:5226764:A:C
NM_000518.5(HBB):c.127T>C (p.Phe43Leu)	HBB|LOC106099062|LOC107133510	F42L, F43L	Hemolytic anemia	Pathogenic(Last reviewed: Jan 1, 1989)	no assertion criteria provided	VCV000015251	11	5247995	11	5226765	15251	30290	rs33924146	NC_000011.10:5226764:A:G
NM_000518.4(HBB):c.125T>G (p.Phe42Cys)	HBB|LOC106099062|LOC107133510	F41C, F42C	HEMOGLOBIN ILMENAU	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015598	11	5247997	11	5226767	15598	30637	rs33926796	NC_000011.10:5226766:A:C
NM_000518.4(HBB):c.125T>C (p.Phe42Ser)	HBB|LOC106099062|LOC107133510	F41S, F42S	not provided|HEMOGLOBIN DENVER	Uncertain significance(Last reviewed: Jan 20, 2017)	criteria provided, single submitter	VCV000015530	11	5247997	11	5226767	15530	30569	rs33926796	NC_000011.10:5226766:A:G
NM_000518.4(HBB):c.125T>A (p.Phe42Tyr)	HBB|LOC106099062|LOC107133510	F41Y, F42Y	HEMOGLOBIN MEQUON	other(Last reviewed: Jul 20, 2016)	no assertion criteria provided	VCV000015264	11	5247997	11	5226767	15264	30303	rs33926796	NC_000011.10:5226766:A:T
NM_000518.5(HBB):c.123G>T (p.Arg41Ser)	HBB|LOC106099062|LOC107133510	R41S	not specified	Uncertain significance(Last reviewed: May 20, 2019)	criteria provided, multiple submitters, no conflicts	VCV000439134	11	5247999	11	5226769	439134	432692	rs33918778	NC_000011.10:5226768:C:A
NM_000518.5(HBB):c.123G>C (p.Arg41Ser)	HBB|LOC106099062|LOC107133510	R40S, R41S	HEMOGLOBIN AUSTIN	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015102	11	5247999	11	5226769	15102	30141	rs33918778	NC_000011.10:5226768:C:G
NM_000518.5(HBB):c.122G>A (p.Arg41Lys)	HBB|LOC106099062|LOC107133510	R41K	not specified|not provided|HEMOGLOBIN ATHENS-GEORGIA	Conflicting interpretations of pathogenicity(Last reviewed: Aug 28, 2018)	criteria provided, conflicting interpretations	VCV000015099	11	5248000	11	5226770	15099	30138	rs34831026	NC_000011.10:5226769:C:T
NM_000518.5(HBB):c.120G>C (p.Gln40His)	HBB|LOC106099062|LOC107133510	Q40H	not provided	Uncertain significance(Last reviewed: Nov 18, 2018)	criteria provided, single submitter	VCV000801183	11	5248002	11	5226772	801183	789500	rs34663314	NC_000011.10:5226771:C:G
NM_000518.5(HBB):c.119A>G (p.Gln40Arg)	HBB|LOC106099062|LOC107133510	Q39R, Q40R	HEMOGLOBIN TIANSHUI	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015372	11	5248003	11	5226773	15372	30411	rs35973315	NC_000011.10:5226772:T:C
NM_000518.5(HBB):c.118C>A (p.Gln40Lys)	LOC107133510|HBB|LOC106099062	Q40K	not specified	Uncertain significance(Last reviewed: Oct 8, 2018)	criteria provided, single submitter	VCV000811501	11	5248004	11	5226774	811501	799653	rs11549407	NC_000011.10:5226773:G:T
NM_000518.5(HBB):c.118C>T (p.Gln40Ter)	HBB|LOC106099062|LOC107133510	Q40*	alpha Thalassemia|Susceptibility to malaria|Erythrocytosis 6, familial|Heinz body anemia|Methemoglobinemia, beta-globin type|Fetal hemoglobin quantitative trait locus 1|beta Thalassemia|Beta-thalassemia, dominant inclusion body type|Hb SS disease|Thoracic scoliosis|Hypoplasia of the ulna|Abnormality of the hand|Anemia|Splenomegaly|Microcytic anemia|not specified|Hb SS disease|beta Thalassemia|beta^0^ Thalassemia|not provided	Pathogenic(Last reviewed: Dec 24, 2019)	criteria provided, multiple submitters, no conflicts	VCV000015402	11	5248004	11	5226774	15402	30441	rs11549407	NC_000011.10:5226773:G:A
NM_000518.5(HBB):c.117C>T (p.Thr39=)	HBB|LOC106099062|LOC107133510		not specified	Likely benign(Last reviewed: Nov 4, 2019)	criteria provided, single submitter	VCV000928759	11	5248005	11	5226775	928759	917088		NC_000011.10:5226774:G:A
NM_000518.5(HBB):c.116C>T (p.Thr39Ile)	HBB|LOC106099062|LOC107133510	T38I, T39I	HEMOGLOBIN LA CORUNA	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015622	11	5248006	11	5226776	15622	30661	rs34703513	NC_000011.10:5226775:G:A
NM_000518.5(HBB):c.116C>A (p.Thr39Asn)	HBB|LOC106099062|LOC107133510	T38N, T39N	HEMOGLOBIN HINWIL	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015549	11	5248006	11	5226776	15549	30588	rs34703513	NC_000011.10:5226775:G:T
NM_000518.5(HBB):c.115A>C (p.Thr39Pro)	HBB|LOC106099062|LOC107133510	T38P, T39P	HEMOGLOBIN HAZEBROUCK	other(Last reviewed: Jul 20, 2016)	no assertion criteria provided	VCV000015191	11	5248007	11	5226777	15191	30230	rs34571024	NC_000011.10:5226776:T:G
NM_000518.5(HBB):c.114G>A (p.Trp38Ter)	HBB|LOC106099062|LOC107133510	W38*	not specified|beta Thalassemia|beta^0^ Thalassemia|Hemoglobinopathy|not provided	Pathogenic/Likely pathogenic(Last reviewed: Jun 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000015405	11	5248008	11	5226778	15405	30444	rs33974936	NC_000011.10:5226777:C:T
NM_000518.5(HBB):c.113G>A (p.Trp38Ter)	LOC107133510|HBB|LOC106099062	W38*	beta Thalassemia|not specified	Pathogenic(Last reviewed: Jan 24, 2017)	criteria provided, single submitter	VCV000439782	11	5248009	11	5226779	439782	433088	rs33991059	NC_000011.10:5226778:C:T
NM_000518.5(HBB):c.113G>C (p.Trp38Ser)	HBB|LOC106099062|LOC107133510	W37S, W38S	HEMOGLOBIN HIROSE	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015199	11	5248009	11	5226779	15199	30238	rs33991059	NC_000011.10:5226778:C:G
NM_000518.5(HBB):c.112T>G (p.Trp38Gly)	HBB|LOC106099062|LOC107133510	W37G, W38G	HEMOGLOBIN HOWICK	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015529	11	5248010	11	5226780	15529	30568	rs33994623	NC_000011.10:5226779:A:C
NM_000518.5(HBB):c.112T>A (p.Trp38Arg)	HBB|LOC106099062|LOC107133510	W37R, W38R	HEMOGLOBIN ROTHSCHILD	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015331	11	5248010	11	5226780	15331	30370	rs33994623	NC_000011.10:5226779:A:T
NM_000518.4(HBB):c.110C>A (p.Pro37His)	HBB|LOC106099062|LOC107133510	P36H, P37H	HEMOGLOBIN VILA REAL|Erythrocytosis 6, familial	Pathogenic(Last reviewed: Jan 14, 2020)	criteria provided, single submitter	VCV000015578	11	5248012	11	5226782	15578	30617	rs33993004	NC_000011.10:5226781:G:T
NM_000518.4(HBB):c.110C>G (p.Pro37Arg)	HBB|LOC106099062|LOC107133510	P36R, P37R	HEMOGLOBIN SUNNYBROOK	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015363	11	5248012	11	5226782	15363	30402	rs33993004	NC_000011.10:5226781:G:C
NM_000518.4(HBB):c.109C>G (p.Pro37Ala)	HBB|LOC106099062|LOC107133510	P36A, P37A	HEMOGLOBIN BRIE COMTE ROBERT	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015575	11	5248013	11	5226783	15575	30614	rs33948615	NC_000011.10:5226782:G:C
NM_000518.4(HBB):c.109C>T (p.Pro37Ser)	HBB|LOC106099062|LOC107133510	P36S, P37S	HEMOGLOBIN NORTH CHICAGO	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015289	11	5248013	11	5226783	15289	30328	rs33948615	NC_000011.10:5226782:G:A
NM_000518.4(HBB):c.109C>A (p.Pro37Thr)	HBB|LOC106099062|LOC107133510	P36T, P37T	HEMOGLOBIN LINKOPING|HEMOGLOBIN MEILAHTI	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015249	11	5248013	11	5226783	15249	30288	rs33948615	NC_000011.10:5226782:G:T
NM_000518.5(HBB):c.108C>G (p.Tyr36Ter)	HBB|LOC106099062|LOC107133510	Y36*	beta Thalassemia	Pathogenic(Last reviewed: Nov 25, 2019)	no assertion criteria provided	VCV000869263	11	5248014	11	5226784	869263	857491		NC_000011.10:5226783:G:C
NM_000518.5(HBB):c.108C>A (p.Tyr36Ter)	HBB|LOC106099062|LOC107133510	Y36*	beta Thalassemia|beta^0^ Thalassemia	Pathogenic(Last reviewed: Jul 31, 2019)	criteria provided, single submitter	VCV000015408	11	5248014	11	5226784	15408	30447	rs33982568	NC_000011.10:5226783:G:T
NM_000518.5(HBB):c.107A>G (p.Tyr36Cys)	HBB|LOC106099062|LOC107133510	Y36C	beta Thalassemia	Pathogenic(Last reviewed: Nov 25, 2019)	no assertion criteria provided	VCV000869262	11	5248015	11	5226785	869262	857492		NC_000011.10:5226784:T:C
NM_000518.5(HBB):c.107A>T (p.Tyr36Phe)	HBB|LOC106099062|LOC107133510	Y35F, Y36F	HEMOGLOBIN PHILLY	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015310	11	5248015	11	5226785	15310	30349	rs35857380	NC_000011.10:5226784:T:A
NM_000518.5(HBB):c.104T>A (p.Val35Asp)	HBB|LOC106099062|LOC107133510	V34D, V35D	HEMOGLOBIN SANTANDER	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015605	11	5248018	11	5226788	15605	30644	rs1135101	NC_000011.10:5226787:A:T
NM_000518.5(HBB):c.103G>T (p.Val35Phe)	LOC106099062|LOC107133510|HBB	V34F, V35F	Erythrocytosis|Erythrocytosis 6, familial	Pathogenic(Last reviewed: Aug 21, 1980)	no assertion criteria provided	VCV000015312	11	5248019	11	5226789	15312	30351	rs1141387	NC_000011.10:5226788:C:A
NM_000518.5(HBB):c.100G>A (p.Val34Met)	HBB|LOC106099062|LOC107133510	V34M	not specified|HEMOGLOBIN RIO CLARO	Uncertain significance(Last reviewed: Nov 27, 2017)	criteria provided, single submitter	VCV000015566	11	5248022	11	5226792	15566	30605	rs1141370	NC_000011.10:5226791:C:T
NM_000518.4(HBB):c.98T>A (p.Leu33Gln)	LOC107133510|HBB|LOC106099062	L33Q		no interpretation for the single variant	no interpretation for the single variant	VCV000478852	11	5248024	11	5226794	478852	30572	rs33948578	NC_000011.10:5226793:A:T
NM_000518.4(HBB):c.98T>C (p.Leu33Pro)	HBB|LOC106099062|LOC107133510	L33P	HEMOGLOBIN KOBE|HEMOGLOBIN PERTH|HEMOGLOBIN ABRAHAM LINCOLN	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015308	11	5248024	11	5226794	15308	30347	rs33948578	NC_000011.10:5226793:A:G
NM_000518.4(HBB):c.98T>G (p.Leu33Arg)	HBB|LOC106099062|LOC107133510	L32R, L33R	HEMOGLOBIN CASTILLA	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015132	11	5248024	11	5226794	15132	30171	rs33948578	NC_000011.10:5226793:A:C
NM_000518.5(HBB):c.95T>G (p.Leu32Arg)	HBB|LOC106099062|LOC107133510	L31R, L32R	HEMOGLOBIN HAKKARI	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015544	11	5248027	11	5226797	15544	30583	rs33920173	NC_000011.10:5226796:A:C
NM_000518.4(HBB):c.95T>C (p.Leu32Pro)	HBB|LOC106099062|LOC107133510	L32P	HEMOGLOBIN YOKOHAMA	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015394	11	5248027	11	5226797	15394	30433	rs33920173	NC_000011.10:5226796:A:G
NM_000518.5(HBB):c.94C>G (p.Leu32Val)	HBB|LOC106099062|LOC107133510	L32V	HEMOGLOBIN MUSCAT	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015509	11	5248028	11	5226798	15509	30548	rs33956555	NC_000011.10:5226797:G:C
NM_000518.5(HBB):c.93G>C (p.Arg31Ser)	HBB|LOC106099062|LOC107133510	R31S	beta Thalassemia	Pathogenic(Last reviewed: Nov 25, 2019)	no assertion criteria provided	VCV000869321	11	5248029	11	5226799	869321	857494		NC_000011.10:5226798:C:G
NM_000518.5(HBB):c.93G>T (p.Arg31Ser)	HBB|LOC106099062|LOC107133510	R30S, R31S	Heinz body anemia|not specified|not provided	Uncertain significance(Last reviewed: Nov 11, 2019)	criteria provided, multiple submitters, no conflicts	VCV000015368	11	5248029	11	5226799	15368	30407	rs1135071	NC_000011.10:5226798:C:A
NM_000518.5(HBB):c.93-1G>C	HBB|LOC106099062|LOC107133510		not provided|beta^0^ Thalassemia|beta Thalassemia	Pathogenic(Last reviewed: Mar 25, 2019)	criteria provided, multiple submitters, no conflicts	VCV000439166	11	5248030	11	5226800	439166	432694	rs33943001	NC_000011.10:5226799:C:G
NM_000518.5(HBB):c.93-1G>A	HBB|LOC106099062|LOC107133510		beta Thalassemia|not provided|beta^0^ Thalassemia	Pathogenic(Last reviewed: Jun 30, 2017)	criteria provided, multiple submitters, no conflicts	VCV000015446	11	5248030	11	5226800	15446	30485	rs33943001	NC_000011.10:5226799:C:T
NM_000518.5(HBB):c.93-2A>C	HBB|LOC106099062|LOC107133510		not provided|beta Thalassemia|Hemoglobinopathy	Pathogenic(Last reviewed: May 11, 2018)	criteria provided, multiple submitters, no conflicts	VCV000439167	11	5248031	11	5226801	439167	432695	rs63750513	NC_000011.10:5226800:T:G
NM_000518.5(HBB):c.93-2A>G	HBB|LOC106099062|LOC107133510		beta Thalassemia|beta^0^ Thalassemia	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000015562	11	5248031	11	5226801	15562	30601	rs63750513	NC_000011.10:5226800:T:C
NM_000518.5(HBB):c.93-3T>G	HBB|LOC106099062|LOC107133510		beta Thalassemia|Beta-plus-thalassemia	Pathogenic(Last reviewed: May 9, 2016)	criteria provided, single submitter	VCV000036341	11	5248032	11	5226802	36341	45005	rs34527846	NC_000011.10:5226801:A:C
NM_000518.5(HBB):c.93-6C>T	HBB|LOC106099062|LOC107133510		not provided	Uncertain significance(Last reviewed: Oct 11, 2016)	criteria provided, single submitter	VCV000496008	11	5248035	11	5226805	496008	487555	rs1554918048	NC_000011.10:5226804:G:A
NM_000518.5(HBB):c.93-14T>C	LOC106099062|LOC107133510|HBB		not provided	Uncertain significance(Last reviewed: Jun 11, 2018)	criteria provided, single submitter	VCV000619861	11	5248043	11	5226813	619861	611305	rs1428777319	NC_000011.10:5226812:A:G
NM_000518.5(HBB):c.93-15T>G	HBB|LOC106099062|LOC107133510		Hemoglobinopathy|beta^0^ Thalassemia|beta Thalassemia	Pathogenic/Likely pathogenic(Last reviewed: Dec 28, 2017)	criteria provided, multiple submitters, no conflicts	VCV000550356	11	5248044	11	5226814	550356	546666	rs35456885	NC_000011.10:5226813:A:C
NM_000518.5(HBB):c.93-15T>C	HBB|LOC106099062|LOC107133510		not specified	Likely benign	criteria provided, single submitter	VCV000256348	11	5248044	11	5226814	256348	254208	rs35456885	NC_000011.10:5226813:A:G
NM_000518.5(HBB):c.93-18C>T	HBB|LOC106099062|LOC107133510		not provided	Likely benign(Last reviewed: Dec 31, 2019)	criteria provided, single submitter	VCV000795005	11	5248047	11	5226817	795005	787776	rs777028217	NC_000011.10:5226816:G:A
NM_000518.5(HBB):c.93-21G>A	HBB|LOC106099062|LOC107133510		alpha Thalassemia|Susceptibility to malaria|Erythrocytosis 6, familial|Heinz body anemia|Methemoglobinemia, beta-globin type|Fetal hemoglobin quantitative trait locus 1|beta Thalassemia|Beta-thalassemia, dominant inclusion body type|Hb SS disease|Beta thalassemia major|not specified|not provided|beta Thalassemia|Beta-plus-thalassemia|Fetal hemoglobin quantitative trait locus 1|Hb SS disease	Pathogenic(Last reviewed: May 3, 2020)	criteria provided, multiple submitters, no conflicts	VCV000015454	11	5248050	11	5226820	15454	30493	rs35004220	NC_000011.10:5226819:C:T
NM_000518.5(HBB):c.93-23T>C	HBB|LOC106099062|LOC107133510		beta Thalassemia|not specified|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Dec 31, 2019)	criteria provided, conflicting interpretations	VCV000036340	11	5248052	11	5226822	36340	45004	rs111851677	NC_000011.10:5226821:A:G
NM_000518.5(HBB):c.93-24A>G	HBB|LOC106099062|LOC107133510		not provided	Uncertain significance(Last reviewed: Dec 26, 2016)	criteria provided, single submitter	VCV000496009	11	5248053	11	5226823	496009	487310	rs773687221	NC_000011.10:5226822:T:C
NM_000518.5(HBB):c.93-40C>T	HBB|LOC106099062|LOC107133510		not specified|not provided	Likely benign(Last reviewed: Dec 31, 2019)	criteria provided, multiple submitters, no conflicts	VCV000796462	11	5248069	11	5226839	796462	787779	rs556727592	NC_000011.10:5226838:G:A
NM_000518.5(HBB):c.92+47T>G	HBB|LOC106099062|LOC107133510		not provided	Benign(Last reviewed: Dec 31, 2019)	criteria provided, single submitter	VCV000751477	11	5248113	11	5226883	751477	775734	rs369341845	NC_000011.10:5226882:A:C
NM_000518.5(HBB):c.92+36C>A	HBB|LOC106099062|LOC107133510		not provided	Likely benign(Last reviewed: Dec 31, 2019)	criteria provided, single submitter	VCV000753822	11	5248124	11	5226894	753822	775854	rs776904725	NC_000011.10:5226893:G:T
NM_000518.5(HBB):c.92+13G>T	HBB|LOC106099062|LOC107133510		beta Thalassemia	Benign(Last reviewed: Nov 25, 2019)	no assertion criteria provided	VCV000869245	11	5248147	11	5226917	869245	857571		NC_000011.10:5226916:C:A
NM_000518.5(HBB):c.92+6T>A	LOC106099062|LOC107133510|HBB		not specified	Uncertain significance(Last reviewed: Sep 6, 2016)	criteria provided, single submitter	VCV000439165	11	5248154	11	5226924	439165	432696	rs35724775	NC_000011.10:5226923:A:T
NM_000518.5(HBB):c.92+6T>C	HBB|LOC106099062|LOC107133510		alpha Thalassemia|Susceptibility to malaria|Erythrocytosis 6, familial|Heinz body anemia|Methemoglobinemia, beta-globin type|Fetal hemoglobin quantitative trait locus 1|beta Thalassemia|Beta-thalassemia, dominant inclusion body type|Hb SS disease|Hb SS disease|not provided|not specified|beta Thalassemia|Hemoglobin E|Beta-plus-thalassemia|Fetal hemoglobin quantitative trait locus 1	Conflicting interpretations of pathogenicity(Last reviewed: Dec 24, 2019)	criteria provided, conflicting interpretations	VCV000015450	11	5248154	11	5226924	15450	30489	rs35724775	NC_000011.10:5226923:A:G
NM_000518.5(HBB):c.92+5G>A	HBB|LOC106099062|LOC107133510		not provided|beta Thalassemia|Beta-plus-thalassemia	Pathogenic/Likely pathogenic(Last reviewed: Apr 19, 2019)	criteria provided, multiple submitters, no conflicts	VCV000015449	11	5248155	11	5226925	15449	30488	rs33915217	NC_000011.10:5226924:C:T
NM_000518.5(HBB):c.92+5G>T	HBB|LOC106099062|LOC107133510		not provided|not specified|Beta thalassemia major|beta Thalassemia|Beta-plus-thalassemia	Pathogenic(Last reviewed: Aug 6, 2018)	criteria provided, multiple submitters, no conflicts	VCV000015448	11	5248155	11	5226925	15448	30487	rs33915217	NC_000011.10:5226924:C:A
NM_000518.5(HBB):c.92+5G>C	HBB|LOC106099062|LOC107133510		not provided|beta Thalassemia|alpha Thalassemia|Susceptibility to malaria|Erythrocytosis 6, familial|Heinz body anemia|Methemoglobinemia, beta-globin type|Fetal hemoglobin quantitative trait locus 1|beta Thalassemia|Beta-thalassemia, dominant inclusion body type|Hb SS disease|Hb SS disease|not specified|Beta-plus-thalassemia	Pathogenic(Last reviewed: Nov 18, 2019)	criteria provided, multiple submitters, no conflicts	VCV000015447	11	5248155	11	5226925	15447	30486	rs33915217	NC_000011.10:5226924:C:G
NM_000518.5(HBB):c.92+4G>A	HBB|LOC106099062|LOC107133510		not provided	Uncertain significance(Last reviewed: Nov 11, 2016)	criteria provided, single submitter	VCV000496007	11	5248156	11	5226926	496007	487449	rs1377832836	NC_000011.10:5226925:C:T
NM_000518.5(HBB):c.92+2T>G	HBB|LOC106099062|LOC107133510		not provided|beta^0^ Thalassemia|not specified|beta Thalassemia	Pathogenic(Last reviewed: Sep 14, 2020)	criteria provided, multiple submitters, no conflicts	VCV000619860	11	5248158	11	5226928	619860	611306	rs33956879	NC_000011.10:5226927:A:C
NM_000518.5(HBB):c.92+2T>A	HBB|LOC106099062|LOC107133510		beta^0^ Thalassemia|beta Thalassemia|not provided	Pathogenic(Last reviewed: May 6, 2019)	criteria provided, multiple submitters, no conflicts	VCV000038667	11	5248158	11	5226928	38667	47272	rs33956879	NC_000011.10:5226927:A:T
NM_000518.5(HBB):c.92+2T>C	HBB|LOC106099062|LOC107133510		not provided|beta Thalassemia|not specified	Pathogenic(Last reviewed: Sep 28, 2018)	criteria provided, multiple submitters, no conflicts	VCV000036334	11	5248158	11	5226928	36334	44998	rs33956879	NC_000011.10:5226927:A:G
NM_000518.5(HBB):c.92+1G>C	HBB|LOC106099062|LOC107133510		beta Thalassemia	Pathogenic(Last reviewed: Nov 25, 2019)	no assertion criteria provided	VCV000869246	11	5248159	11	5226929	869246	857572		NC_000011.10:5226928:C:G
NM_000518.5(HBB):c.92+1G>T	HBB|LOC106099062|LOC107133510		not specified|not provided|beta^0^ Thalassemia|beta Thalassemia|Hb SS disease	Pathogenic/Likely pathogenic(Last reviewed: Dec 23, 2019)	criteria provided, multiple submitters, no conflicts	VCV000015437	11	5248159	11	5226929	15437	30476	rs33971440	NC_000011.10:5226928:C:A
NM_000518.5(HBB):c.92+1G>A	HBB|LOC106099062|LOC107133510		not specified|alpha Thalassemia|Susceptibility to malaria|Erythrocytosis 6, familial|Heinz body anemia|Methemoglobinemia, beta-globin type|Fetal hemoglobin quantitative trait locus 1|beta Thalassemia|Beta-thalassemia, dominant inclusion body type|Hb SS disease|beta Thalassemia|not provided|beta^0^ Thalassemia|Hb SS disease	Pathogenic(Last reviewed: Dec 26, 2019)	criteria provided, multiple submitters, no conflicts	VCV000015436	11	5248159	11	5226929	15436	30475	rs33971440	NC_000011.10:5226928:C:T
NM_000518.5(HBB):c.92G>A (p.Arg31Lys)	HBB|LOC106099062|LOC107133510	R31K	beta Thalassemia|not provided	Likely pathogenic(Last reviewed: Dec 7, 2018)	criteria provided, multiple submitters, no conflicts	VCV000036337	11	5248160	11	5226930	36337	45001	rs33960103	NC_000011.10:5226929:C:T
NM_000518.4(HBB):c.92G>C (p.Arg31Thr)	HBB|LOC106099062|LOC107133510	R31T	not provided|beta Thalassemia|not specified|Hb SS disease	Pathogenic(Last reviewed: Nov 12, 2019)	criteria provided, multiple submitters, no conflicts	VCV000015234	11	5248160	11	5226930	15234	30273	rs33960103	NC_000011.10:5226929:C:G
NM_000518.5(HBB):c.91A>G (p.Arg31Gly)	HBB|LOC106099062|LOC107133510	R31G	beta Thalassemia	Pathogenic(Last reviewed: Nov 25, 2019)	no assertion criteria provided	VCV000869243	11	5248161	11	5226931	869243	857496		NC_000011.10:5226930:T:C
NM_000518.5(HBB):c.91A>C (p.Arg31=)	HBB|LOC106099062|LOC107133510		beta Thalassemia	Likely pathogenic(Last reviewed: Aug 30, 2018)	criteria provided, single submitter	VCV000590773	11	5248161	11	5226931	590773	581709	rs35684407	NC_000011.10:5226930:T:G
NM_000518.5(HBB):c.90C>A (p.Gly30=)	HBB|LOC106099062|LOC107133510		not provided	Likely benign(Last reviewed: Dec 12, 2018)	criteria provided, single submitter	VCV000748718	11	5248162	11	5226932	748718	752701	rs35578002	NC_000011.10:5226931:G:T
NM_000518.5(HBB):c.90C>T (p.Gly30=)	HBB|LOC106099062|LOC107133510		beta Thalassemia	Pathogenic(Last reviewed: Dec 7, 2016)	criteria provided, single submitter	VCV000038682	11	5248162	11	5226932	38682	47287	rs35578002	NC_000011.10:5226931:G:A
NM_000518.5(HBB):c.89G>A (p.Gly30Asp)	HBB|LOC106099062|LOC107133510	G29D, G30D	HEMOGLOBIN LUFKIN	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015252	11	5248163	11	5226933	15252	30291	rs35685286	NC_000011.10:5226932:C:T
NM_000518.5(HBB):c.88G>A (p.Gly30Ser)	HBB|LOC106099062|LOC107133510	G29S, G30S	HEMOGLOBIN TIZI-OUZOU	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015615	11	5248164	11	5226934	15615	30654	rs33974277	NC_000011.10:5226933:C:T
NM_000518.5(HBB):c.87G>C (p.Leu29=)	HBB|LOC106099062|LOC107133510		not specified	Likely benign(Last reviewed: Dec 16, 2019)	criteria provided, single submitter	VCV000928760	11	5248165	11	5226935	928760	917089		NC_000011.10:5226934:C:G
NM_000518.4(HBB):c.86T>G (p.Leu29Arg)	HBB|LOC106099062|LOC107133510	L28R, L29R	HEMOGLOBIN CHESTERFIELD	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015491	11	5248166	11	5226936	15491	30530	rs33916412	NC_000011.10:5226935:A:C
NM_000518.4(HBB):c.86T>A (p.Leu29Gln)	HBB|LOC106099062|LOC107133510	L28Q, L29Q	HEMOGLOBIN ST. LOUIS|Heinz body anemia	Pathogenic, other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015361	11	5248166	11	5226936	15361	30400	rs33916412	NC_000011.10:5226935:A:T
NM_000518.4(HBB):c.86T>C (p.Leu29Pro)	HBB|LOC106099062|LOC107133510	L28P, L29P	HEMOGLOBIN GENOVA|HEMOGLOBIN HYOGO	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015183	11	5248166	11	5226936	15183	30222	rs33916412	NC_000011.10:5226935:A:G
NM_000518.5(HBB):c.85C>T (p.Leu29=)	HBB|LOC106099062|LOC107133510		Fetal hemoglobin quantitative trait locus 1|not specified|Hemoglobin E|Hb SS disease|beta Thalassemia	Conflicting interpretations of pathogenicity(Last reviewed: Feb 14, 2020)	criteria provided, conflicting interpretations	VCV000879840	11	5248167	11	5226937	879840	868121		NC_000011.10:5226936:G:A
NM_000518.5(HBB):c.85C>A (p.Leu29Met)	HBB|LOC106099062|LOC107133510	L28M, L29M	HEMOGLOBIN CHILE	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015568	11	5248167	11	5226937	15568	30607	rs33958088	NC_000011.10:5226936:G:T
NM_000518.5(HBB):c.84C>T (p.Ala28=)	HBB|LOC106099062|LOC107133510		not specified|not provided	Likely benign(Last reviewed: Jul 10, 2019)	criteria provided, multiple submitters, no conflicts	VCV000439781	11	5248168	11	5226938	439781	433089	rs748296717	NC_000011.10:5226937:G:A
NM_000518.4(HBB):c.83C>A (p.Ala28Asp)	HBB|LOC106099062|LOC107133510	A27D, A28D	HEMOGLOBIN VOLGA|HEMOGLOBIN DRENTHE	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015386	11	5248169	11	5226939	15386	30425	rs33954632	NC_000011.10:5226938:G:T
NM_000518.4(HBB):c.83C>T (p.Ala28Val)	HBB|LOC106099062|LOC107133510	A27V, A28V	HEMOGLOBIN GRANGE-BLANCHE	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015184	11	5248169	11	5226939	15184	30223	rs33954632	NC_000011.10:5226938:G:A
NM_000518.5(HBB):c.82G>T (p.Ala28Ser)	HBB|LOC106099062|LOC107133510	A28S	not provided|beta Thalassemia|Hb SS disease|HEMOGLOBIN KNOSSOS|Beta-knossos-thalassemia|Beta-plus-thalassemia|Hemoglobinopathy	Pathogenic/Likely pathogenic(Last reviewed: Dec 18, 2018)	criteria provided, multiple submitters, no conflicts	VCV000015239	11	5248170	11	5226940	15239	30278	rs35424040	NC_000011.10:5226939:C:A
NM_000518.5(HBB):c.81G>C (p.Glu27Asp)	HBB|LOC106099062|LOC107133510	E27D	Hemoglobinopathy	Pathogenic(Last reviewed: Jan 1, 2018)	no assertion criteria provided	VCV000599394	11	5248171	11	5226941	599394	590730	rs281864581	NC_000011.10:5226940:C:G
NM_000518.4(HBB):c.80A>C (p.Glu27Ala)	HBB|LOC106099062|LOC107133510	E26A, E27A	HEMOGLOBIN TRIPOLI	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015614	11	5248172	11	5226942	15614	30653	rs33915112	NC_000011.10:5226941:T:G
NM_000518.4(HBB):c.80A>G (p.Glu27Gly)	HBB|LOC106099062|LOC107133510	E26G, E27G	Hb aubenas	Pathogenic(Last reviewed: May 1, 1996)	no assertion criteria provided	VCV000015554	11	5248172	11	5226942	15554	30593	rs33915112	NC_000011.10:5226941:T:C
NM_000518.4(HBB):c.80A>T (p.Glu27Val)	HBB|LOC106099062|LOC107133510	E26V, E27V	HEMOGLOBIN HENRI MONDOR	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015194	11	5248172	11	5226942	15194	30233	rs33915112	NC_000011.10:5226941:T:A
NM_000518.5(HBB):c.79G>T (p.Glu27Ter)	HBB|LOC106099062|LOC107133510	E27*	not provided|beta Thalassemia|Hemoglobinopathy	Pathogenic(Last reviewed: Jun 4, 2018)	criteria provided, multiple submitters, no conflicts	VCV000038650	11	5248173	11	5226943	38650	47255	rs33950507	NC_000011.10:5226942:C:A
NM_000518.5(HBB):c.79G>A (p.Glu27Lys)	HBB|LOC106099062|LOC107133510	E27K	not specified|Hb SS disease|beta Thalassemia|Hemoglobin E disease|not provided|Malaria, resistance to|Hemoglobin E/beta thalassemia disease|Hemoglobin E|Beta-plus-thalassemia|Anemia	Pathogenic(Last reviewed: Jan 2, 2020)	criteria provided, multiple submitters, no conflicts	VCV000015161	11	5248173	11	5226943	15161	30200	rs33950507	NC_000011.10:5226942:C:T
NM_000518.5(HBB):c.77G>A (p.Gly26Asp)	HBB|LOC106099062|LOC107133510	G26D	HEMOGLOBIN J (AUCKLAND)	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015212	11	5248175	11	5226945	15212	30251	rs35474880	NC_000011.10:5226944:C:T
NM_000518.4(HBB):c.76G>C (p.Gly26Arg)	HBB|LOC106099062|LOC107133510	G25R, G26R	HEMOGLOBIN G (TAIWAN-AMI)	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015179	11	5248176	11	5226946	15179	30218	rs34404985	NC_000011.10:5226945:C:G
NM_000518.5(HBB):c.75T>A (p.Gly25=)	HBB|LOC106099062|LOC107133510		not specified|Hb SS disease|beta Thalassemia|Beta-plus-thalassemia|not provided	Pathogenic/Likely pathogenic(Last reviewed: Dec 20, 2019)	criteria provided, multiple submitters, no conflicts	VCV000015459	11	5248177	11	5226947	15459	30498	rs33951465	NC_000011.10:5226946:A:T
NM_000518.4(HBB):c.74G>T (p.Gly25Val)	HBB|LOC106099062|LOC107133510	G24V, G25V	HEMOGLOBIN SAVANNAH	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015344	11	5248178	11	5226948	15344	30383	rs33968721	NC_000011.10:5226947:C:A
NM_000518.4(HBB):c.74G>A (p.Gly25Asp)	HBB|LOC106099062|LOC107133510	G24D, G25D	HEMOGLOBIN MOSCVA	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015275	11	5248178	11	5226948	15275	30314	rs33968721	NC_000011.10:5226947:C:T
NM_000518.5(HBB):c.73G>C (p.Gly25Arg)	HBB|LOC106099062|LOC107133510	G24R, G25R	HEMOGLOBIN RIVERDALE-BRONX	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015328	11	5248179	11	5226949	15328	30367	rs33972975	NC_000011.10:5226948:C:G
NM_000518.4(HBB):c.71T>C (p.Val24Ala)	HBB|LOC106099062|LOC107133510	V23A, V24A	HEMOGLOBIN ZOETERWOUDE	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015618	11	5248181	11	5226951	15618	30657	rs33945546	NC_000011.10:5226950:A:G
NM_000518.4(HBB):c.71T>A (p.Val24Asp)	HBB|LOC106099062|LOC107133510	V23D, V24D	not provided|HEMOGLOBIN STRASBOURG	Uncertain significance(Last reviewed: Nov 28, 2018)	criteria provided, single submitter	VCV000015358	11	5248181	11	5226951	15358	30397	rs33945546	NC_000011.10:5226950:A:T
NM_000518.4(HBB):c.71T>G (p.Val24Gly)	HBB|LOC106099062|LOC107133510	V23G, V24G	HEMOGLOBIN MIYASHIRO	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015270	11	5248181	11	5226951	15270	30309	rs33945546	NC_000011.10:5226950:A:C
NM_000518.5(HBB):c.70G>C (p.Val24Leu)	HBB|LOC106099062|LOC107133510	V24L	not provided	Uncertain significance(Last reviewed: Feb 27, 2017)	criteria provided, single submitter	VCV000496002	11	5248182	11	5226952	496002	487451	rs33929459	NC_000011.10:5226951:C:G
NM_000518.5(HBB):c.70G>A (p.Val24Ile)	HBB|LOC106099062|LOC107133510	V24I	Hemoglobinopathy	Pathogenic(Last reviewed: Jan 1, 2018)	no assertion criteria provided	VCV000478897	11	5248182	11	5226952	478897	38470	rs33929459	NC_000011.10:5226951:C:T
NM_000518.4(HBB):c.70G>T (p.Val24Phe)	HBB|LOC106099062|LOC107133510	V24F	Erythrocytosis 6, familial|HEMOGLOBIN PALMERSTON NORTH	Pathogenic, other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015306	11	5248182	11	5226952	15306	30345	rs33929459	NC_000011.10:5226951:C:A
NM_000518.4(HBB):c.68A>G (p.Glu23Gly)	HBB|LOC106099062|LOC107133510	E23G	not specified|HEMOGLOBIN G (TAIPEI)|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Dec 17, 2018)	criteria provided, conflicting interpretations	VCV000015178	11	5248184	11	5226954	15178	30217	rs33936254	NC_000011.10:5226953:T:C
NM_000518.4(HBB):c.68A>C (p.Glu23Ala)	HBB|LOC106099062|LOC107133510	E23A	not specified|not provided|HEMOGLOBIN G (HSIN-CHU)|HEMOGLOBIN G (TAEGU)|HEMOGLOBIN G (COUSHATTA)|HEMOGLOBIN G (SASKATOON)|beta Thalassemia	Conflicting interpretations of pathogenicity(Last reviewed: May 28, 2019)	criteria provided, conflicting interpretations	VCV000015171	11	5248184	11	5226954	15171	30210	rs33936254	NC_000011.10:5226953:T:G
NM_000518.4(HBB):c.68A>T (p.Glu23Val)	HBB|LOC106099062|LOC107133510	E22V, E23V	not provided|HEMOGLOBIN D (GRANADA)	Uncertain significance(Last reviewed: Jul 17, 2018)	criteria provided, single submitter	VCV000015149	11	5248184	11	5226954	15149	30188	rs33936254	NC_000011.10:5226953:T:A
NM_000518.5(HBB):c.67G>T (p.Glu23Ter)	HBB|LOC106099062|LOC107133510	E23*	beta Thalassemia	Pathogenic(Last reviewed: Nov 25, 2019)	no assertion criteria provided	VCV000869359	11	5248185	11	5226955	869359	857504		NC_000011.10:5226954:C:A
NM_000518.4(HBB):c.67G>A (p.Glu23Lys)	HBB|LOC106099062|LOC107133510	E23K	not provided|HEMOGLOBIN E (SASKATOON)	Uncertain significance(Last reviewed: Oct 4, 2017)	criteria provided, single submitter	VCV000015162	11	5248185	11	5226955	15162	30201	rs33959855	NC_000011.10:5226954:C:T
NM_000518.4(HBB):c.67G>C (p.Glu23Gln)	HBB|LOC106099062|LOC107133510	E23Q	not provided|HEMOGLOBIN D (IRAN)	Conflicting interpretations of pathogenicity(Last reviewed: Feb 18, 2018)	criteria provided, conflicting interpretations	VCV000015151	11	5248185	11	5226955	15151	30190	rs33959855	NC_000011.10:5226954:C:G
NM_000518.5(HBB):c.65A>G (p.Asp22Gly)	HBB|LOC106099062|LOC107133510	D21G, D22G	HEMOGLOBIN CONNECTICUT	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015142	11	5248187	11	5226957	15142	30181	rs33977536	NC_000011.10:5226956:T:C
NM_000518.4(HBB):c.64G>C (p.Asp22His)	HBB|LOC106099062|LOC107133510	D21H, D22H	HEMOGLOBIN KARLSKOGA	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015520	11	5248188	11	5226958	15520	30559	rs33950093	NC_000011.10:5226957:C:G
NM_000518.4(HBB):c.64G>T (p.Asp22Tyr)	HBB|LOC106099062|LOC107133510	D21Y, D22Y	HEMOGLOBIN YUSA|not provided	Likely benign(Last reviewed: Jan 25, 2018)	criteria provided, single submitter	VCV000015399	11	5248188	11	5226958	15399	30438	rs33950093	NC_000011.10:5226957:C:A
NM_000518.4(HBB):c.64G>A (p.Asp22Asn)	HBB|LOC106099062|LOC107133510	D21N, D22N	HEMOGLOBIN COCODY	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015140	11	5248188	11	5226958	15140	30179	rs33950093	NC_000011.10:5226957:C:T
NM_000518.5(HBB):c.62T>A (p.Val21Glu)	HBB|LOC106099062|LOC107133510	V20E, V21E	HEMOGLOBIN TROLLHAETTAN	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015539	11	5248190	11	5226960	15539	30578	rs33918474	NC_000011.10:5226959:A:T
NM_000518.5(HBB):c.61G>A (p.Val21Met)	HBB|LOC106099062|LOC107133510	V20M, V21M	HEMOGLOBIN OLYMPIA|not provided|Erythrocytosis 6, familial	Pathogenic(Last reviewed: Jun 22, 2018)	criteria provided, single submitter	VCV000015300	11	5248191	11	5226961	15300	30339	rs35890959	NC_000011.10:5226960:C:T
NM_000518.5(HBB):c.60C>A (p.Asn20Lys)	HBB|LOC106099062|LOC107133510	N19K, N20K	HEMOGLOBIN D (OULED RABAH)	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015153	11	5248192	11	5226962	15153	30192	rs63750840	NC_000011.10:5226961:G:T
NM_000518.5(HBB):c.59A>G (p.Asn20Ser)	HBB|LOC106099062|LOC107133510	N20S	not specified|beta Thalassemia|HEMOGLOBIN MALAY|Beta-malay-thalassemia|Beta-plus-thalassemia|not provided	Pathogenic(Last reviewed: May 2, 2019)	criteria provided, multiple submitters, no conflicts	VCV000015258	11	5248193	11	5226963	15258	30297	rs33972047	NC_000011.10:5226962:T:C
NM_000518.5(HBB):c.58A>G (p.Asn20Asp)	HBB|LOC106099062|LOC107133510	N19D, N20D	HEMOGLOBIN ALAMO	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015093	11	5248194	11	5226964	15093	30132	rs34866629	NC_000011.10:5226963:T:C
NM_000518.5(HBB):c.57G>A (p.Val19=)	HBB|LOC106099062|LOC107133510		not specified|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Aug 28, 2019)	criteria provided, conflicting interpretations	VCV000496001	11	5248195	11	5226965	496001	487559	rs1554918177	NC_000011.10:5226964:C:T
NM_000518.5(HBB):c.56T>G (p.Val19Gly)	HBB|LOC106099062|LOC107133510	V19G	not specified|not provided	Uncertain significance(Last reviewed: Jul 16, 2020)	criteria provided, multiple submitters, no conflicts	VCV000496000	11	5248196	11	5226966	496000	487512	rs35382661	NC_000011.10:5226965:A:C
NM_000518.5(HBB):c.55G>A (p.Val19Met)	HBB|LOC106099062|LOC107133510	V18M, V19M	HEMOGLOBIN BADEN	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015517	11	5248197	11	5226967	15517	30556	rs35802118	NC_000011.10:5226966:C:T
NM_000518.5(HBB):c.54G>C (p.Lys18Asn)	HBB|LOC106099062|LOC107133510	K17N, K18N	HEMOGLOBIN J (AMIENS)	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015210	11	5248198	11	5226968	15210	30249	rs36006214	NC_000011.10:5226967:C:G
NM_000518.5(HBB):c.52A>T (p.Lys18Ter)	HBB|LOC106099062|LOC107133510	K18*	alpha Thalassemia|Susceptibility to malaria|Erythrocytosis 6, familial|Heinz body anemia|Methemoglobinemia, beta-globin type|Fetal hemoglobin quantitative trait locus 1|beta Thalassemia|Beta-thalassemia, dominant inclusion body type|Hb SS disease|Hb SS disease|not specified|beta Thalassemia|beta^0^ Thalassemia|not provided	Pathogenic(Last reviewed: Jan 2, 2020)	criteria provided, multiple submitters, no conflicts	VCV000015401	11	5248200	11	5226970	15401	30440	rs33986703	NC_000011.10:5226969:T:A
NM_000518.5(HBB):c.51C>T (p.Gly17=)	HBB|LOC106099062|LOC107133510		not specified	Likely pathogenic(Last reviewed: Sep 25, 2018)	criteria provided, single submitter	VCV000811787	11	5248201	11	5226971	811787	799654	rs370075492	NC_000011.10:5226970:G:A
NM_000518.5(HBB):c.50G>A (p.Gly17Asp)	HBB|LOC106099062|LOC107133510	G17D	HEMOGLOBIN J (BALTIMORE)|not provided|not specified	Conflicting interpretations of pathogenicity(Last reviewed: Dec 7, 2018)	criteria provided, conflicting interpretations	VCV000015213	11	5248202	11	5226972	15213	30252	rs33962676	NC_000011.10:5226971:C:T
NM_000518.5(HBB):c.49G>C (p.Gly17Arg)	HBB|LOC106099062|LOC107133510	G16R, G17R	HEMOGLOBIN D (BUSHMAN)	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015148	11	5248203	11	5226973	15148	30187	rs63751285	NC_000011.10:5226972:C:G
NM_000518.5(HBB):c.48G>A (p.Trp16Ter)	HBB|LOC106099062|LOC107133510	W16*	not provided|beta Thalassemia	Pathogenic(Last reviewed: Dec 3, 2017)	criteria provided, multiple submitters, no conflicts	VCV000038646	11	5248204	11	5226974	38646	47251	rs34716011	NC_000011.10:5226973:C:T
NM_000518.5(HBB):c.47G>A (p.Trp16Ter)	HBB|LOC106099062|LOC107133510	W16*	not specified|beta Thalassemia|Hb SS disease|beta^0^ Thalassemia|not provided	Pathogenic(Last reviewed: Dec 19, 2019)	criteria provided, multiple submitters, no conflicts	VCV000015403	11	5248205	11	5226975	15403	30442	rs63750783	NC_000011.10:5226974:C:T
NM_000518.5(HBB):c.46T>G (p.Trp16Gly)	HBB|LOC106099062|LOC107133510	W15G, W16G	HEMOGLOBIN RANDWICK	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015324	11	5248206	11	5226976	15324	30363	rs33946157	NC_000011.10:5226975:A:C
NM_000518.5(HBB):c.46T>A (p.Trp16Arg)	HBB|LOC106099062|LOC107133510	W15R, W16R	HEMOGLOBIN BELFAST	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015107	11	5248206	11	5226976	15107	30146	rs33946157	NC_000011.10:5226975:A:T
NM_000518.5(HBB):c.45G>A (p.Leu15=)	HBB|LOC106099062|LOC107133510		not specified	Conflicting interpretations of pathogenicity(Last reviewed: Jun 5, 2018)	criteria provided, conflicting interpretations	VCV000440467	11	5248207	11	5226977	440467	432698	rs762782573	NC_000011.10:5226976:C:T
NM_000518.4(HBB):c.44T>G (p.Leu15Arg)	HBB|LOC106099062|LOC107133510	L14R, L15R	not specified|HEMOGLOBIN SOGN|not provided	Uncertain significance(Last reviewed: Jun 22, 2017)	criteria provided, multiple submitters, no conflicts	VCV000015355	11	5248208	11	5226978	15355	30394	rs33935445	NC_000011.10:5226977:A:C
NM_000518.4(HBB):c.44T>C (p.Leu15Pro)	HBB|LOC106099062|LOC107133510	L14P, L15P	not provided|HEMOGLOBIN SAKI	Uncertain significance(Last reviewed: Aug 15, 2019)	criteria provided, single submitter	VCV000015341	11	5248208	11	5226978	15341	30380	rs33935445	NC_000011.10:5226977:A:G
NM_000518.5(HBB):c.41C>T (p.Ala14Val)	HBB|LOC106099062|LOC107133510	A14V	not provided|not specified	Uncertain significance(Last reviewed: Mar 18, 2019)	criteria provided, multiple submitters, no conflicts	VCV000619858	11	5248211	11	5226981	619858	611101	rs35203747	NC_000011.10:5226980:G:A
NM_000518.5(HBB):c.41C>A (p.Ala14Asp)	HBB|LOC106099062|LOC107133510	A13D, A14D	HEMOGLOBIN J (LENS)	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015223	11	5248211	11	5226981	15223	30262	rs35203747	NC_000011.10:5226980:G:T
NM_000518.5(HBB):c.39T>C (p.Thr13=)	HBB|LOC106099062|LOC107133510		not specified	Likely benign(Last reviewed: Aug 28, 2019)	criteria provided, single submitter	VCV000495999	11	5248213	11	5226983	495999	487453	rs1554918207	NC_000011.10:5226982:A:G
NM_000518.5(HBB):c.35T>A (p.Val12Asp)	HBB|LOC106099062|LOC107133510	V11D, V12D	HEMOGLOBIN WINDSOR	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015389	11	5248217	11	5226987	15389	30428	rs35140348	NC_000011.10:5226986:A:T
NM_000518.4(HBB):c.[34G>A;364G>A]	LOC106099062|HBB|LOC107133510|LOC110006319	V12I, E122K	HEMOGLOBIN O (TIBESTI)	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000446746	11|11	5248218	11|11	5226988	446746	30228|30331	rs33974228|rs33946267	NC_000011.10:5226987:C:T|NC_000011.10:5225677:C:T
NM_000518.4(HBB):c.34G>T (p.Val12Phe)	HBB|LOC106099062|LOC107133510	V11F, V12F	HEMOGLOBIN WASHTENAW|not provided	Uncertain significance(Last reviewed: May 24, 2018)	criteria provided, single submitter	VCV000015535	11	5248218	11	5226988	15535	30574	rs33974228	NC_000011.10:5226987:C:A
NM_000518.4(HBB):c.34G>A (p.Val12Ile)	HBB|LOC106099062|LOC107133510	V12I	not provided|Hb SS disease|HEMOGLOBIN HAMILTON|Hemoglobin E|Fetal hemoglobin quantitative trait locus 1|beta Thalassemia	Uncertain significance(Last reviewed: Oct 3, 2018)	criteria provided, multiple submitters, no conflicts	VCV000015189	11	5248218	11	5226988	15189	30228	rs33974228	NC_000011.10:5226987:C:T
NM_000518.5(HBB):c.33C>T (p.Ala11=)	HBB|LOC106099062|LOC107133510		not specified	Likely benign(Last reviewed: Nov 30, 2016)	criteria provided, single submitter	VCV000439156	11	5248219	11	5226989	439156	432699	rs35799536	NC_000011.10:5226988:G:A
NM_000518.5(HBB):c.33C>A (p.Ala11=)	HBB|LOC106099062|LOC107133510		not provided	Conflicting interpretations of pathogenicity(Last reviewed: Dec 31, 2019)	criteria provided, conflicting interpretations	VCV000439155	11	5248219	11	5226989	439155	432700	rs35799536	NC_000011.10:5226988:G:T
NM_000518.4(HBB):c.32C>T (p.Ala11Val)	HBB|LOC106099062|LOC107133510	A10V, A11V	HEMOGLOBIN IRAQ-HALABJA	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015571	11	5248220	11	5226990	15571	30610	rs33947457	NC_000011.10:5226989:G:A
NM_000518.4(HBB):c.32C>A (p.Ala11Asp)	HBB|LOC106099062|LOC107133510	A10D, A11D	HEMOGLOBIN ANKARA	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015097	11	5248220	11	5226990	15097	30136	rs33947457	NC_000011.10:5226989:G:T
NM_000518.5(HBB):c.31G>A (p.Ala11Thr)	LOC107133510|HBB|LOC106099062	A11T	not specified	Likely benign(Last reviewed: Jan 12, 2017)	criteria provided, single submitter	VCV000439152	11	5248221	11	5226991	439152	432702	rs63750717	NC_000011.10:5226990:C:T
NM_000518.4(HBB):c.29C>A (p.Ser10Tyr)	HBB|LOC106099062|LOC107133510	S10Y	HEMOGLOBIN BREM-SUR-MER	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015619	11	5248223	11	5226993	15619	30658	rs33918131	NC_000011.10:5226992:G:T
NM_000518.4(HBB):c.29C>G (p.Ser10Cys)	LOC107133510|HBB|LOC106099062	S10C	HEMOGLOBIN PORTO ALEGRE|not provided|not specified	Likely benign(Last reviewed: Jul 10, 2019)	criteria provided, multiple submitters, no conflicts	VCV000015316	11	5248223	11	5226993	15316	30355	rs33918131	NC_000011.10:5226992:G:C
NM_000518.5(HBB):c.27G>C (p.Lys9Asn)	HBB|LOC106099062|LOC107133510	K8N, K9N	HEMOGLOBIN LIMASSOL	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015593	11	5248225	11	5226995	15593	30632	rs35198910	NC_000011.10:5226994:C:G
NM_000518.4(HBB):c.26A>G (p.Lys9Arg)	HBB|LOC106099062|LOC107133510	K8R, K9R	HEMOGLOBIN LUCKNOW	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015572	11	5248226	11	5226996	15572	30611	rs33932981	NC_000011.10:5226995:T:C
NM_000518.4(HBB):c.26A>T (p.Lys9Met)	HBB|LOC106099062|LOC107133510	K8M, K9M	HEMOGLOBIN NAKANO	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015548	11	5248226	11	5226996	15548	30587	rs33932981	NC_000011.10:5226995:T:A
NM_000518.4(HBB):c.26A>C (p.Lys9Thr)	HBB|LOC106099062|LOC107133510	K8T, K9T	HEMOGLOBIN RIO GRANDE	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015327	11	5248226	11	5226996	15327	30366	rs33932981	NC_000011.10:5226995:T:G
NM_000518.4(HBB):c.25A>G (p.Lys9Glu)	HBB|LOC106099062|LOC107133510	K8E, K9E	HEMOGLOBIN N (TIMONE)	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015281	11	5248227	11	5226997	15281	30320	rs33926764	NC_000011.10:5226996:T:C
NM_000518.4(HBB):c.25A>C (p.Lys9Gln)	HBB|LOC106099062|LOC107133510	K8Q, K9Q	HEMOGLOBIN J (LUHE)	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015225	11	5248227	11	5226997	15225	30264	rs33926764	NC_000011.10:5226996:T:G
NM_000518.4(HBB):c.23A>G (p.Glu8Gly)	HBB|LOC106099062|LOC107133510	E8G	not specified|not provided|HEMOGLOBIN G (SAN JOSE)	Conflicting interpretations of pathogenicity(Last reviewed: Sep 4, 2018)	criteria provided, conflicting interpretations	VCV000015176	11	5248229	11	5226999	15176	30215	rs34387455	NC_000011.10:5226998:T:C
NM_000518.5(HBB):c.22G>T (p.Glu8Ter)	HBB|LOC106099062|LOC107133510	E8*	beta Thalassemia	Pathogenic(Last reviewed: Nov 25, 2019)	no assertion criteria provided	VCV000869271	11	5248230	11	5227000	869271	857519		NC_000011.10:5226999:C:A
NM_000518.5(HBB):c.22G>A (p.Glu8Lys)	HBB|LOC106099062|LOC107133510	E8K	not specified	Pathogenic(Last reviewed: Nov 21, 1981)	no assertion criteria provided	VCV000015353	11	5248230	11	5227000	15353	30392	rs34948328	NC_000011.10:5226999:C:T
NM_000518.5(HBB):c.21G>A (p.Glu7=)	HBB|LOC106099062|LOC107133510		not specified	Likely benign(Last reviewed: Jun 5, 2020)	criteria provided, single submitter	VCV000933190	11	5248231	11	5227001	933190	921474		NC_000011.10:5227000:C:T
NM_000518.4(HBB):c.[205C>T;20A>T]	HBB|LOC106099062|LOC107133510	E7V, L69F	HEMOGLOBIN JAMAICA PLAIN	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000446748	11|11	5248232	11|11	5227002	446748	30372|30652	rs334|rs33961459	NC_000011.10:5227001:T:A|NC_000011.10:5226686:G:A
NM_000518.4(HBB):c.[20A>T;428C>T]	LOC106099062|HBB|LOC107133510|LOC110006319	E7V, A143V	HEMOGLOBIN S (TRAVIS)	Pathogenic(Last reviewed: Jan 1, 1992)	no assertion criteria provided	VCV000446738	11|11	5248232	11|11	5227002	446738	30372|38472	rs334|rs33921821	NC_000011.10:5227001:T:A|NC_000011.10:5225613:G:A
NM_000518.4(HBB):c.[20A>T;70G>A]	HBB|LOC106099062|LOC107133510	E7V, V24I	HEMOGLOBIN S (ANTILLES)	Pathogenic(Last reviewed: Jun 1, 1997)	no assertion criteria provided	VCV000446735	11|11	5248232	11|11	5227002	446735	30372|38470	rs334|rs33929459	NC_000011.10:5227001:T:A|NC_000011.10:5226951:C:T
NM_000518.4(HBB):c.[176C>G;20A>T]	HBB|LOC106099062|LOC107133510	E7V, P59R	HEMOGLOBIN ZIGUINCHOR	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000446731	11|11	5248232	11|11	5227002	446731	30372|30437	rs334|rs33991472	NC_000011.10:5227001:T:A|NC_000011.10:5226715:G:C
NM_000518.5(HBB):c.20A>T (p.Glu7Val)	HBB|LOC106099062|LOC107133510	E7V	Susceptibility to malaria|Heinz body anemia|Fetal hemoglobin quantitative trait locus 1|beta Thalassemia|Beta-thalassemia, dominant inclusion body type|Hb SS disease|Sickle cell disease and related diseases|not specified|Malaria, resistance to|not provided|beta Thalassemia|HEMOGLOBIN S|Hemoglobin E|Fetal hemoglobin quantitative trait locus 1|Inborn genetic diseases|Hb SS disease|Anemia	Conflicting interpretations of pathogenicity(Last reviewed: Jan 3, 2020)	criteria provided, conflicting interpretations	VCV000015333	11	5248232	11	5227002	15333	30372	rs334	NC_000011.10:5227001:T:A
NM_000518.4(HBB):c.20A>C (p.Glu7Ala)	HBB|LOC106099062|LOC107133510	E6A, E7A	HEMOGLOBIN G (MAKASSAR)	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015175	11	5248232	11	5227002	15175	30214	rs334	NC_000011.10:5227001:T:G
NM_000518.5(HBB):c.19G>T (p.Glu7Ter)	HBB|LOC106099062|LOC107133510	E7*	beta Thalassemia	Pathogenic(Last reviewed: Nov 25, 2019)	no assertion criteria provided	VCV000869230	11	5248233	11	5227003	869230	857520		NC_000011.10:5227002:C:A
NM_000518.4(HBB):c.[19G>A;286A>G]	HBB|LOC106099062|LOC107133510	E7K, K96E	HEMOGLOBIN ARLINGTON PARK	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000446729	11|11	5248233	11|11	5227003	446729	30165|30317	rs33930165|rs33914359	NC_000011.10:5227002:C:T|NC_000011.10:5226605:T:C
NM_000518.4(HBB):c.19G>C (p.Glu7Gln)	HBB|LOC106099062|LOC107133510	E6Q, E7Q	HEMOGLOBIN MACHIDA	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015243	11	5248233	11	5227003	15243	30282	rs33930165	NC_000011.10:5227002:C:G
NM_000518.4(HBB):c.19G>A (p.Glu7Lys)	HBB|LOC106099062|LOC107133510	E7K	not specified|not provided|beta Thalassemia|Malaria, resistance to|HEMOGLOBIN C|Hb SS disease	Pathogenic(Last reviewed: Dec 31, 2019)	criteria provided, multiple submitters, no conflicts	VCV000015126	11	5248233	11	5227003	15126	30165	rs33930165	NC_000011.10:5227002:C:T
NM_000518.5(HBB):c.17C>G (p.Pro6Arg)	HBB|LOC106099062|LOC107133510	P5R, P6R	HEMOGLOBIN WARWICKSHIRE	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015387	11	5248235	11	5227005	15387	30426	rs34769005	NC_000011.10:5227004:G:C
NM_000518.5(HBB):c.16C>T (p.Pro6Ser)	HBB|LOC106099062|LOC107133510	P6S	HEMOGLOBIN TYNE|not provided	Uncertain significance(Last reviewed: Apr 24, 2018)	criteria provided, multiple submitters, no conflicts	VCV000015540	11	5248236	11	5227006	15540	30579	rs33912272	NC_000011.10:5227005:G:A
NM_000518.5(HBB):c.12G>C (p.Leu4=)	HBB|LOC106099062|LOC107133510		not provided	Likely benign(Last reviewed: Nov 19, 2018)	criteria provided, single submitter	VCV000794722	11	5248240	11	5227010	794722	784026	rs1589893645	NC_000011.10:5227009:C:G
NM_000518.5(HBB):c.11T>A (p.Leu4Gln)	HBB|LOC106099062|LOC107133510	L4Q	not specified	Uncertain significance(Last reviewed: Mar 13, 2017)	criteria provided, single submitter	VCV000439132	11	5248241	11	5227011	439132	432703	rs63750720	NC_000011.10:5227010:A:T
NM_000518.5(HBB):c.10C>A (p.Leu4Met)	HBB|LOC106099062|LOC107133510	L4M	not specified	Uncertain significance(Last reviewed: Sep 6, 2017)	criteria provided, single submitter	VCV000632844	11	5248242	11	5227012	632844	621362	rs34126315	NC_000011.10:5227011:G:T
NM_000518.5(HBB):c.9T>C (p.His3=)	HBB|LOC106099062|LOC107133510		Fetal hemoglobin quantitative trait locus 1|Hemoglobin E|Hb SS disease|beta Thalassemia|not specified	Benign(Last reviewed: Jan 13, 2018)	criteria provided, multiple submitters, no conflicts	VCV000193106	11	5248243	11	5227013	193106	190271	rs713040	NC_000011.10:5227012:A:G
NM_000518.5(HBB):c.9T>A (p.His3Gln)	HBB|LOC106099062|LOC107133510	H2Q, H3Q	HEMOGLOBIN OKAYAMA	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015296	11	5248243	11	5227013	15296	30335	rs713040	NC_000011.10:5227012:A:T
NM_000518.4(HBB):c.8A>T (p.His3Leu)	HBB|LOC106099062|LOC107133510	H2L, H3L	HEMOGLOBIN GRAZ	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015518	11	5248244	11	5227014	15518	30557	rs33983205	NC_000011.10:5227013:T:A
NM_000518.5(HBB):c.8A>C (p.His3Pro)	HBB|LOC106099062|LOC107133510	H2P, H3P	not specified	Uncertain significance(Last reviewed: Nov 1, 2019)	criteria provided, single submitter	VCV000015261	11	5248244	11	5227014	15261	30300	rs33983205	NC_000011.10:5227013:T:G
NM_000518.4(HBB):c.8A>G (p.His3Arg)	HBB|LOC106099062|LOC107133510	H2R, H3R	HEMOGLOBIN DEER LODGE	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015156	11	5248244	11	5227014	15156	30195	rs33983205	NC_000011.10:5227013:T:C
NM_000518.5(HBB):c.7C>T (p.His3Tyr)	HBB|LOC106099062|LOC107133510	H2Y, H3Y	HEMOGLOBIN FUKUOKA	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015167	11	5248245	11	5227015	15167	30206	rs35906307	NC_000011.10:5227014:G:A
NM_000518.5(HBB):c.6G>A (p.Val2=)	HBB|LOC106099062|LOC107133510		not specified	Likely benign(Last reviewed: Aug 28, 2019)	criteria provided, single submitter	VCV000495994	11	5248246	11	5227016	495994	487517	rs1349384278	NC_000011.10:5227015:C:T
NM_000518.5(HBB):c.5T>G (p.Val2Gly)	HBB|LOC106099062|LOC107133510	V1G, V2G	HEMOGLOBIN WATFORD	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015587	11	5248247	11	5227017	15587	30626	rs33949930	NC_000011.10:5227016:A:C
NM_000518.5(HBB):c.5T>C (p.Val2Ala)	HBB|LOC106099062|LOC107133510	V2A	not specified|HEMOGLOBIN RALEIGH	Uncertain significance(Last reviewed: Dec 28, 2018)	criteria provided, multiple submitters, no conflicts	VCV000015323	11	5248247	11	5227017	15323	30362	rs33949930	NC_000011.10:5227016:A:G
NM_000518.5(HBB):c.5T>A (p.Val2Glu)	HBB|LOC106099062|LOC107133510	V1E, V2E	HEMOGLOBIN DOHA	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015159	11	5248247	11	5227017	15159	30198	rs33949930	NC_000011.10:5227016:A:T
NM_000518.5(HBB):c.4G>T (p.Val2Leu)	HBB|LOC106099062|LOC107133510	V1L, V2L	Hb niigata	Pathogenic(Last reviewed: Mar 1, 1997)	no assertion criteria provided	VCV000015558	11	5248248	11	5227018	15558	30597	rs33958358	NC_000011.10:5227017:C:A
NM_000518.5(HBB):c.4G>A (p.Val2Met)	HBB|LOC106099062|LOC107133510	V1M, V2M	HEMOGLOBIN SOUTH FLORIDA|not specified	Uncertain significance(Last reviewed: Apr 19, 2019)	criteria provided, multiple submitters, no conflicts	VCV000015359	11	5248248	11	5227018	15359	30398	rs33958358	NC_000011.10:5227017:C:T
NM_000518.5(HBB):c.3G>T (p.Met1Ile)	HBB|LOC106099062|LOC107133510	M1I	beta Thalassemia	Pathogenic(Last reviewed: Nov 25, 2019)	no assertion criteria provided	VCV000869316	11	5248249	11	5227019	869316	857526		NC_000011.10:5227018:C:A
NM_000518.5(HBB):c.3G>C (p.Met1Ile)	HBB|LOC106099062|LOC107133510	M1I	beta Thalassemia	Pathogenic(Last reviewed: Nov 25, 2019)	no assertion criteria provided	VCV000869315	11	5248249	11	5227019	869315	857527		NC_000011.10:5227018:C:G
NM_000518.5(HBB):c.3G>A (p.Met1Ile)	HBB|LOC106099062|LOC107133510	M1I	not specified|beta Thalassemia|not provided|beta^0^ Thalassemia	Pathogenic(Last reviewed: Feb 6, 2017)	criteria provided, multiple submitters, no conflicts	VCV000015519	11	5248249	11	5227019	15519	30558	rs33930702	NC_000011.10:5227018:C:T
NM_000518.5(HBB):c.2T>A (p.Met1Lys)	HBB|LOC106099062|LOC107133510	M1K	not provided|beta Thalassemia	Pathogenic/Likely pathogenic(Last reviewed: Feb 18, 2019)	criteria provided, multiple submitters, no conflicts	VCV000495986	11	5248250	11	5227020	495986	487518	rs33941849	NC_000011.10:5227019:A:T
NM_000518.5(HBB):c.2T>C (p.Met1Thr)	HBB|LOC106099062|LOC107133510	M1T	beta Thalassemia|beta^0^ Thalassemia|Beta-thalassemia, lermontov type|not provided|not specified	Pathogenic/Likely pathogenic(Last reviewed: Jul 10, 2017)	criteria provided, multiple submitters, no conflicts	VCV000036310	11	5248250	11	5227020	36310	44974	rs33941849	NC_000011.10:5227019:A:G
NM_000518.5(HBB):c.2T>G (p.Met1Arg)	HBB|LOC106099062|LOC107133510	M1R	not specified|Hb SS disease|beta Thalassemia|not provided|beta^0^ Thalassemia	Pathogenic(Last reviewed: Jul 14, 2020)	criteria provided, multiple submitters, no conflicts	VCV000015434	11	5248250	11	5227020	15434	30473	rs33941849	NC_000011.10:5227019:A:C
NM_000518.5(HBB):c.1A>C (p.Met1Leu)	HBB|LOC106099062|LOC107133510	M1L	beta Thalassemia	Pathogenic(Last reviewed: Nov 25, 2019)	no assertion criteria provided	VCV000869231	11	5248251	11	5227021	869231	857528		NC_000011.10:5227020:T:G
NM_000518.5(HBB):c.1A>G (p.Met1Val)	LOC106099062|LOC107133510|HBB	M1V	not provided|beta Thalassemia|Hemoglobinopathy	Pathogenic(Last reviewed: Feb 9, 2018)	criteria provided, multiple submitters, no conflicts	VCV000439140	11	5248251	11	5227021	439140	432704	rs34563000	NC_000011.10:5227020:T:C
NM_000518.5(HBB):c.-4C>T	LOC107133510|HBB|LOC106099062		not specified	Uncertain significance(Last reviewed: Mar 6, 2020)	criteria provided, single submitter	VCV000918087	11	5248255	11	5227025	918087	915038		NC_000011.10:5227024:G:A
NM_000518.5(HBB):c.-10A>G	HBB|LOC106099062|LOC107133510		not provided|not specified	Uncertain significance(Last reviewed: Mar 31, 2020)	criteria provided, multiple submitters, no conflicts	VCV000619852	11	5248261	11	5227031	619852	611102	rs747545656	NC_000011.10:5227030:T:C
NM_000518.5(HBB):c.-15C>A	HBB|LOC106099062|LOC107133510		beta Thalassemia	Uncertain significance(Last reviewed: Aug 18, 2011)	criteria provided, single submitter	VCV000036290	11	5248266	11	5227036	36290	44954	rs193922550	NC_000011.10:5227035:G:T
NM_000518.5(HBB):c.-18C>G	HBB|LOC106099062|LOC107133510		beta Thalassemia	Pathogenic(Last reviewed: Jul 29, 2019)	criteria provided, single submitter	VCV000393704	11	5248269	11	5227039	393704	380594	rs34135787	NC_000011.10:5227038:G:C
NM_000518.5(HBB):c.-21T>C	HBB|LOC106099062|LOC107133510		not specified	Uncertain significance(Last reviewed: Sep 11, 2020)	criteria provided, single submitter	VCV000981109	11	5248272	11	5227042	981109	969172		NC_000011.10:5227041:A:G
NM_000518.5(HBB):c.-23A>G	HBB|LOC106099062|LOC107133510		not provided	Uncertain significance(Last reviewed: Sep 6, 2016)	criteria provided, single submitter	VCV000495985	11	5248274	11	5227044	495985	487531	rs1010004981	NC_000011.10:5227043:T:C
NM_000518.5(HBB):c.-25T>C	HBB|LOC106099062|LOC107133510		beta Thalassemia	Uncertain significance	no assertion criteria provided	VCV000265987	11	5248276	11	5227046	265987	260797	rs886039874	NC_000011.10:5227045:A:G
NM_000518.5(HBB):c.-29G>A	HBB|LOC106099062|LOC107133510		Hemoglobinopathy|beta Thalassemia	Pathogenic(Last reviewed: May 30, 2018)	criteria provided, single submitter	VCV000393702	11	5248280	11	5227050	393702	380595	rs34704828	NC_000011.10:5227049:C:T
NM_000518.5(HBB):c.-31C>T	HBB|LOC106099062|LOC107133510		not provided|Fetal hemoglobin quantitative trait locus 1|beta Thalassemia|Hemoglobin E|Hb SS disease|not specified	Conflicting interpretations of pathogenicity(Last reviewed: Dec 5, 2018)	criteria provided, conflicting interpretations	VCV000036291	11	5248282	11	5227052	36291	44955	rs63750628	NC_000011.10:5227051:G:A
NM_000518.5(HBB):c.-35A>G	HBB|LOC106099062|LOC107133510		beta Thalassemia	Benign(Last reviewed: Nov 25, 2019)	no assertion criteria provided	VCV000869257	11	5248286	11	5227056	869257	857529		NC_000011.10:5227055:T:C
NM_000518.5(HBB):c.-50A>C	HBB|LOC106099062|LOC107133510		beta Thalassemia|not specified|not provided	Pathogenic/Likely pathogenic(Last reviewed: Mar 6, 2019)	criteria provided, multiple submitters, no conflicts	VCV000036292	11	5248301	11	5227071	36292	44956	rs34305195	NC_000011.10:5227070:T:G
NM_000518.5(HBB):c.-51T>C	HBB|LOC106099062|LOC107133510		not specified|not provided	Uncertain significance(Last reviewed: Sep 21, 2020)	criteria provided, multiple submitters, no conflicts	VCV000036293	11	5248302	11	5227072	36293	44957	rs386134236	NC_000011.10:5227071:A:G
NM_000518.4(HBB):c.-71G>A	HBB|LOC106099062|LOC107133510		not provided	Uncertain significance(Last reviewed: Jul 28, 2016)	criteria provided, single submitter	VCV000496003	11	5248322	11	5227092	496003	487454	rs1554918264	NC_000011.10:5227091:C:T
NM_000518.4(HBB):c.-73C>T	LOC107133510|HBB|LOC106099062		not provided	Uncertain significance(Last reviewed: Jan 20, 2016)	criteria provided, single submitter	VCV000496004	11	5248324	11	5227094	496004	487312	rs1554918265	NC_000011.10:5227093:G:A
NC_000011.10:g.5227096C>A	HBB|LOC106099062|LOC107133510		beta Thalassemia	Pathogenic(Last reviewed: Nov 25, 2019)	no assertion criteria provided	VCV000869256	11	5248326	11	5227096	869256	857530		NC_000011.10:5227095:C:A
NM_000518.5(HBB):c.-75G>A	HBB|LOC106099062|LOC107133510		not provided	Uncertain significance(Last reviewed: Mar 26, 2018)	criteria provided, single submitter	VCV000619859	11	5248326	11	5227096	619859	611307	rs63750400	NC_000011.10:5227095:C:T
NM_000518.5(HBB):c.-75G>C	HBB|LOC106099062|LOC107133510		not provided|beta Thalassemia|not specified	Conflicting interpretations of pathogenicity(Last reviewed: Jan 16, 2019)	criteria provided, conflicting interpretations	VCV000036294	11	5248326	11	5227096	36294	44958	rs63750400	NC_000011.10:5227095:C:G
NC_000011.10:g.5227097T>G	HBB|LOC106099062|LOC107133510		beta Thalassemia	Pathogenic(Last reviewed: Nov 25, 2019)	no assertion criteria provided	VCV000869286	11	5248327	11	5227097	869286	857531		NC_000011.10:5227096:T:G
NC_000011.10:g.5227098T>A	HBB|LOC106099062|LOC107133510		beta Thalassemia	Pathogenic(Last reviewed: Nov 25, 2019)	no assertion criteria provided	VCV000869287	11	5248328	11	5227098	869287	857532		NC_000011.10:5227097:T:A
NM_000518.5(HBB):c.-78A>G	HBB|LOC106099062|LOC107133510		not specified|beta Thalassemia|not provided|Beta-plus-thalassemia|Hb SS disease	Pathogenic/Likely pathogenic(Last reviewed: Dec 27, 2019)	criteria provided, multiple submitters, no conflicts	VCV000015471	11	5248329	11	5227099	15471	30510	rs33931746	NC_000011.10:5227098:T:C
NM_000518.5(HBB):c.-78A>C	HBB|LOC106099062|LOC107133510		not specified|not provided|Beta-plus-thalassemia|Hb SS disease|beta Thalassemia	Pathogenic(Last reviewed: Sep 16, 2019)	criteria provided, multiple submitters, no conflicts	VCV000015470	11	5248329	11	5227099	15470	30509	rs33931746	NC_000011.10:5227098:T:G
NC_000011.10:g.5227100T>G	HBB|LOC106099062|LOC107133510		beta Thalassemia	Pathogenic(Last reviewed: Nov 25, 2019)	no assertion criteria provided	VCV000869288	11	5248330	11	5227100	869288	857533		NC_000011.10:5227099:T:G
NM_000518.5(HBB):c.-79A>G	HBB|LOC106099062|LOC107133510		alpha Thalassemia|Susceptibility to malaria|Erythrocytosis 6, familial|Heinz body anemia|Methemoglobinemia, beta-globin type|Fetal hemoglobin quantitative trait locus 1|beta Thalassemia|Beta-thalassemia, dominant inclusion body type|Hb SS disease|beta Thalassemia|not provided|Beta-plus-thalassemia	Pathogenic(Last reviewed: Dec 12, 2019)	criteria provided, multiple submitters, no conflicts	VCV000015469	11	5248330	11	5227100	15469	30508	rs34598529	NC_000011.10:5227099:T:C
NC_000011.10:g.5227101A>G	HBB|LOC106099062|LOC107133510		Beta-plus-thalassemia|beta Thalassemia	Pathogenic(Last reviewed: Nov 25, 2019)	no assertion criteria provided	VCV000869290	11	5248331	11	5227101	869290	857535		NC_000011.10:5227100:A:G
NC_000011.10:g.5227101A>C	HBB|LOC106099062|LOC107133510		beta Thalassemia	Pathogenic(Last reviewed: Nov 25, 2019)	no assertion criteria provided	VCV000869289	11	5248331	11	5227101	869289	857534		NC_000011.10:5227100:A:C
NM_000518.5(HBB):c.-80T>A	HBB|LOC106099062|LOC107133510		not specified|beta Thalassemia|Beta-plus-thalassemia|not provided	Pathogenic/Likely pathogenic(Last reviewed: Dec 20, 2019)	criteria provided, multiple submitters, no conflicts	VCV000015467	11	5248331	11	5227101	15467	30506	rs33980857	NC_000011.10:5227100:A:T
NM_000518.5(HBB):c.-81A>G	HBB|LOC106099062|LOC107133510		Beta thalassemia intermedia|not provided|beta Thalassemia|Beta-plus-thalassemia	Pathogenic(Last reviewed: Aug 17, 2020)	criteria provided, multiple submitters, no conflicts	VCV000015466	11	5248332	11	5227102	15466	30505	rs33981098	NC_000011.10:5227101:T:C
NM_000518.4(HBB):c.-82C>T	LOC107133510|HBB|LOC106099062		not provided|beta Thalassemia|not specified	Conflicting interpretations of pathogenicity(Last reviewed: Mar 18, 2019)	criteria provided, conflicting interpretations	VCV000439163	11	5248333	11	5227103	439163	432705	rs34500389	NC_000011.10:5227102:G:A
NM_000518.5(HBB):c.-82C>A	HBB|LOC106099062|LOC107133510		beta Thalassemia|Beta-plus-thalassemia	Pathogenic(Last reviewed: Nov 25, 2019)	no assertion criteria provided	VCV000015492	11	5248333	11	5227103	15492	30531	rs34500389	NC_000011.10:5227102:G:T
NM_000518.4(HBB):c.-83G>T	HBB|LOC106099062|LOC107133510		not provided	Uncertain significance(Last reviewed: Jun 29, 2016)	criteria provided, single submitter	VCV000496006	11	5248334	11	5227104	496006	487536	rs1160543272	NC_000011.10:5227103:C:A
NC_000011.10:g.5227112T>G	HBB|LOC106099062|LOC107133510		beta Thalassemia|not provided	Uncertain significance(Last reviewed: Nov 8, 2018)	criteria provided, single submitter	VCV000801194	11	5248342	11	5227112	801194	789684	rs1589893790	NC_000011.10:5227111:T:G
NM_000518.5(HBB):c.-92C>T	HBB|LOC106099062|LOC107133510		not specified	Uncertain significance(Last reviewed: Feb 5, 2018)	criteria provided, single submitter	VCV000632842	11	5248343	11	5227113	632842	621819	rs397515291	NC_000011.10:5227112:G:A
NM_000518.5(HBB):c.-92C>G	HBB|LOC106099062|LOC107133510		beta Thalassemia|not provided|not specified	Conflicting interpretations of pathogenicity(Last reviewed: Jun 5, 2019)	criteria provided, conflicting interpretations	VCV000036298	11	5248343	11	5227113	36298	44962	rs397515291	NC_000011.10:5227112:G:C
NM_000518.4(HBB):c.-100G>A	HBB|LOC106099062|LOC107133510		not provided	Uncertain significance(Last reviewed: Aug 26, 2016)	criteria provided, multiple submitters, no conflicts	VCV000495972	11	5248351	11	5227121	495972	487561	rs281864524	NC_000011.10:5227120:C:T
NM_000518.4(HBB):c.-102G>T	HBB|LOC106099062|LOC107133510		not provided	Uncertain significance(Last reviewed: Jun 30, 2017)	criteria provided, single submitter	VCV000495973	11	5248353	11	5227123	495973	487313	rs1554918277	NC_000011.10:5227122:C:A
NM_000518.5(HBB):c.-106G>C	HBB|LOC106099062|LOC107133510		Hb SS disease|beta Thalassemia|not specified|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Sep 10, 2020)	criteria provided, conflicting interpretations	VCV000036281	11	5248357	11	5227127	36281	44945	rs63750681	NC_000011.10:5227126:C:G
NC_000011.10:g.5227142G>A	HBB|LOC106099062|LOC107133510		beta Thalassemia|not provided	Pathogenic/Likely pathogenic(Last reviewed: Jul 23, 2020)	criteria provided, multiple submitters, no conflicts	VCV000801184	11	5248372	11	5227142	801184	789685	rs281864518	NC_000011.10:5227141:G:A
NC_000011.10:g.5227143A>T	HBB|LOC106099062|LOC107133510		beta Thalassemia	Pathogenic(Last reviewed: Nov 25, 2019)	no assertion criteria provided	VCV000869326	11	5248373	11	5227143	869326	857537		NC_000011.10:5227142:A:T
NM_000518.4(HBB):c.-122T>G	HBB|LOC106099062|LOC107133510		not provided|not specified	Uncertain significance(Last reviewed: Sep 19, 2016)	criteria provided, multiple submitters, no conflicts	VCV000439133	11	5248373	11	5227143	439133	432706	rs1272414751	NC_000011.10:5227142:A:C
NC_000011.10:g.5227147G>T	HBB|LOC106099062|LOC107133510		beta Thalassemia	Pathogenic(Last reviewed: Nov 25, 2019)	no assertion criteria provided	VCV000869327	11	5248377	11	5227147	869327	857538		NC_000011.10:5227146:G:T
NM_000518.5(HBB):c.-133G>A	HBB|LOC106099062|LOC107133510		beta Thalassemia|not specified|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Sep 18, 2018)	criteria provided, conflicting interpretations	VCV000036282	11	5248384	11	5227154	36282	44946	rs72561473	NC_000011.10:5227153:C:T
NM_000518.5(HBB):c.-136C>T	HBB|LOC106099062|LOC107133510		beta Thalassemia	Likely pathogenic(Last reviewed: Aug 18, 2011)	criteria provided, single submitter	VCV000036284	11	5248387	11	5227157	36284	44948	rs33994806	NC_000011.10:5227156:G:A
NM_000518.5(HBB):c.-136C>G	HBB|LOC106099062|LOC107133510		beta Thalassemia|not provided|Beta-plus-thalassemia	Pathogenic(Last reviewed: Apr 20, 2017)	criteria provided, single submitter	VCV000015465	11	5248387	11	5227157	15465	30504	rs33994806	NC_000011.10:5227156:G:C
NM_000518.5(HBB):c.-137C>T	HBB|LOC106099062|LOC107133510		Hb SS disease|beta Thalassemia|Hemoglobinopathy|not specified	Pathogenic(Last reviewed: Jul 6, 2018)	criteria provided, multiple submitters, no conflicts	VCV000036287	11	5248388	11	5227158	36287	44951	rs33941377	NC_000011.10:5227157:G:A
NM_000518.5(HBB):c.-137C>A	HBB|LOC106099062|LOC107133510		beta Thalassemia|Susceptibility to malaria|Hb SS disease|Fetal hemoglobin quantitative trait locus 1|Erythrocytosis 6, familial|Methemoglobinemia, beta-globin type|Heinz body anemia|beta Thalassemia|Beta-thalassemia, dominant inclusion body type|alpha Thalassemia|not specified|Hemoglobinopathy|not provided	Pathogenic/Likely pathogenic(Last reviewed: Dec 28, 2018)	criteria provided, multiple submitters, no conflicts	VCV000036285	11	5248388	11	5227158	36285	44949	rs33941377	NC_000011.10:5227157:G:T
NM_000518.5(HBB):c.-137C>G	HBB|LOC106099062|LOC107133510		Beta thalassemia intermedia|not provided|beta Thalassemia|Beta-plus-thalassemia	Pathogenic/Likely pathogenic(Last reviewed: Dec 23, 2019)	criteria provided, multiple submitters, no conflicts	VCV000015464	11	5248388	11	5227158	15464	30503	rs33941377	NC_000011.10:5227157:G:C
NC_000011.10:g.5227159G>C	HBB|LOC106099062|LOC107133510		beta Thalassemia	Pathogenic(Last reviewed: Nov 25, 2019)	no assertion criteria provided	VCV000869328	11	5248389	11	5227159	869328	857539		NC_000011.10:5227158:G:C
NM_000518.5(HBB):c.-138C>A	LOC106099062|LOC107133510|HBB		beta Thalassemia|Hemoglobinopathy|not provided|Beta-plus-thalassemia|Fetal hemoglobin quantitative trait locus 1|Erythrocytosis 6, familial|Heinz body anemia|Hb SS disease|alpha Thalassemia|beta Thalassemia|Beta-thalassemia, dominant inclusion body type|Methemoglobinemia, beta-globin type|Susceptibility to malaria	Pathogenic/Likely pathogenic(Last reviewed: Nov 1, 2018)	criteria provided, multiple submitters, no conflicts	VCV000393701	11	5248389	11	5227159	393701	380597	rs33944208	NC_000011.10:5227158:G:T
NM_000518.5(HBB):c.-138C>T	HBB|LOC106099062|LOC107133510		not specified|beta Thalassemia|Beta-plus-thalassemia|Hemoglobinopathy|not provided	Pathogenic/Likely pathogenic(Last reviewed: Dec 23, 2019)	criteria provided, multiple submitters, no conflicts	VCV000015460	11	5248389	11	5227159	15460	30499	rs33944208	NC_000011.10:5227158:G:A
NM_000518.4(HBB):c.-140C>G	HBB|LOC106099062|LOC107133510		not specified|beta Thalassemia	Uncertain significance(Last reviewed: Mar 18, 2019)	criteria provided, single submitter	VCV000495975	11	5248391	11	5227161	495975	487562	rs34999973	NC_000011.10:5227160:G:C
NM_000518.5(HBB):c.-140C>T	HBB|LOC106099062|LOC107133510		not specified|Beta thalassemia intermedia|beta Thalassemia|not provided|Beta-plus-thalassemia	Pathogenic/Likely pathogenic(Last reviewed: Jan 16, 2019)	criteria provided, multiple submitters, no conflicts	VCV000015514	11	5248391	11	5227161	15514	30553	rs34999973	NC_000011.10:5227160:G:A
NM_000518.5(HBB):c.-142C>T	HBB|LOC106099062|LOC107133510		Beta thalassemia intermedia|beta Thalassemia|Beta-plus-thalassemia	Pathogenic(Last reviewed: Oct 14, 2019)	criteria provided, single submitter	VCV000015462	11	5248393	11	5227163	15462	30501	rs34883338	NC_000011.10:5227162:G:A
NM_000518.4(HBB):c.-150T>A	LOC107133510|HBB|LOC106099062		not provided	Uncertain significance(Last reviewed: Aug 30, 2016)	criteria provided, single submitter	VCV000495979	11	5248401	11	5227171	495979	487539	rs1448799110	NC_000011.10:5227170:A:T
NM_000518.5(HBB):c.-151C>T	HBB|LOC106099062|LOC107133510		beta Thalassemia|not provided|Beta-plus-thalassemia	Pathogenic(Last reviewed: Dec 31, 2019)	criteria provided, multiple submitters, no conflicts	VCV000015461	11	5248402	11	5227172	15461	30500	rs63751208	NC_000011.10:5227171:G:A
NC_000011.10:g.5227269T>C	HBB|LOC106099062|LOC107133510		not provided	Benign(Last reviewed: Dec 31, 2019)	criteria provided, single submitter	VCV000695665	11	5248499	11	5227269	695665	685290	rs76306358	NC_000011.10:5227268:T:C
NC_000011.10:g.5227294A>G	HBB|LOC106099062|LOC107133510		not provided	Benign(Last reviewed: Dec 31, 2019)	criteria provided, single submitter	VCV000695336	11	5248524	11	5227294	695336	685291	rs139703273	NC_000011.10:5227293:A:G
NC_000011.10:g.5227411G>A	HBB|LOC106099062|LOC107133510		beta Thalassemia	Benign(Last reviewed: Nov 25, 2019)	no assertion criteria provided	VCV000869329	11	5248641	11	5227411	869329	857540		NC_000011.10:5227410:G:A
NC_000011.10:g.5227540G>A	HBB|LOC106099062|LOC107133510		beta Thalassemia	Benign(Last reviewed: Nov 25, 2019)	no assertion criteria provided	VCV000869330	11	5248770	11	5227540	869330	857541		NC_000011.10:5227539:G:A
NM_000518.4:c.91+6T>C	HBB		beta Thalassemia	Pathogenic(Last reviewed: May 14, 2015)	no assertion criteria provided	VCV000393705					393705	380598		
HBB, -101C-G, PROMOTER	HBB		Beta-plus-thalassemia	Pathogenic(Last reviewed: Sep 1, 2004)	no assertion criteria provided	VCV000015586					15586	30625		
HBB, CAP, A-C	HBB		Beta-plus-thalassemia	Pathogenic(Last reviewed: Nov 26, 1987)	no assertion criteria provided	VCV000015477					15477	30516		
HBB, TYR145ASN-TO-ASP	HBB	Y145N	HEMOGLOBIN OSLER|HEMOGLOBIN NANCY|HEMOGLOBIN FORT GORDON|Erythrocytosis 6, familial	Pathogenic, other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015301					15301	30340		
